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ABSTRACT
Pantelopoulos, Alexandros, Ph.D, Department of Computer Science & Engineering, Wright State University, 2010.
Prognosis: A Wearable System for Health Monitoring of People at Risk.

Wearable Health Monitoring Systems (WHMS) have drawn a lot of attention
from the research community and the industry during the last decade. The development of such systems has been motivated mainly by increasing healthcare costs and by
the fact that the world population is ageing. In addition to that, R&D in WHMS has
been propelled by recent technological advances in miniature bio-sensing devices,
smart textiles, microelectronics and wireless communications techniques.
These portable health systems can comprise various types of small physiological sensors, which enable continuous monitoring of a variety of human vital signs and
other physiological parameters such as heart rate, respiration rate, body temperature,
blood pressure, perspiration, oxygen saturation, electrocardiogram (ECG), body posture and activity etc. As a result, and also due to their embedded transmission modules
and processing capabilities, wearable health monitoring systems can constitute lowcost and unobtrusive solutions for ubiquitous health, mental and activity status monitoring.
The majority of the currently developed WHMS research prototypes and
products provide the basic functionality of continuously logging and transmitting physiological data. However, WHMS have the potential of achieving early detection and
diagnosis of critical health changes that could enable prevention of health hazardous
episodes. To do that, they should be able to learn individual user baselines and also
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employ advanced information processing algorithms and diagnostics in order to discover problems autonomously and detect alarming health trends, and consequently,
inform medical professionals for further assistance.
In an effort to advance the capabilities of a wearable system towards these
goals, we focus in this dissertation on the development of a novel WHMS, called Prognosis. The developed prototype platform includes the following innovative features,
which constitute the main research contributions of this work: a) a novel and highly
accurate methodology for classifying ECG recordings on a resource constrained device
which is based on the Matching Pursuits algorithm and a Neural Network, b) a physiological data fusion scheme based on a fuzzy regular formal language model, whereby
the current state of the corresponding fuzzy Finite State Machine signifies the current
health state and context of the patient, c) the extension of the decision making methodology based on a modified Fuzzy Petri Net (FPN) model, d) the integration of a userlearning strategy based on a neural-fuzzy extension of the FPN, e) the incorporation of
a system-patient dialogue interaction in order to capture non-measurable patient
symptoms such as chest pain, dizziness, malaise etc and finally f) the prototyping of
the system based on a smart-phone that runs multi-threaded J2ME software for handling multiple simultaneous Bluetooth connections with off-the-shelf wireless biosensors.
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1.1

CHAPTER 1: INTRODUCTION
Health demographics and the need for advanced ITbased health management solutions
It is a fact that the global population is both growing and ageing [1], [2].

As a consequence of this demographic change there has also been a corresponding increase of chronic age-related diseases, such as congestive heart failure, dementia, sleep apnea, cancer, diabetes and chronic obstructive pulmonary disease [3], [4]. Furthermore, the total number of people suffering from
some type of disability (either life-long, or injury related or more commonly
related to chronic conditions) will continue to rise [5]. In addition to that, approximately 33% of persons over the age of 65 and 50% of persons over the age
of 85 experience a fall each year [6], [7]. For this population, health care costs
are increasing [8], quality of life and productivity are reclining and in many
cases family members serve as primary care assistants.
These issues along with the challenges of effectively managing and
treating postoperative rehabilitation patients, disabled people and persons
with special abilities, highlight the requirement for new and innovative ways
to deliver healthcare to patients. In response to that, information and communication technologies are expected to provide the means to realize personalized, low cost and citizen-centered healthcare solutions to address the pre1

viously stated challenges [8]. Moreover, as people are becoming more eager to
participate actively in their own health management [10] and as healthcare
providers are looking for ways to facilitate a distributed approach to delivering
their services rather than through conventional large centralized institutions, a
variety of health information networks is being developed. These networks
seek to link hospitals, healthcare professionals, care providers, laboratories and
ultimately people’s homes [11] in order to realize a closed-loop health monitoring, management and delivery system. Going even further, enabling real-time
physiological, activity and mental status monitoring can in many cases lead to
early detection and diagnosis of critical health changes, that are otherwise not
guaranteed to be observed during routine short-time check-up visits to doctors,
and could thus enable prevention of a variety of health hazards and risks [10],
while also saving billions of dollars annually [12].

1.2

Health monitoring devices and wearable systems
Health monitoring devices constitute the front-end components of the

health information network and are primary responsible for a) collecting physiological data from the patient/user and b) transmitting them securely and reliably to a remote monitoring location. Traditionally, ‚crude‛ and bulky monitoring devices have been employed to collect patient vital signs, for example
bedside Holter ECG monitors as the ones used in Intensive Care Units (ICU).
2

Obviously, devices of such size and cost, that also include several wires and
require the patient to be immobilized in order to acquire reliable measurements, are unsuitable when ubiquitous, unobtrusive, long-term and low-cost
health monitoring is desired.
As a result, personal health monitoring devices need due to the inherent
nature of their application to be of small size and weight and they have to be
portable and autonomous as well, e.g. they should ensure long-term operation
without supervision and without recharging. Recent advances in microelectronics, nanotechnology, miniaturized bio-sensors, wireless communication
techniques, low power computing, battery technologies and effective information processing have provided the means to realize wearable non-invasive systems that can monitor the wearer’s health condition continuously and in realtime [8], [11], [13], [14].
Wearable health monitoring systems (WHMS) may comprise various
types of miniature sensors, wearable or even implantable. Bio-sensors are capable of measuring significant physiological parameters like heart rate, blood
pressure, body and skin temperature, oxygen saturation, respiration rate, electrocardiogram etc. The acquired measurements are in turn communicated either via a wireless or a wired link to a central node, for example a Personal Digital Assistant (PDA), a smart-phone or even to a microcontroller board, which
may then in turn display the corresponding information on a user interface or
3

transmit the aggregated vital signs to a medical center server. Finally at the
health provider’s end, the medical personnel and supervising physicians can
have instant access to real-time physiological measurements and the medical
history of several in and out-of-hospital monitored patients by securely connecting to the medical center’s servers. This described scenario is graphically
illustrated in Fig. 1-1 for the case of one single patient using a WHMS. Fig. 1-1
also introduces the term Body Area Network (BAN), which is widely used
when referring to WHMS that employ bio-sensors with wireless communication capabilities.

Fig. 1-1. The health monitoring network structure
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Setting aside the required network infrastructure to realize the health
service paradigm that is presented in Fig. 1-1 and focusing mainly on the
WHMS or BAN side we can observe that a wearable medical system may encompass a wide variety of components: sensors, wearable materials, smart textiles, actuators, power supplies, wireless communication modules and links,
control and processing units, interface for the user, software and advanced algorithms for data extracting and decision making. In addition to that, wearable
systems for health monitoring need to satisfy certain strict medical criteria
while operating under several ergonomic constraints and significant hardware
resource limitations [14], [15], [16].
For example, wearable systems must ensure portability and unobtrusiveness to the user, which means that their form and weight factor should be
small, their on-body placement must not interfere with the user’s daily activities, the bio-sensors should not irritate the patient’s skin and also there
shouldn’t be any unwanted radiation or infection concerns. Technical limitations include hardware resource constraints, most importantly processor
speed, memory availability, data storage space and power supply. Furthermore, WHMS are expected to perform robustly in cases of high physiological
signal noise and of measurement artifacts due to patient movement and misplacement/bad contact of bio-sensors with the skin, in cases of low connectivi-
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ty, low battery etc. Finally, these personal portable systems must ensure patient
privacy by providing reliable and secure medical data transmission and access.
The above mentioned parameters of WHMS highlight the fact that designing such a system is a very challenging task since a lot of highly constraining and often conflicting requirements need to be taken into account by the system’s designers. Furthermore it is our point of view that there is no single ideal
design for such systems, but rather a trade-off between ‚antagonizing‛ parameters that need to be balanced based on the specific area of application [14].

1.3

The need for WHMS with embedded decision support
As described so far, WHMS can serve the purpose of continuously col-

lecting physiological measurements from the user and then storing the sensed
data locally or streaming them continuously to a remote location. However this
type of service on its own, while it still may provide a useful tool in the hands
of physicians and care givers, is not sufficient as a standalone function to address the issues mentioned in section 1.1. To illustrate this point, we can consider the case where a supervising physician logs in at a terminal in his office to
manually supervise the real-time readings and the physiological measurement
history of several patients, let us suppose ten patients, that he is directly responsible for. The doctor himself will have to tediously go through a large
amount of data for each patient to investigate the health status and health trend
6

of every individual, using up a lot of his time and subsequently costing a lot of
money to the patients themselves. Furthermore, what is most important is that
if a health hazard is to be identified and addressed in the moment of occurrence, the doctor or the caregiver needs to be manually supervising the collected data of each patient at any given moment. In addition to that, simple
physiological readings are unlikely to provide a complete picture of the overall
health status and context of any patient.
The previous discussion underlines the fact that wearable health monitoring devices need to be able to provide additional or context-aware information to physicians than just plain raw sensor readings. The measured vital parameters need to be combined with the wearer’s context and his activity level
to provide a more comprehensive picture of his/her overall physiological state
[8]. For example reporting sensor readings of high pulse rate does not itself
provide sufficient information to the care giver regarding the user’s health status. However, high pulse rate combined with indications of high activity or
low activity may indicate completely different and more specific health information and may call for different or even no actions from the care giver.
In addition to context-aware sensing capabilities, WHMS need to be
able to identify alarming changes in sensor measurements that could possibly
indicate a health hazard. In the simplest case, this refers to reporting values
that exceed predefined safety thresholds, e.g. systolic blood pressure values
7

over 140 mmHg or temperature readings over 100°F. However, even in this
case, different sensor readings may point to different health conditions according to the user’s context, his medical history and his individual physiology.
Furthermore, as the ultimate goal is to perform early identification or even
prevention of diseases and health episodes, it is made obvious that advanced
logic and intelligence is required in order for the WHMS to be able to identify
alarming trends in the health status of the user and also to be able to provide
patient-adapted alarms or even diagnoses.
The previous discussion presents the main motivation behind the research presented in this dissertation. Specifically, our goal is to establish an operational framework for multi-sensor WHMS that can support embedded and
patient-adaptive decision support, while at the same time being able to meaningfully interact with the patient by using an automated user-device dialogue
system.
The organization of the rest of the chapters in this dissertation is as follows: Chapter 2 presents a survey on wearable health monitoring systems,
where a wide variety of system implementations and approaches are being reviewed and discussed. In Chapter 3 we concentrate on the issue of ECG signal
processing on a resource constrained device and we examine methods for detecting unusable noise-corrupted recordings and denoising the rest of the signal. We will also present a robust, highly accurate and efficient methodology
8

for ECG beat classification. Chapter 4 will provide a detailed insight into the
organizational design and principles, the proposed physiological data fusion
strategy and into the operation model of the proposed WHMS framework,
which is termed ‚Prognosis‛. In Chapter 5, we will present an alternative representation of the knowledge-base and the decision making process in the
WHMS concept by employing a modified Fuzzy Petri Net model. This will be
proven useful for the Patient-learning approach proposed in Chapter 6, which
will be based on a neuro-fuzzy approach and will employ gradient descent methods in order to compute optimal parameters for decision making. Chapter 7
describes the interaction scheme between the patient and the device and discusses a developed simulation framework for our system. In Chapter 8, the
current implementation of the proposed system based on off-the-shelf components (smart-phone and Bluetooth-enabled bio-sensors) is described. Finally,
we will conclude with a discussion on the research contributions of this dissertation and also with a look into possible future research that could extend and
improve the results of this study.
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2

CHAPTER 2: A SURVEY ON WEARABLE HEALTH
MONITORING SYSTEMS
In this chapter a comprehensive survey on the current state-of-the-art in

research and development of wearable low-cost unobtrusive systems for
health-monitoring is presented. A variety of system implementations either for
general purpose or even for application specific health monitoring are reviewed in order to identify current technological achievements, potentials and
shortcomings as well.
Before beginning the review on the wide variety of WHMS prototypes
or commercial products that have been developed so far, a brief discussion on
available biosensors for wearable technologies and on wireless communication
techniques employed in wearable systems is provided.

2.1

Physiological Signals and Biosensors
In this subsection a list of several sensing technologies is provided,

which can be integrated as part of a wearable health-monitoring system, along
with their corresponding measured physiological signals. The measurement of
these vital bio-signals and their subsequent processing for feature extraction,
leads to a collection of real-time gathered physiological parameters, which can
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give an overall estimation of the user’s health condition at any given time. This
list can be seen in Table 2-1.

Table 2-1. Biosensors and Biosignals
Type of Bio-signal

Type of Sensor

Electrocardiogram
(ECG)

Skin/Chest electrodes

Blood pressure (systolic & diastolic)

Arm cuff-based monitor

Body and/or skin
temperature
Respiration rate

Temperature probe or skin
patch
Piezoelectric/piezoresistive
sensor

Description of measured data
Electrical activity of the heart (continuous
waveform showing the contraction and relaxation phases of the cardiac cycles)
Refers to the force exerted by circulating blood
on the walls of blood vessels, especially the
arteries
A measure of the body's ability to generate and
get rid of heat
Number of movements indicative of inspiration
and expiration per unit time (breathing rate)
Indicates the oxygenation or the amount of
oxygen that is being “carried” in a patient’s
blood

Oxygen saturation

Pulse Oximeter

Heart rate

Pulse Oximeter/skin electrodes

Frequency of the cardiac cycle

Perspiration (sweating) or skin conductivity

Galvanic Skin Response

Electrical conductance of the skin is associated
with the activity of the sweat glands

Heart sounds

Phonocardiograph

Blood glucose

Strip-base glucose meters

Electromyogram
(EMG)
Electroencephalogram
(EEG)
Body Movements

2.2

Skin electrodes
Scalp-placed electrodes
Accelerometer

A record of heart sounds, produced by a properly placed on the chest microphone (stethoscope)
Measurement of the amount of glucose (main
type/source of sugar/energy) in blood
Electrical activity of the skeletal muscles (characterizes the neuromuscular system)
Measurement of electrical spontaneous brain
activity and other brain potentials
Measurement of acceleration forces in the 3D
space

Wireless Communication Standards for WHMS
Transmission of measured data in the overall context of wearable

health-monitoring systems needs to be performed for two different purposes:
a) for communicating the collected physiological signals from the bio-sensors
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to the system’s central node and b) for sending the aggregated measurements
from the wearable system to a remote medical station or to a physician’s cell
phone.
Type a) transmission of data or else short-range transmission can be
handled either by wires or by multiple wireless links. In the former case, the
user’s mobility and comfortableness can be severely hindered by the use of
wires and moreover there is an increased risk of system failure [17]. A more
favorable approach to this matter is the use of conductive yarns to transmit the
measurements collected from sensors integrated on some type of flexible
smart-textile clothing [18]. Alternatively, in the latter case, autonomous sensor
nodes can form a Body Area Network (BAN) or Body Sensor Network (BSN),
usually in the basic configuration of a star topology, transmitting the data to
the BAN’s central node, which can be a Personal Digital Assistant (PDA), a
smart-phone, a pocket PC or a custom designed microcontroller-based device.
The most commonly employed wireless communication standards in
BAN’s are IEEE 802.15.1 (Bluetooth) [19] and 802.15.4 (widely referred to as
Zigbee [20], although Zigbee includes the specification of network, security and
application layers on top of the official standard). Other technologies for shortrange intra-BAN communication include Infrared (IrDA), the Medical Implant
Communication Service (MICS) [21] and Ultra-Wideband (UWB) [1]. Table 2-2
summarizes some of the basic technical specifications of these technologies.
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Existing standards fail to address the requirements of BANs, either due to security concerns [22] or interference problems [23] or due to form factor of
hardware modules or power consumption. As a response to these issues, the
802.15.6 IEEE Task Group [24] is planning the development of a communication standard optimized for low power devices and operation on, in or around
the human body. Furthermore the Bluetooth Special Interest Group (SIG) announced recently the addition of an alternative protocol stack, e.g. the Bluetooth low energy, an ultra-low power technology for devices with limited battery capacity allowing consumption of only a small fraction of the power of the
original Bluetooth products, which is targeting sports & wellness, and healthcare devices.

Table 2-2. Wireless Communication Standards
Range
(typical)

Data Rate
(max)
20kbps/
40kbps/
250kbps

Power
Cons.*

Cost per
chip

Frequency

30mW

$2

868MHz/ 915MHz/
2.4GHz

Zigbee

10-75m

Bluetooth

10-100m

1-3Mbps

2.5100mW

$3

2.4GHz

IrDA

1m

16Mbps

-

$2

Infrared

MICS

2m

500kbps

25μW

-

402-405 MHz

802.11g

200m

54Mbps

1W

$9

2.4GHz

*Power consumption refers to maximum consumed power when the chip is on and it is
sending/receiving.

Finally, regarding type b) data transmission or else long-range communication between the WHMS and a remote station or device, there is a wide variety of available wireless technologies that can serve that goal. Such technolo13

gies include WLAN, GSM, GPRS, UMTS and WiMAX, which can offer wide
coverage and ubiquitous network access. Furthermore, future advances in 4G
(fourth generation) mobile communication systems are expected to guarantee
worldwide seamless access to the Internet at much higher data-rates [25] and
thus to facilitate more efficiently the need for gathering real-time measurements from a wearable health-monitoring system at a remote location.

2.3

R&D in Wearable Health Monitoring Systems
In this section, several types of wearable health-monitoring systems are

discussed. Since during the last ten years there have been numerous research
efforts and products that can be classified as WHMS, in this review we attempt
to categorize them a) based on whether they are commercial products or research prototypes and b) based on their hardware configuration, e.g. BANbased, smart textile-based, microcontroller or custom hardware-based etc. Research efforts will be examined first, followed by a short review on commercially available systems.

2.3.1

Research Prototypes

2.3.1.1

Systems based on a microcontroller board or on custom designed platforms
Wearable systems that fall in this category are those that use some type

of microcontroller board as a physiological data-collecting platform and that
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are usually based on wired transmission of bio-signals from the sensors to the
processing board.
The Media Laboratory of MIT, Cambridge developed LiveNet, a flexible
distributed mobile platform aiming at long-term health monitoring applications with real-time data processing and streaming and context classification
[26]. LiveNet used a Linux-based PDA mobile device, a modular sensor hub
(SAK2) for gathering, processing and interpreting real-time contextual data
and an integrated physiological board (BioSense), which incorporates a 3D accelerometer, ECG, EMG and galvanic skin conductance sensors and which allows interfacing with a wide range of commercially available sensors. Furthermore, a 3-layer software architecture has been developed, which supports
communication between group-based applications, efficient distribution and
processing of higher bandwidth digital signals and the implementation of realtime context classifiers for wearable applications. Finally the MIT Wearable
Computing Group, in collaboration with several healthcare providers, has initiated various pilot studies using the LiveNet system, which include soldiers’
health monitoring in harsh environments, automated Parkinson symptom detection system, Epilepsy seizure detection and long-term behavioral modeling.
Overall, LiveNet targets real-time feature extraction and classification of medical conditions, as well as closed-loop medical feedback systems.
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AMON or the advanced care and alert portable telemedical monitor
was a project financed by the EU FP5 IST program [27]. It resulted in the development of a wrist-worn device, which is capable of measuring blood pressure,
skin temperature, blood oxygen saturation and a one lead ECG. In addition to
that it incorporated a two-axis accelerometer for correlating user activity with
the measured vital signs. The researchers designed also the GSM based secure
cellular communication link, as well as the software package for the telemedicine center, where the physicians could analyze the received data from the
wrist-worn device in greater detail. The AMON prototype was innovative in
that it included many miniaturized sensors all integrated through nonstandard
placement in a wrist-worn part and in that it also included evaluation software
for real-time processing and analysis of the measured vital signs. The development of the AMON wearable health monitoring device aimed at high-risk
cardiac/respiratory patients who would be confined to the hospital or their
homes.
After the processing of the raw data, a classification of normal, deviant,
risk, high risk or error was derived as an estimation of the patient’s health condition using specific limit values for each vital sign, taken from the World
Health Organization. According to the estimated condition, appropriate actions
were made from the device, like initialization of additional measurements for
validation/re-estimation, risk alarms, transmission of data to the medicine cen16

ter etc. Although the conducted validation study revealed problems regarding
the reliability of the measured data and the wearability of the device, the general idea of the device was very well received by the users.
Lin et al. [28] describe the development of a real-time wireless physiological monitoring system (RTWPMS), which is based on a digital, low-power
2nd generation cordless phone and a custom made medical examination module
measuring blood pressure, heart rate and temperature. A GPS module is also
incorporated and sensor interfacing is done through serial ports. System architecture includes also a wireless base station (handles physical transmission/reception of messages/ commands), a voice/data exchange device
(processes data and commands) and a network management center for overall
system control. Conducted tests with system in nursing centers and hospitals
validated its ability to transfer voice and data end-to-end at low error rates
from multiple sources simultaneously. However the wearable examination system is too bulky for ambulatory and continuous monitoring and the utilized RF
technology is out-dated as identified by the authors as well.
LifeGuard [29] is a multiparameter wearable physiological monitoring
system for space and terrestrial applications, whose core element is a crew
physiologic observation device (CPOD), which is capable of measuring two
ECG leads, respiration rate via impedance plethysmography, heart rate, oxygen saturation, body temperature, blood pressure and body movement. Typi17

cal off-the-shelf sensors are use for measuring most of the bio-signals, which
are interfaced through wired connections to CPOD data logger that can either
send the data via Bluetooth to a base-station or record them for 9h continuously on a memory card. The data logger is based on a PIC μC and uses 2 AAA
batteries. The authors conducted a series of verification and validation tests at
extreme environments and tested the ability of satellite transmission of collected data with the obtained results indicating acceptable accuracy for the collected data and real-time transmission of measurements to remote locations.
A prototype portable system capable of measuring phonocardiography
(PCG), electrocardiography and body temperature is described in [30]. The developed system consists of a capacitor-type microphone inserted on a stethoscope for PCG detection, a 3-lead ECG, a temperature sensor, a measuring
board including a CPU, a Bluetooth transceiver and an A/D module and a PDA
with an external memory unit. The functionality of the whole system is controlled by the PDA user by issuing commands to the measuring circuit. The
PDA’s insufficient computational power is said to enforce certain function limitations to the system in terms of PCG and ECG sampling rates. In addition to
that, the system consists of too many large sized external components and it is
too dependable on the end user (measurements are initiated from the PDA, not
automatically or event-driven), making it impractical and uncomfortable for
long-term unobtrusive monitoring of a patient’s vital signs.
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Finally, the development of a medical wearable device targeting braininjured children is described in [31]. The medical device is able to measure
blood oxygen saturation and heart rate through a finger-placed pulse oximeter,
respiration rate by using a piezoelectric sensor placed on a belt worn on the
chest and body movement by using a dual axis thermal accelerometer. The
measured data are stored into a multimedia card, which are in turn transmitted
at prescribed time intervals through Bluetooth to a home PC. From the home
PC the data are finally transmitted through an ADSL Internet connection (or
UMTS) to the Medical Service Center. The implemented system aims at detecting events such as nocturnal apnea, but has the disadvantage of low wearability due to the wired connections between the individual sensors and the wearable Bluetooth module, while no validation tests have been performed as in the
case of the previously discussed system.

2.3.1.2

Systems based on smart textiles
Systems in this category are based on a vest or T-shirt with bio-sensors

integrated on the garment.
The MyHeart project supported by the European Commission and involving 33 partners from 10 different countries, including industrial partners
such as Philips, Nokia, Vodafone and Medtronic, aimed at fighting cardiovascular diseases (CVD) by prevention and early diagnosis [32]. It adopted the use
of smart clothes, where the sensing modules are either garment-integrated or
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simply embedded on the piece of clothing [33], [34]. The underlying concept
relies on the use of tiny conductive wires knitted like normal textile yarns. In
that way the wearable system is very comfortable for the user, no wireless
modules are needed for the sensors and the whole system needs only one centralized on-body power supply, thus resulting in significant decrease of the
overall system’s size. One main device is used to control the on-garment bus
and is also responsible for the synchronization and the power supply for all the
on-body components. The developed textile-sensors include an ECG and an
activity sensor. An algorithm capable of classifying the activity into resting,
lying, walking, running and going up/downstairs has been implemented, with
very high accuracy. Finally the MyHeart project developed heart belts as well,
that could be worn across the chest or attached to a standard bra or to the
waistband of standard underwear [35].
The WEALTHY (Wearable Health Care System) project, part of the
fifth framework program of the European Commission and completed in 2005,
has developed a wearable garment, covering the whole upper body and worn
under normal clothing, capable of recording biomechanical variables and physiological signals [36]. The WEALTHY system targets clinical patients during
rehabilitation and other high-risk patients, such as elderly people, individuals
with chronic diseases and others. The sensor elements, which have been integrated in fabric form (using conducting and piezoresistive materials) on a tex20

tile structure [37], [38], are able to monitor a 3-lead ECG, EMG placed on the
arms, thoracic and abdominal respiration rate, body position and movement,
skin and core temperature. On demand measurements of blood pressure and
oxygen saturation can also be obtained. The wearable garment incorporates
also an analog and digital signal processing module with GPRS or Bluetooth
wireless transmission capabilities. Algorithms to remove artifacts introduced in
the measured signals by motion have also been implemented, along with the
ability to generate alert messages and synoptic patient tables.
MagIC [39], developed by researchers in Milan, Italy, is a washable sensorized vest including fully woven textile sensors for ECG and respiration rate
monitoring and a portable electronic board, which evaluates the wearer’s motion level and is responsible for signal preprocessing and data transmission
through Bluetooth to a local PC or PDA. The wearable system incorporates also
skin temperature sensors and it mostly aims at use from elderly people or cardiac patients for home monitoring, enabling however also ambulatory daily life
health monitoring. The data collected from the evaluation tests performed,
showed that the system achieves very good acquired signal quality (except in
the case of maximal physical activity) and that it is also able to correctly identify atrial fibrillation episodes and atrial and ventricular ectopic beats.
The MERMOTH (Medical Remote Monitoring of clothes) project, completed in 2006 and is also a European IST FP6 program and part of a wider
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group of six other European Projects in Smart Fabrics and Interactive Textiles
[40], has produced a low-cost, knitted, comfortable and stretchable sensing
garment [41]. The developed garment incorporates conductive and electrostrictive fabrics and yarns and dry electrodes, enabling the measurement of ECG,
respiratory inductance plethysmography, skin temperature and activity
through accelerometers. A PDA is connected to the microcontroller that is
used to interface with the sensors on the garment, providing an RF link to a
local PC for display and measurement interpretation.
Finally, researchers in [42] describe Smart Vest, a wearable physiological monitoring system that consists of a vest, which uses a variety of sensors
integrated on the garment’s fabric to simultaneously collect several bio-signals
in a non-invasive and unobtrusive manner. The parameters measured are ECG,
PPG, heart rate, blood pressure, body temperature and GSR. Furthermore it is
stated that the ECG can be recorded without the use of gel and that its recording is free of baseline noise and motion artifacts due to hardwareimplemented high-pass, low-pass and notch filters. Moreover, blood pressure
is calculated non-invasively via PPT, where the implemented detection algorithm is individually calibrated based on the user’s ECG. Provided results from
validation tests confirm to the most part the author’s claims regarding the accuracy of the measured physiological parameters. Furthermore, the sensors are

22

connected to a central processing unit, which is capable of correlating the acquired measurements to derive an overall picture of the wearer’s health.

2.3.1.3

Mote-based Body Area Networks
In this sub-section we take a look at WHMS that employ motes, e.g.

wirelessly enabled tiny nodes, to form a Body Area Network, where every
mote is responsible for collecting one or more types of physiological data and
transmitting them to a central node or base station. For a more detailed review
of BANs the reader should refer to [1].
In [43], the development of a prototyped wearable wireless body area
network (WWBAN) is described. The proposed system consists of common offthe-self wireless sensor platforms using ZigBee (IEEE 802.15.4) compliant transceivers and ultra low-power microcontrollers. Custom sensor platforms, that
perform data collection and preprocessing and that are equipped with accelerometers or bioamplifiers for ECG or EMG, have been developed and have
been integrated on the commercially available Telos platforms from Moteiv,
which use the event-driven TinyOS operating system. The lack of standardization in platforms, system software support and wireless communication for
WBANs is underlined and discussed throughout this study. Furthermore, as a
means of addressing the issue of limited power resources on the motes and extending their operational lifetime, the authors propose to perform on-board
advanced signal processing of the acquired bio-signals to reduce the wireless
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transmission duty cycle and thus the power consumption as well. However
limited computing resources, real-time signal processing requirements and limited memory space make this task even harder.
Researchers in Harvard University have developed CodeBlue [44], a
medical sensor network platform for multi-patient monitoring environments
based on the ZigBee compliant MicaZ and Telos motes, including custom designed biosensor boards for pulse oximetry, 3-lead ECG, EMG and motion activity. The Codeblue project also addressed issues of reliable communication
between medical sensors, multiple receivers (PDA’s carried by doctors and
nurses) and various high data rates. In that direction, a software framework
has been implemented, which provides protocols for device discovery, publish/subscribe multihop routing and a simple query interface allowing end users to dynamically request specific data from a specified network node. Besides
that, CodeBlue uses an RF-based localization system, to track the location of
patients and caregivers. The system was evaluated in a 30-node testbed in
terms of network metrics such as packet loss, fairness across multiple paths etc,
indicating that further work on reliable communication, bandwidth limitation
issues and security is needed.
A BAN based on the IEEE 802.15.4 protocol is presented in [45]. The
BAN follows a star topology and it is formed of two main types of devices: a)
Sensor communication modules (SCM), which are able to interface with both
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analog and digital sensors and b) a personal data processing unit (PDPU),
which is in charge of coordinating the BAN, controlling the communication
with all the SCMs as well as the communication with external networks (via
USB, Wi-Fi or GPRS). Synchronization in the BAN is handled via the protocolsupported beacon primitives, which are also used to carry commands about
sensor configuration parameters (sampling rate, gain etc), sensor activation/deactivation and data transmission. The SCMs are 802.15.4 compliant prototypes, designed as a four-layer PCB and the PDPU (powered by a Lithiumion rechargeable battery) is also a custom design, which includes an ARM
Thumb Processor, a GPRS modem, a Wi-Fi module, a Security Digital memory
card, a simple two line LCD display and a five-button based joystick. The
firmware of the PDPU is an embedded Linux OS. Employed biosensors include
a sensor recording arterial blood pressure, micro-electrodes for ECG measurement, position sensors and respiration sensors.
Chung et al [46] present a custom developed u-healthcare system,
which consists of custom 802.15.4 capable nodes that interface with ECG and
blood pressure sensors as well as with a basic cell-phone device for data display and signal feature extraction. The novelty of the projects consists in
transmitting only identified suspicious ECG and BP patterns to the hospital’s
server. This is done by first extracting simple ECG features (such as QRS duration, RR interval, R magnitude etc) and making a decision based on simple if25

then-else rules. In the same manner, blood pressure measurements extracted
from a wrist-sensor are transmitted as well in case they are found to be out of
range. In [47], Chung et al. present more details regarding the hardware of the
ubiquitous sensor nodes (USN), which are also extended to include accelerometers and SpO2 sensors.
Other research projects that utilize Zigbee motes for BANs include: a)
the BAN described in [48], where researchers have included ECG, PPG and
PCG sensors and have implemented a synchronous sampling mechanism for
data synchronization, b) WiMoCA [49], developed by researchers in Italy. A
star topology network is formed by sensor nodes with a palmtop PC functioning as a base station and which aims at posture recognition, gait pattern recognition and balance detection applications, c) Bi-FI [50], an embedded sensor/system architecture for wireless biosignal recording, employing ECG, EEG
and SpO2 sensors, where the main goal is to perform on-board DSP to remove
the bandwidth bottleneck imposed by the transceiver, d) BASUMA [51], which
uses sensors equipped with the ZigBee compliant Philips AquisGrain platform.
It aims at long-term monitoring of chronically ill patients and uses several custom non-invasive sensors for monitoring parameters such as ECG, air and
blood content of the thorax, body temperature, breathing rate and cough control, blood pressure, pulse rate and oxygen saturation, e) a body sensor network earpiece [52], which includes a pulse oximeter and a 3D accelerometer
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and which aims at monitoring postoperative recovery at home in patients undergoing abdominal surgery. The proposed device is based on the BSN node,
developed from the Department of Computing in Imperial College and it includes intelligent algorithm for recognizing the type and the intensity of the
user’s activity.
Besides Zigbee, other technologies have been utilized for BANs. For instance, in [53] the authors propose the use of intra-body communication for
exchanging information between wearable electronic sensors within a BAN. To
validate that claim, a prototype transmission system is constructed using aluminum electrodes powered by a 3V DC source and operating in the 10.7MHz
frequency modulation (FM) band. The communication module was interfaced
with a finger-tip pulse oximeter measuring heart rate and oxygen saturation in
blood and transmitted the sensed data over a distance of 30cm. The illustrated
results indicate acceptable communication quality, but probably insufficient
reliability for types of data requiring high accuracy and low distortion.
Yuce et al. [54] presented a recently developed wireless body sensor
network hardware, which uses the recently allocated MICS (Medical Implant
Communication Service) band. The system prototype consists of a pulse rate
and a temperature sensor, a Central Control Unit (CCU) and a receiver station
at a medical center. The developed system has overall very small size and cost
and can achieve very low power consumption. However, the latter is accom27

plished by keeping the sensor nodes in sleep node most of the time (one measurement every 5 or 10 min) and by using a polling approach to acquire the data.
Finally, Human++, a research project in the Netherlands, has developed
a body area network consisting of three sensor nodes and a base station [55].
Each sensor node is responsible for acquiring, amplifying, filtering, processing
and wirelessly transmitting multi-channel signals of ECG, EEG and EMG,
while the base station functions as a data collector in star topology, regulating
the information flow. The developed system is able to run autonomously for 3
months on two AA batteries. In addition to that, Belgium research centre IMEC
has developed a very promising prototype of a body-heat powered autonomous pulse oximeter [56], powered completely through a wrist-worn, watch-size,
thermoelectric generator which transforms the wearer’s body heat into electrical energy and uses, instead of a battery module, a super-capacitor for shorttime energy storage.

2.3.1.4

WHMS based on commercial Bluetooth sensors and cell-phones
The first example in this category is HealthGear from Microsoft [57].

The prototype released so far consists of a non-invasive blood oximeter, a sensing board providing the sampled oxygen saturation and heart rate signals, a
Bluetooth module for wireless transmission of the measured signals, AAA battery power supply and a cell phone to provide the user interface. This current
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exemplary application aimed at monitoring users during their sleep to detect
sleep apnea events. Two methods for the automated detection of sleep apnea
events are proposed. The first one works in the time domain and detects apnea
events after statistically evaluating threshold values for the oxygen saturation
level, while the second one works in the frequency domain trying to detect
peaks in a filtered periodogram of the oximetry signal.
The system was evaluated by twenty individuals and according to the
results, there were no technical problems and the system was completely successful in detecting mild and severe OSA. The users reported also that the wearability and the functionality of the whole system were good. However the
measurements taken were not compared with a polysomnograph for validating
the results.
HeartToGo [58] is a cell-phone-based wearable platform, capable of
continuously monitoring the user’s ECG signal via a wireless ECG sensor, of
analyzing the electrocardiogram in real time and possibly detecting any abnormal patterns pertaining to cardiovascular disease. The proposed system is
able to adapt to the individual user’s physiological conditions through the use
of artificial neural network – based machine learning schemes, which can possibly result in more accurate classification of ECG patterns.
Leijdekkers et al. [59] has developed a heart attack self-test application
implemented on a Personal Health Monitor system which includes a conven29

tional mobile phone and a Bluetooth enabled ECG sensor. The mobile phone
serves the function of analyzing the streaming data from the sensor in real-time
and transmitting them to a heart specialist. In the illustrated application, a
simple user interface on the phone is used to acquire feedback from the user
about his symptoms and in case the patient’s health condition is found to be at
risk, based on his answers, the emergency services will be contacted.
Another Bluetooth PAN approach is described in [60], where researchers have employed a smart-phone to collect physiological data from Bluetoothenabled sensors (a pulse oximeter and a GPS module), to detect alarming conditions and to transmit the encrypted data via GPRS or Wi-Fi. Similarly, the
Mobile Care System with Alert Mechanism presented in [61] utilizes a Bluetooth blood pressure monitor and ECG sensor and a mobile phone as the processing core for symptom recognition and alert message generation based on
different urgency levels.
Finally, the work described in [62] presents a wearable device for continuous ECG monitoring, where the ECG sensor continuously transmits the
measured and amplified ECG signal to the Hand Held Device (HHD), which is
a common PDA. The PDA serves as the ‚intelligent‛ device of the system, in
that it processes, analyzes and saves the recorded ECG measurements. An algorithm for detecting arrhythmia events, is implemented on the HHD, which
has also a documented true detection rate of 99.2%. The HHD communicates
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via GPRS with a remote clinical station, transmitting alarm signals along with
the recorded ECG waveforms. The doctor at the station end can setup the limits
for the specified alarm detections, such as bradycardia, tachycardia and arrhythmia. When an abnormal ECG activity is detected, the HHD will record 1
min of the ECG signal and transmit it to the base station and it will also calculate heart rate and some other parameters based on the measured waveform.

2.3.1.5

Other types of WHMS
In this last sub-category of research prototypes we will take a look at

some interesting wearable systems that could not be directly classified to one of
the previous categories.
Such a system is AUBADE [63], developed from the University of Ioannina in Greece, a wearable system that performs evaluation of the emotional
state of an individual targeting environments where human subjects operate at
extreme stress conditions. The developed prototype consists of a mask containing sixteen EMG textile fireproof sensors, a three-lead ECG and respiration rate
sensors located on the chest of the subject and a textile sensor measuring electrodermal activity (or galvanic skin response or skin conductance activity)
placed inside a glove. A 3D facial representation mechanism and an intelligent
emotion recognition module have also been implemented classifying the individual’s psychological condition from a set of emotions.
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Another interesting effort is described in [64], where the authors describe a system that uses a wearable ECG device to detect the motion artifacts
(distortions) and classify the type of Body Movement Activity (BMA) from the
ECG signal itself. This novel study targets situations where dynamic heart
monitoring is required, e.g. in case of mobile patients. The pre-processed ECG
beat observations are used by a supervised learning approach, based on principal component analysis (PCA), to train the BMA classifiers for sitting still, up
and down, movement of left, right or both arms, walking on a level floor and
climbing stairs up and down.
A wearable system for measuring emotion-related physiological parameters has been developed at Fraunhofer IGD Rostock [65]. It uses a glove as
garment hosting a sensor unit which collects data from skin conductivity and
skin temperature sensors and a conventional chest belt from Polar as a heart
rate sensor. The sensor unit communicates wirelessly using an ISM band transceiver with a base station, which can generate events, such as detection of certain physiological states, although this process is not described in the current
study. The reader interested further in glove-based systems and their applications should refer to the comprehensive study of such systems presented in
[59].
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2.3.2

Commercially available WHMS
In this final category of WHMS, we will briefly discuss several commer-

cially available wearable systems for health-monitoring application.
For example a lot of manufacturers like Nonin [66], Philips [67], Nellcor
[68], Agilent [69], Redding Medical [70] and others are providing small, wearable, low-cost and lightweight finger-tip pulse oximeters, that provide real-time
display of measured heart rate and blood oxygen saturation. Other examples
are the heart rate monitors manufactured from Polar [71] and Omron [72],
which use a chest worn belt and wristwatch for display of measurements.
Other commercial systems include Vivago WristCare [73], a wrist-worn
device, which monitors skin temperature, skin conductivity and movement. A
similar device is the SenseWear Armband developed from BodyMedia [74],
which in addition monitors ambient temperature and heat flow. Both devices
include a wireless transmitter for communicating the collected data and possible alarms to a base station for further evaluation by a professional clinician.
WelchAllyn has developed the Micropaq Monitor [75], a wearable device worn in a carrying pouch, which can perform pulse oximetry and up to 5lead ECG monitoring. Another example of commercially available health monitoring systems is the portable polysomnography systems from CleveMed [76],
which collect multiple channels of EEG, ECG, EMG, EOG, airflow, snore, thoracic and abdominal respiratory efforts, body position and pulse oximetry and
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can transmit the measured data wirelessly to any location by using a simple
ISM band transmitter.
VivoMetrics has developed LifeShirt [77], a washable light-weight vest
which includes respiratory rate sensors, 1-lead ECG for heart rate measurement
and an accelerometer for activity monitoring. Foster-Miller’s Watchdog [78]
physiological monitoring tool is a garment-based system capable of monitoring
heart rate, respiration rate, posture, activity, skin temperature and GPS location. Another example is the SmartShirt [79] system from Sensatex, a T-shirtbased wearable system using conductive fiber sensors to measure ECG, respiration rate and blood pressure.
CardioNet has developed a mobile cardiac outpatient telemetry system
(MCOT) for ambulatory ECG monitoring, aiming at helping physicians diagnose and treat patients with arrhythmias [80]. Other products include the Bioharness monitor from Zephyr Inc. [81], a chest belt that monitors ECG, respiration rate, skin temperature and activity and is wirelessly enabled and the SpO2,
ECG and glucose wireless sensors from Alive Technologies [82]. Furthermore,
Schiller [83] and Corscience [84] have also developed small portable Bluetooth
ECG monitors.
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2.4

Maturity Evaluation
In this section we attempt to evaluate the most representative and ‚pre-

vailing‛ systems from the ones discussed in the previous sections. The choice
of the systems to be evaluated was based upon:
their ability to measure multiple parameters
the amount and the detail level of their provided documentation
the frequency of their citation by other projects
the extent to which they utilize state-of-the-art hardware technologies
the incorporation of intelligent algorithms for feature extraction and/or decision support
The systems that have been chosen for evaluation are listed in Table 2-3
along with a description of their hardware and communication modules, the
physiological parameters that are measured and the projects’ stated application
field.
Several features have been chosen for the evaluation of the various
wearable systems. In Table 2-4 a list of these features is provided along with a
brief description for each one.
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Table 2-3. Selected Wearable Health Monitoring Systems
Project
Title/Institution

Hardware
Description

Communication
Modules

A) LiveNet (MIT) [26]

PDA, microcontroller
board

wires, 2.4GHz
radio, GPRS

B) AMON (EU IST FP5
program) [27]

Wrist-worn device

GSM link

C) LifeGuard (Stanford
Un.& NASA) [29]
D) MyHeart (EU IST
FP6 program) [32]-[35]

Custom μC-based
device & commercial
bio-sensors
PDA, Textile & electronic sensors on
clothes + heart belt

E) WEALTHY (EU IST
FP5 program) [29]-[31]

Textile & electronic
sensors on jacket

F) MagIC (Un. Of
lan, Italy, Bioeng.
Centre & Cardiac Rehab.Unit ) [36]-[38]

Vest with textile
sensors, custom
electronioc board,
PDA

G) MERMOTH (EU IST
FP6 program) [40],[41]
H) Smart Vest (National Pr. On Smart
Materials, India) [42]

Garment with knitted
dry electrodes, PDA
Vest with woven
sensors, microcontroller
Sensor motes with
custom processing
boards

I) CodeBlue (Harvard
Univ.) [44]

serial cables,
Bluetooth
conductive
yarns, Bluetooth, GSM
conductive
yarns, Bluetooth, GPRS

Measured
Signals*
ECG, BP, R, T,
Sa02, EMG,
GSR,
ECG,
BP, T SaO2, A
ECG, BP, R, T,
SpO2, A
ECG, R, other
vital signs, A
ECG, R, T,
EMG, A

Medical applications
Parkinson symptom & epilepsy seizures detection,
behavioural modelling
High-risk cardiac-respiratory
patients
Medical monitoring in extreme environments (space &
terrestrial)
Prevention and early diagnosis of CVD
Monitoring of rehabilitation &
elderly patients, chronic
diseases
Recording of cardiorespiratory and motion signals during
spontaneous behavior in daily
life and in a clinical environment

Bluetooth

ECG, R, T

conductive
yarns, RF link

ECG, R, T, A

General health monitoring

woven wires,
2.4 GHz ISM RF

ECG, BP, T,
PPG, GSR

General remote health monitoring

Zigbee

ECG, SpO2, A

Real-time physiological status
monitoring with wearable
sensors
Detection & prediction of
human physiological state
(wakefulness, fatigue, stress)
during daily activities
Health monit. and remote
identification of suspicious
health patterns for further
evaluation by physicians
Enable autonomous wearable
sensor networks for general
health monitoring
Monitoring users during their
sleep to detect sleep apnea
events

J) Body area network
(Valencia,Spain&Malta
Un.& Microvitae Tech)
[45]

Zigbee-based motes
& Zigbee-based custom base device

Zigbee, Wi-Fi,
GPRS

ECG, BP, R

K) WSN u-Healthcare
system (Dongseo Un.
Korea) [46], [47]

Custom tiny motes,
cell phone & commercial sensors

Zigbee, CDMA

ECG, BP,
SpO2, A

Zigbee

ECG, EEG,
EMG

Bluetooth

HR, SpO2

Bluetooth,
GPRS

ECG, A

Individualized remote CVD
detection

Bluetooth,
GPRS

ECG, BP, A

Heart-attack self-test for CVD
patients

Microcontroller
board, PDA

wires, Zigbee,
GPRS

ECG

Remote detection of cardiac
arrhythmias

Q) AUDABE (Dept. of
Medical Physics, Ioannina, Greece) [63]

Mask, glove, chest
sensors

wires, Bluetooth, Wi-Fi

ECG, R, GSR,
EMG

R) Lifeshirt (Vivometrics) [77]

Sensors embedded in
vest, PDA

Bluetooth &
wires

ECG, R, A

L) Human++ (IMEC)
[55], [56]
M) HealthGear (Microsoft) [57]
N) HeartToGo (Un. of
Pittsburgh) [58]
O) Personal Health
Monitor (Un. of Tech.
Sydney) [59]
P) Wearable ECG,
arrhythmia detection
(Eng. + Med. Dpts,
Norway) [62]

Miniature low-power
BAN nodes, energy
scavenging
Custom sensing
board, comm.. sensors and cell-phone
Cell phone & comm.
available BT biosensors
Cell phone & comm.
available BT biosensors
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Evaluation of the emotional
state of an individual at environments where subjects
operate at extreme stress
conditions
All-day remote health monitoring

S) Bioharness (Zephyr
Inc) [81]

Chest Belt

Bluetooth or
ISM RF

ECG, R, T, A,
P

Remote monitoring of human
performance and condition in
the real-world

* ECG=electrocardiogram (also implies the measurement of Heart Rate), HR=Heart Rate,
EMG=electromyogram, BP=Blood Pressure, R=Respiration, T=Temperature, P=Posture, GSR=Galvanic Skin
Response, A=Activity, PPG=PhotoPlethysmoGraphy.

Table 2-4. Evaluation Features
Wearability (F1)
Appropriate placement on
the body (F2)
Aesthetic issues (F3)
Data encryption and security (F4)
Operational lifetime (F5)
Real Application (F6)
Real-time Application (F7)
Computational & Storage
Requirements (F8)
Ease of use (F9)
Performance and test in
real cases (F10)
Reliability (F11)
Cost (F12)
Interference Robustness
(F13)
Fault Tolerance (F14)
Scalability (F15)
Decision Support (F16)

The system must have low weight and size.
The system has to be unobtrusive and comfortable, in order not to interfere with the user’s movements and daily activity.
The system should not severely affect the user’s appearance.
Encrypted transmission of measured signals and authentication requirement for private data access.
Ultra low power consumption for long-term, maintenance-free health
monitoring.
The developed system is applicable (and useful) to real-life scenarios/health conditions.
The wearable system produces results, e.g. display of measurements,
alerts, diagnosis etc, in (or near) real-time.
The computational and storage resources required or utilized by the system to achieve desirable results.
The system incorporates a friendly, easy-to-use and easy-to-learn user
interface.
Sufficient results and performance statistics are provided to verify the
system’s functionality in real cases.
The system produces reliable and accurate results.
The amount of money required to produce and purchase the proposed
wearable system.
Availability and reliability of wirelessly transmitted physiological measurements.
The system produces reliable results under any circumstances, such as
various kinds of patient’s movements.
Potentiality of upgrading, enhancing and easily incorporating additional
components to the developed system.
The implemented system includes some type of diagnosis/decision mechanism or an algorithm/pattern recognition system for context aware
sensing of parameters.

The choice of features was based upon the wide range of requirements a wearable biosensor system must meet in order for it to be used in real-life health
monitoring scenarios. Since in the general case there are no ideal objective me-
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trics for evaluating each feature of every system, the evaluation has been done
with relevance to the top approach in each category.
In addition to that we wanted to provide an overall evaluation of the
systems based on the perspective of the parties who are involved in the development and the use of the systems, e.g. the manufacturers, the doctors and the
users. The reason for doing that is because specific features may have different
significance levels for each interested party, for example the on-board computing resources of the system may be a feature that is highly important to the
developer of the system, while it may not be that important to the user who
would be naturally more concerned about the ease of use of the WHMS.
Therefore, after extended discussions with colleagues, department’s students
and doctor acquaintances we decided to grade the importance of each feature
as low (1), medium (2) or high (3), which resulted in an average weight for
every feature depicting its importance in the evaluation of a WHMS. These
weights are presented in Table 2-5.
Finally an overall maturity score was produced for every system in Table 2-3 based on the evaluation of every feature of each system under consideration and by producing a weighted average score according to the weights depicted in Table 2-5. It should be noted that the maturity score of a system corresponds to the level to which the system fulfills its potentials regarding its
available resources and design approach. Therefore, a higher average score
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corresponds to a system that has both reached a top level of development and
also meets the requirements listed in Table 2-4 to the fullest.
Table 2-5. Features’ Weights
Patient’s
perspective

Physician’s
perspective

Manufacturer’s
perspective

Average

F1

3

2

1

2

F2

3

2

1

2

F3

3

1

2

2

F4

2

3

3

3

F5

3

2

2

2.3

F6
F7
F8

3
3
1

3
2
1

3
2
3

3
2.3
1.7

F9

3

2

1

2

F10

3

3

3

3

F11

3

3

3

3

F12

3

1

3

2.3

F13

2

3

2

2.3

F14

3

3

3

3

F15

2

2

2

2

F16

3

2

2

2.3

The corresponding scores are shown in Fig. 2-1. It also be noted that the
purpose of this maturity evaluation is not to criticize the developed systems,
but to identify their development level according to their potentials and to
provide possible direction for further research in the fields that these systems
show a lack of performance.
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Fig. 2-1. Maturity scores for the systems listed in Table 2-3 (1=low, 2=medium-low, 3=good,
4=high, 5=maximum)

2.5

Discussion
As it can be seen from Fig. 2-1, none of the systems reached what was

set as the maximum maturity level. However, from the systems we considered
in the current study, there are several ones that achieved relatively high scores.
These include systems based on smart textiles, which have the advantage of
high wearability and comfortableness to the user and which can achieve a high
degree of reliability due to guaranteeing good contact between the skin and the
bio-sensors even when the subjects are in motion. In addition to those types of
systems, the HeartToGo project and the Personal Health Monitor reveal also a
promising alternative to the design of WHMS, as they leverage commercial cell
phone devices and commercially available bio-sensors to set up a system that is
either able to interact with the user to get additional feedback about his health
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status or to adapt to his/her individual medical history by means of artificial
neural networks.
However, there have been identified several common issues with the
evaluated systems and which constitute a set of challenges that will need to be
addressed by further researchers in order to improve the efficiency, the reliability and the security of WHMS. These challenges include:
Battery technologies and energy scavenging: Power consumption (and
battery size) appears to be perhaps the biggest technical issue and performance
bottleneck in current implementations. Wearable biosensor systems should be
able to operate maintenance-free for long periods (e.g. years). Further research
in power scavenging techniques (through body heat or motion), low-power
transceivers and improvements in battery technologies promise to solve this
problem.
Security of private information: The information collected about the
user, describing his health status, has to remain secure and not be allowed to be
disclosed to anyone besides to the system’s wearer and to the supervising physicians. Thus, proper encryption and authentication mechanisms are required
to ensure the privacy of all the communicated data (sensor-to-sensor communication in the BAN or wearable system to base station transmissions).
Further improvements in sensor miniaturization and efficiency: In
general a lot of the biosensors used in current wearable systems tend to have
41

bulky size and may require very specific on-body placement or body postures
to provide reliable measurements. Further improvements in textile sensors and
advanced sensor design and miniaturization are required to appropriately address these shortcomings.
Clinical validation: Developed systems must be exhaustively tested
and validated by professional physicians.
Standardization and cooperation at all levels: The requirement for interoperability between different communication infrastructures and between
various types of devices, sensors, actuators, health providers etc., underlines
the need for standardization in communication interfaces and cooperation between researchers, medical experts, hardware and textile manufacturers, network providers and other health organizations.
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3

CHAPTER 3: ECG SIGNAL PROCESSING TO MEET THE
CONSTRAINTS OF THE WHMS
In a general remote health monitoring scenario, as discussed in the in-

troductory section, bio-signals are recorded in an unsupervised manner. As a
result two important questions that arise in this situation are: 1) under what
conditions these data were recorded and 2) what do those data actually mean.
Regarding the first question, the issue is whether the recorded data are actually
usable and not corrupted by noise. Physiological sensor technology is currently
far from being robust to measurement artifacts, which can be caused by the user’s movement, or by bad contact between the sensor and the skin or by sensor
fault. As a result there is a requirement for a means to deduce whether and to
what extent the recorded data should be considered reliable or not. Only in the
former case should they be further analyzed by signal processing algorithms
and decision making schemes to avoid producing erroneous results.
The second question raises the issue of data processing, feature extraction and interpretation. More concretely, pertaining to the ECG, the signal
needs to be processed in order to 1) perform de-noising [85], 2) detect heart
beats [86] and finally to classify the recorded beats and rhythms as normal or
abnormal [87]. In addition to that, other signals such as the tri-axial acceleration
captured from on body accelerometers can be analyzed to quantify the amount
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and type of motion the user is currently performing [88]. Finally the recorded
data and the corresponding extracted features can be all fused together to estimate the progression of the user’s health condition. An approach towards
achieving this last goal will be discussed in the next chapter.
In this chapter we will discuss possible approaches to addressing problem 1) as stated above. We will focus on the case of the ECG signal and we will
describe wavelet-based approaches to do the following: a) detect noisecorrupted unusable segments in the signal, b) de-noise the usable portions of
the ECG and c) classify detected heart beats. The algorithms that will be presented constitute incremental improvements of existing methodologies that can
be found in the abundant literature of wavelet-driven ECG denoising and ECG
classification. Analytical and comparative results for the proposed approaches
will be provided and their pros and cons will be discussed. However, before
we do that it would be appropriate to provide a short but comprehensive introduction to the discrete wavelet transform.

3.1

Wavelets

3.1.1

The continuous wavelet transform
The Wavelet Transform has emerged in the past two decades as the

most powerful tool for analysis of transient non-stationary signals [89]. There
have been numerous research efforts that employ the WT in signal processing
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of ECG signals [90]. Its abilities to a) employ a variable window in order to
realize high temporal resolution in high frequencies and high spectrum resolution in low frequencies as well as b) the large set of available wavelet functions
which can utilized to detect various feature morphologies, have been proven
very useful in the analysis of electrocardiograms which are non-stationary in
nature. These features illustrate the superiority of the wavelet transform compared to the short time Fourier transform (STFT), which employs a single window for all frequencies and provides the same resolution at all locations in the
time-frequency plane.

Fig. 3-1. Time-frequency boxes in case of a) a time domain signal, b) a frequency domain signal,
c) STFT and d) a wavelet basis.
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This fact is illustrated graphically in Fig. 3-1, which shows the different time,
frequency or time-frequency resolutions of a time-domain signal, of a frequency-domain signal, of a STFT and of a wavelet basis. The boxes shown in the
two bottom figures are referred to as Heisenberg boxes [89] to denote the fact
that one cannot have arbitrarily high resolution in both time and frequency.
The continuous wavelet transform is defined as the inner product of the
function in question and of a set of dilated and translated wavelet functions:
(Eq. 3-1)
Where s is the scale or dilation parameter, u is the translation or location
parameter and

is the mother wavelet. In order to characterize a function

as a wavelet and thus to use it for wavelet analysis of signals, it must satisfy certain conditions:
1. It must be continuous and differentiable.
2. It must have compact support (or it must decrease quickly towards zero as

).

3. It must have a band-pass-like spectrum (zero mean), e.g.
, where

is the Fourier trans-

form of the wavelet function.
4. It must have finite energy, e.g.

.

5. Finally, it must also satisfy the admissibility criterion:
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.

Wavelet analysis is capable of revealing the following aspects of data:
trends, breakdown points, discontinuities in higher derivatives and selfsimilarity and as a result, it has found numerous applications in signal and image processing [89].
In addition to that the Wavelet Transform (WT) is capable of utilizing
the correlation structure, which is local in both time & frequency and which
might be present in neighboring points, to acquire a sparse representation of a
signal. This is particularly evident with wavelets with a large number of vanishing moments

. If a wavelet has N vanishing moments,

that implies that the approximation order of the wavelet transform is also N or
in other words the wavelet transform is capable of suppressing signals that are
polynomials of degree less or equal to N. This fact makes the wavelet transform particularly applicable to data compression [89].

3.1.2

The discrete wavelet transform
The continuous wavelet transform (CWT) is easy to interpret, since its

redundancy enhances its readability. However, instead of computing the inherently redundant wavelet transform for an infinite amount of scales and translations (which is both time and storage-space consuming), s and u can be chosen to be discrete. A very common choice is the dyadic grid:
(Eq. 3-2)
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The above form expresses the discrete wavelet transform (DWT) and in
this case the wavelet functions (if properly selected) constitute an orthonormal
basis:
(Eq. 3-3)
Using the DWT a signal can be represented by an infinite sum of translated and dilated wavelet functions multiplied by the corresponding wavelet
coefficient dj,k:
(Eq. 3-4)
In order to avoid computing an infinite number of wavelet coefficients
for DWT analysis, a scaling function φ(t) can be employed which can be expressed as an infinite weighted sum of wavelets down to a certain scale j:
(Eq. 3-5)
The scaling function needs to have a low pass spectrum (averaging filter), it must thus satisfy:

. We can now see that a series of dilated

wavelets together with a scaling function can be considered as a filter bank. An
analyzed signal can now be represented as a combined series expansion using
both the so called approximation coefficients (obtained by projecting the signal
onto translations of the scaling function) and the detail coefficients (obtained
by projecting the signal onto dilations and translations of the wavelet function):

,

(Eq. 3-6)
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where j0 is the coarsest scale to which the signal x(t) had been analyzed.
The DWT is implemented via a pair of conjugate mirror filters, a low-pass
FIR filter h (associated with a scaling function φ) and a high-pass FIR filter g
(associated with the wavelet function ψ), which result in what is usually referred to as subband coding. The filters h and g satisfy the following set of relations:
(Eq. 3-7)

or

(Eq. 3-8)

or

(Eq. 3-9)
(Eq. 3-10)
where

,
denotes the complex conjugate of h and ω=2πf is the angular frequen-

cy. The first two equations are sometimes referred to as the ‚twin scale relations‛.
In this case a signal that is decomposed up to a scale n is initially filtered by h and g in order to produce approximation coefficients ai and detail
coefficients di, which are then downsampled to remove the redundancy of the
signal representation. Approximation coefficients in every scale can be further
decomposed via the same scheme, in order to produce the ai and di coefficients
of the next scale. If the discrete signal is of length N=2M, then this scheme allows for up to M levels of decomposition (coefficients are subsampled in each
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scale to avoid redundancy). This process is illustrated in Fig. 3-2. From the
above discussion it is clear that the DWT acts as an octave band filter whereby
by adding higher octave bands we add more detail or resolution to the signal,
hence the name ‚multiresolution analysis‛.

Fig. 3-2. Fast Wavelet Transform (Mallat’s algorithm) implemented with cascaded filters and
downsamplers.

To reconstruct the original signal, the reverse procedure is employed.
This fast inverse wavelet transform reconstructs progressively each aj by inserting zeros between samples of aj+1 and dj+1, filtering and adding the output. For
the reconstruction process, the filters that are employed can be either the same
that were used for the analysis or we can use a different set of filters, which
must however satisfy certain (perfect reconstruction) relations with the deconstruction filters (see Chapters 7.3 and 7.4 in [89]). In the latter case, the wavelets
that are employed are called biorthogonal and they no longer constitute an orthogonal basis for the respective signal space. The advantage in this case however, is that we are able to employ symmetric Finite Impulse Response (FIR)
filters, which as it is known have the property of linear phase response.
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If we remove the downsamplers after each filtering operation and upsample the filter coefficients by a factor 2(j-1) in the jth scale, then we acquire a
translation-invariant signal decomposition, which is of course redundant. This
is referred to as ‚algorithme à trous‛ or else undecimated wavelet transform
(UWT).

3.1.3

Wavelet Packets
Wavelet packets extend the idea of the DWT by basically decomposing

both approximation and detail coefficients in every scale to coarser components (the DWT decomposes only the ai in every scale). This allows the design
of bases with adaptable time-frequency properties.

Fig. 3-3. Wavelet Packet Tree decomposition
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Beginning with the scaling and the wavelet function and the filters h and g one
can iteratively generate appropriate analyzing functions which can be used to
produce a full binary wavelet packet decomposition tree. This is shown graphically in Fig. 3-3.
The produced binary tree is usually pruned by applying some criterion
in order to select an optimal decomposition scheme. The idea behind this approach is to look at each parent node and its two children and quantify the information that is gained by splitting the parent node. If the sum of the entropies, which is the information measure that is usually adopted and is defined
as:

,

(Eq. 3-11)

of the two children is smaller than the entropy of the parent node, then the split
is performed as there is obviously a gain in terms of compression of information.

3.1.4

Matching Pursuits
Matching Pursuit (MP) introduced by Mallat and Zhang [91] is a greedy

algorithm for computing a sub-optimal decomposition of a given signal over a
redundant orthogonal waveform dictionary, by selecting one by one the ‚optimal‛ vector. Let f be the signal to be approximated and
dictionary of vectors (atoms)

be the

, which are discrete-time 1-dimensional signals
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of length n and have unit norm. The MP algorithm works iteratively in order to
decompose f as:
(Eq. 3-12)
where

is the inner product or the projection of the residual

on

:

(Eq. 3-13)
and
(Eq. 3-14)
with

. The question now is which atom should be chosen to project the

residual

at each iteration. According to MP, in order to minimize the resi-

dual given by (Eq. 3-14) in every step, we need to choose the atom that maximizes the absolute value of the inner product given in (Eq. 3-13). The iteration
of the algorithm can be stopped when either a satisfactory signal approximation has been achieved (measured via the normalized residual energy:
) or when the maximum number of atoms for a specific task has
been reached. The iterations of the MP algorithm to derive a sub-optimal approximation of a signal f using M atoms are the following:
1.

,

and

2.
3.
4.
5.
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6.
7. If

then go to 2. else stop and

is the requested sub-optimal

signal approximation.
A variety of waveform dictionaries can be possibly employed with MP,
for example wavelet packets, cosine packets or Gabor atoms. In this work we
studied the use of wavelet packet dictionaries in the approximation of ECG
beats. Our implementation is done in MATLAB and it is based on the WaveLab
library [92].

3.1.5

Denoising with Wavelets
The discrete wavelet transform can be very effectively utilized to re-

move undesired components (noise) from a signal. The conventional wavelet
denoising scheme as proposed by Donoho [93], consists of employing a DWT
decomposition up to a certain scale and then applying soft or hardthresholding techniques to the detail coefficients at all levels in order to suppress the noise components (assuming that all wavelet scales contain noise).
Soft thresholding is defined by the following operation:
(Eq. 3-15)

Similarly, hard thresholding is performed by:
(Eq. 3-16)
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T denotes the applied threshold, which can be selected according to various
estimation procedures [89], [94]:
Stein’s unbiased risk estimate (SURE):
(Eq. 3-17)
Fixed threshold (FIXTHRES):
(Eq. 3-18)
HEURISTIC SURE, which replaces in very noisy conditions the SURE
with the FIXTHRES estimate.
MINIMAXI, which applies a fixed threshold given by:
(Eq. 3-19)
As stated in [94], the underlying signal model assumes that the noise is
additive and normally distributed with zero mean and unit variance. As a result, we have to rescale the estimated thresholds when dealing with unscaled
and non-white noise. A very common rescaling approach is given by:
(Eq. 3-20)

,

where:

(Eq. 3-21)
and

is the estimated standard deviation of the noise [95], which can either be

computed from the coefficients in the finest decomposition scale or in a scaleby-scale manner.
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The de-noising algorithm is concluded by reconstructing the signal using the inverse DWT with the modified (shrunken) detail coefficients. For more
details on the algorithm by Donoho the interested reader can refer to [93] and
[95].
A similar approach consists of performing optimal wavelet packet decomposition and then thresholding the resulting coefficients before reversing
the whole process to reconstruct the denoised signal estimate. However, looking for the optimal tree is a time-consuming process, especially in the case of
processing real-time data. As a result thresholding can be applied directly to
the full wavelet packet tree.

3.2

Dealing with Noise in the ECG

3.2.1

The Electrocardiogram (ECG)
The ECG is a recording of the electrical activity of the heart. It can be record-

ed and monitored in a non-invasive and relatively unobtrusive manner as we saw in
the survey of WHMS. The standard ECG (or EKG) is measured by appropriately placing
10 electrodes on the patient’s body and by measuring 12 ECG leads as the potential
difference between a pair of electrodes or between an electrode and a ground reference point. An idealized ECG can be seen in Fig. 3-4.
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Fig. 3-4. An “ideal” ECG signal

In this figure we can see the types of waves that compose the ECG
waveform, e.g. the P wave, the QRS complex and the T wave. For a physiological interpretation of the mechanisms behind the formation of these waves, the
reader can refer to [96] or to any other of the wide variety of books regarding
cardiology and ECG interpretation. The R peak is usually referred to as the ‚fiducial‛ point and its detection is associated with precisely determining the occurrence of a heart beat. In Fig. 3-4 we can also see annotations regarding the
most important ECG features, such as the QRS width and the ST segment, the
accurate detection of which carries significant important diagnostic information [87], as depressed ST segments may be a sign of ischemic episodes and
elevated ST segments may indicate myocardial infarction.
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As it was stated before, the ECG signal depicted in Fig. 3-4 constitutes
an idealized case, whereby noise is absent and detection of the prominent ECG
waves and their corresponding boundaries is rather straightforward. However,
in real-life scenarios ECG recordings will be contaminated by several types of
noise: low frequency noise (causing what is referred to as baseline drift or
wander) due to respiration and movement, high frequency noise due to muscle
noise (EMG noise) and noise at 50 or 60Hz due to power-line interference. Furthermore, according to electrode placement and to corresponding lead measurement, some of the ECG peaks and waves depicted in Fig. 3-4 may or may
not be present (or may even be inverted) [96].
An example of an ECG signal contaminated by several noise sources is
given in Fig. 3-5. This signal has been taken from record 121 of the MIT-BIH
Arrhythmia database [99], which has been widely adopted as the reference database when evaluating QRS detection and ECG beat classification algorithms.
The ECG recording depicted in Fig. 3-5 is clearly contaminated with lowfrequency noise, which causes a slowly varying drift of the signal’s baseline.
Furthermore the presence of high frequency noise is evident as well as it can be
observed as high frequency ripples on the segments between two R peaks. As a
result, in order to detect significant diagnostic information and extract features
of interest from the ECG, appropriate signal filtering and conditioning needs to
be performed at a first stage.
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Fig. 3-5. Example ECG recording with evident baseline drift

3.2.2

Detecting noise-corrupted segments
An important issue in ambulatory ECG recordings is that of complete

signal corruption of the signal due to measurement artifacts or sensor malfunction. The DWT can be employed in this case in order to analyze the energy content of the recorded signal at different scales and if values are detected over or
under empirically set thresholds, then we may deduct that the signal is corrupted or that there is a low-energy unusable section (in case the wearable sensor has been removed or misplaced). A similar approach utilizing FIR and IIR
filters is described in [97].
Here we want to describe the detection of noise-corrupted ECG segments using a DWT based approach. In Fig. 3-6 we can see part of an ECG recording recorded with the WHMS platform (which will be fully described in
Chapter 8) and processed offline using MATLAB. An important thing to note
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here is that the ECG trace provided by the Bioharness ECG sensor [81] is bandpass filtered, where the band is about 15 to 75 Hz.

Fig. 3-6. An ECG segment, part of which is severely corrupted by noise caused by movement.

It is evident that there is a part of the signal, starting at about the 28th second,
that is severely corrupted by noise (in this case from abrupt chest movements
which significantly affected the contact surface between the ECG sensors and
the subject’s chest).
In Fig. 3-7 we can see four levels of approximation coefficients (obtained using the Coiflet wavelet of order N=5) of the same signal that is depicted in Fig. 3-6. We notice that the noise we are dealing with here has significant low frequency contents which of course interfere with the heart beat
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waves, which at the first half of the signal, where the ECG is almost noise-free,
have been smoothed down. This is particularly obvious at the coarsest decomposition scale. As a result, the approximation coefficients at level 4 offer a
means by which we could discriminate between normal ECG and the noise
type in question.

Fig. 3-7. 4 levels of approximation (using Coif5 wavelet) coefficients of the ECG shown in Fig. 3-6.

A way to take advantage of this feature is to compute the amount of
energy that is being carried in a window of length N of DWT coefficients by
calculating:
(Eq. 3-22)
For a more smooth power estimate over time it is more favorable to first
square the approximation coefficients and then to apply a low-pass filter, as
proposed in [97], to smoothly average the power estimate. This is done by em61

ploying a variable length Hamming window, whereby the length of the window is adjusted according to the instantaneous heart rate estimate. The length
of the Hamming window is computed as:
(Eq. 3-23)
where Fs is the sampling frequency of the ECG (250 Hz in the case of the
Bioharness [81]), HR is the instantaneous heart rate estimate (which can be taken from the estimate given by the Bioharness or by an averaged HR estimate
from recent RR intervals), n is the decomposition level (level 4 in this case) and
finally b is a bias to account for the heart rate variability as a result of which
successive RR intervals may show significant variation (here b=10, chosen empirically).
Before showing how the resulting energy estimate can be utilized to
detect corrupted ECG segments, we should briefly refer to other types of signal
corruption in the ambulatory ECG. Of particular interest is the case whereby
the ECG becomes corrupted due to permanent displacement of the wearable
sensor or even due to the user taking it off. Such a case is depicted in Fig. 3-8,
where a noisy signal is produced initially due to sensor displacement and then
due to the user taking off the chest belt. It would be very useful if we were able
to instantly detect such a scenario as well.
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Fig. 3-8. An ECG segment, part of which is severely corrupted by noise caused by sensor
displacement.

By employing the energy estimation scheme described before we are
indeed able to detect the described cases where severe ‚non-reversible‛ artifacts are created in the ECG. This is schematically illustrated in Fig. 3-9. To
detect events such as the one depicted in Fig. 3-6 we can employ a heuristically-set threshold (depicted as T2 in Fig. 3-9b), above which we can deduce that
the ECG has been corrupted. Similarly for low energy portions such as in the
case shown in Fig. 3-8, we can employ a lower threshold (depicted as T1 in Fig.
3-9b) on the smoothed energy estimate, under which samples are discarded as
well. To improve the detection of corrupted ECG segments we can utilize the
high frequency detail coefficients (d1) to recognize segments of abnormally high
concentration of high frequency components (keeping in mind that the ECG
transmitted by the Bioharness chest band has been low-pass filtered to remove
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high frequencies). In this case the employed threshold is shown in Fig. 3-9c as
T3.

Fig. 3-9. Detection of corrupted ECG segments with appropriate thresholding on the energy
estimates.

Putting everything together we get the power estimates shown in Fig.
3-9. By selecting heuristically appropriate thresholds we can detect the severely
distorted signal portions. In the 80 sec ECG segment shown in Fig. 3-9, there
are 3 types of occasions whereby noise is introduced in a nonreversible manner
in the ECG. By empirically estimating two thresholds for the energy estimate
shown in the second graph of Fig. 3-9 (computed from the 4th level of approximation coefficients) and another threshold for the lower graph (taken from the
energy estimate of d1) we can recognize the parts of the signal that need to be
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discarded. This thresholding operation creates three separate masks and by
combining them we can identify the samples to be discarded. This is depicted
graphically in Fig. 3-10, where the original ECG signal is plotted on top, while
on the bottom we can see the mask that corresponds to each of the three thresholds. Combining these three masks together yields the final noise mask,
which is shown as a thick black line in Fig. 3-10.

Fig. 3-10. Original ECG signal and estimated noise masks.

3.2.3

ECG de-noising with the undecimated wavelet packet transform
The DWT has been widely employed in the de-noising of the ECG [85],

[90], [98]. Research has proved [98] that employing the undecimated (or sometimes referred to as stationary) wavelet transform, can lead to better denoising
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results, due to the redundancy which is inherent in the transform. In addition
to that, the effectiveness of using wavelet packet thresholding has been studied
by Tikkanen [94] and has been shown to be inferior to DWT denoising. However, there has not been a study utilizing the undecimated wavelet packet
transform (UWPT) of the ECG to perform coefficient thresholding in order to
remove the noise of the signal. Such an approach could combine both the advantages of the wavelet packet transform (coarser analysis of the signal’s details) and of the undecimated wavelet transform (time-invariant analysis). This
is the approach that has been adopted in the current study, e.g. after each decomposition step both approximation and detail coefficients are decomposed
and the decimation stages are removed while the filters in each stage are upsampled.
To examine the effectiveness of employing the UWPT for ECG denoising we compare it with DWT and UWT denoising. By experimenting with various wavelet types we were surprised to find that UWPT denoising performed
at best when the Haar basis (or else the Walsh wavelet packets) was used (especially in very noisy environments). Also the optimal decomposition stage for
using Stein’s unbiased risk estimate (SURE) was found to be level 4. The noise
level on each scale was estimated adaptively as described by (Eq. 3-20) and (Eq.
3-21). We utilized ECG recordings from the MIT-BIH Arrhythmia database [99]
to compare the above approaches. In general, the UWPT proved to be slightly
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more effective than UWT denoising. To illustrate the fact that the Haar wavelet
yields better denoising performance than other wavelet families we can refer to
Fig. 3-11, where an ECG segment taken from record 103 of the MIT-BIH Arrhythmia database has been extracted and then ‚contaminated‛ with Additive
White Gaussian Noise (AWGN) resulting in a signal with signal-to-noise ratio
(SNR) equal to 4dB. Then this signal is denoised using several approaches and
as we can see, the approach that utilizes the undecimated Haar wavelet packet
transform to perform denoising yields the higher output SNR.

Fig. 3-11. Denoising performance of different approaches on ECG segment taken from the MITBIH Arrhythmia Database, Record 103 with AWGN: a) Original ECG, b) Noisy ECG (SNR=4dB), c)
Haar UWT denoising (SNR=15.08dB), d) Haar UWPT denoising (SNR=15.11dB), e) Coif3 UWT
denoising (SNR=14.60dB), f) Coif3 UWPT denoising (SNR=14.28dB), g) Sym3 DWT denoising
(SNR=9.62dB), h) Coif3 DWT denoising (SNR=11.58dB). (Note: In the figure the UWT is denoted
as SWT according to MATLAB’s terminology)

We should note here that the SNR has been computed by:
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,

(Eq. 3-24)

where x[n] is the original sequence and xe[n] is the noisy or the denoised signal.
To further evaluate the performance of the denoising approaches compared in Fig. 3-11 we examined their efficiency in denoising an ECG segment
which contains irregular heart beats (such as Premature Ventricular Contractions). Such a case is depicted in Fig. 3-12 where an ECG extracted from record
208 of the MIT-BIH Arrhythmia database has been used. In this case as well,
the Haar UWPT denoising approach yields the best performance.

Fig. 3-12. Denoising performance of different approaches on ECG segment taken from the MITBIH Arrhythmia Database, Record 208 with AWGN: a) Original ECG, b) Noisy ECG (SNR=4dB), c)
Haar UWT denoising (SNR=14.29dB), d) Haar UWPT denoising (SNR=14.41dB), e) Coif3 UWT
denoising (SNR=14.06dB), f) Coif3 UWPT denoising (SNR=14.07dB), g) Sym3 DWT denoising
(SNR=11.11dB), h) Coif3 DWT denoising (SNR=11.92dB). (Note: In the figure the UWT is
denoted as SWT according to MATLAB’s terminology)
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So far we have considered only additive Gaussian white noise. Although this noise model provides the most common means of estimating and
comparing the performances of denoising algorithms, the type of noise that is
usually introduced in the ECG does not have such ideal characteristics (if we
consider the overall noise component as a superposition of different noise
sources such as electrode noise, motion artifacts, electromyographic noise etc).
Additionally, as Clifford et al. have stated in an excellent book about ECG signal processing and analysis [100]: ‚…the assumption that most noise is Gaussian in nature is approximately correct (due to the central limit theorem)‛. The
authors of [100] also state that a noise model that is very representative of the
type of observation noise that is introduced in the ECG signal is ‚pink noise‛,
which is characterized by a power spectrum which is proportional to 1/f, where
f is the frequency.
Thus, in order to evaluate the performance of the various wavelet denoising approaches under a more realistic noise model, we compare their performances under additive pink noise as well. This is shown in Fig. 3-13 for the
case of the same signal segment as the one analyzed in Fig. 3-11. Additive pink
noise has been added to the ECG signal of the first plot resulting in a noisy signal with SNR 5dB. The denoised waveforms do not have a SNR as high as the
ones of Fig. 3-11 (white noise), but the basic morphological characteristics of
the waves are retained after the denoising process. In addition to that, the
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Haar-based UWPT denoising yields the best performance in this case as well
(SNR=6.79dB).

Fig. 3-13. Denoising performance of different approaches on ECG segment taken from the MITBIH Arrhythmia Database, Record 103 with additive pink noise: a) Original ECG, b) Noisy ECG
(SNR=5dB), c) Haar UWT denoising (SNR=6.73dB), d) Haar UWPT denoising (SNR=6.79dB), e)
Coif3 UWT denoising (SNR=6.48dB), f) Coif3 UWPT denoising (SNR=6.42dB), g) Sym3 DWT
denoising (SNR=6.03dB), h) Coif3 DWT denoising (SNR=6.41dB). (Note: In the figure the UWT is
denoted as SWT according to MATLAB’s terminology)

Finally we will compare the performance of UWT, UWPT and DWT
denoising on the same signal segment for various SNRs in order to validate our
previous results in cases of higher or lower signal-to-noise ratios. The noisy
ECG will be decomposed using UWP and UWPT with Haar basis function and
DWT with Symmlet 3 basis (which is very effective in the DWT case, although
coif3 denoising tends to yield better performance for lower SNRs).
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In Fig. 3-14 we can see the same ECG segment from record 103 that was
used before in the first plot. The second plot shows that signal with AWGN
and SNR=5dB. The SNR of the UWT denoised signal (third plot) was 15.73dB,
of the UWPT (fourth plot) 16.62dB and of the DWT (fifth plot) 12.64dB. In addition to that, UWPT produced 2.17% Mean Square Error (MSE) compared to
2.67% in the UWT case, while the MSE in the QRS complexes area was 1.18%
and 1.62% accordingly. The latter result along with visual supervision of the
obtained waveforms proves also that UWPT denoising performs better in retaining important beat features, such as the Q, R and S waves.

Fig. 3-14. a) Original ECG (record 103), b) Noisy ECG with AWGN, c) Haar UWT denoised, d) Haar
UWPT denoised, e) Sym3 DWT denoised.
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Fig. 3-15 plots the SNRout against the SNRin that was obtained for the
above signal for various white noise levels.

Fig. 3-15. SNRout vs SNRin for various noise levels for the signal shown in Fig. 3-14.

Finally in Fig. 3-16 we can see the ECG signal of Fig. 3-14 on the top
plot, while on the second plot the same signal with added pink noise is depicted (SNR=5dB). The third plot shows the Haar UWT denoised signal
(7.84dB), the fourth one shows the Haar UWPT denoised ECG (7.97dB) and the
last one shows the result of sym3 DWT denoising (6.72dB). Moreover, UWPT
produced 15.95% Mean Square Error (MSE) compared to 16.41% in the UWT
case, while the MSE in the QRS complexes area was 3.40% and 4.67% accordingly, a fact which further highlights the ability of the UWPT-based denoising
in reconstructing more accurately the high frequency components of the signal.
Fig. 3-17 shows the SNRout against the SNRin that was obtained for the above
signal for various pink noise levels.
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Fig. 3-16. Original ECG (record 103), b) Noisy ECG with pink noise, c) Haar UWT denoised, d)
Haar UWPT denoised, e) Sym3 DWT denoised.

Fig. 3-17. SNRout vs SNRin for various noise levels for the signal shown in Fig. 3-16.
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3.3

Classifying ECG beats

3.3.1

A brief note on the MIT-BIH Arrhythmia database
The MIT-BIH Arrhythmia database includes various recordings, of

many common and life-threatening arrhythmias. It contains 48 recordings,
each one containing two 30-min ECG signals, each one taken from a different
lead. The data have been band-pass filtered at 0.1-100 Hz and they have been
digitized using a 360 Hz sampling frequency and an 11 bit resolution.

3.3.2

Beat detection
As it was stated previously, the most important part in ECG signal

processing is the detection of the fiducial points, e.g. the R peaks or what is referred to as the QRS complex. While there have been proposed several methods
in order to achieve that goal [86], the method that was proposed by Pan and
Tomkins [101] and which was later improved by Hamilton and Tomkins [102]
has been proven to be very reliable and has been widely employed by several
researchers. This method employs low-pass and high-pass filters to get rid of
noise and frequency components that correspond to waves other than the QRS
complex and then uses a differentiation filter, a squaring stage and a moving
window integration to derive a feature signal. By applying some simple rules
on the feature signal the QRS complexes can be reliably detected. This process
can be seen in Fig. 3-18 and Fig. 3-19 for the case of the same ECG recording
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that was depicted in Fig. 3-5. The output of each one of the 6 stages of the Hamilton-Tomkins algorithm is shown, leading up to the detection of the ECG
peaks.

Fig. 3-18. First three stages of the Hamilton-Tomkins algorithm

Fig. 3-19. Last three stages of the Hamilton-Tomkins algorithm

The displayed QRS complex detection algorithm has high accuracy and
provides close to real-time performance while not being very computationally
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intensive. The next step of an ECG processing unit is the characterization of
each detected ECG beat as normal or abnormal. Examples of abnormal ECG
beats are: Premature Ventricular Contraction, Atrial Premature Beat, right or
left Bundle Branch Blocks and escape beats. The detection of these abnormal
beats allows the heart rhythm evolution to be followed and various types of
arrhythmia to be recognized [103]. This is discussed in greater detail in the following section.

3.3.3

Using matching-pursuit-based features to derive an efficient
ECG classification method
The electrocardiogram (ECG) is a well studied medical tool for the as-

sessment of the heart’s function. As it provides a continuous recording of the
electrical activity of the heart, it is utilized by physicians in order to diagnose
heart conditions such as arrhythmias and cardiovascular disease. However,
arrhythmic patterns tend to appear infrequently and thus long-term 24-hour
ECG recordings are usually needed which are acquired using the so called Holter monitors [104]. Moreover, advances in wearable health monitoring technology have propelled the development of a variety of research prototypes and
commercially available systems that are capable of taking ambulatory ECG recordings [14]. Automatic interpretation of electrocardiographic data is thus required to identify patterns of interest in unsupervised ECG recordings.
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Automated ECG classification has been a topic of high interest in the
biomedical engineering research community for more than 3 decades now
[105], [106]. Several approaches have been proposed for extracting features
from the ECG beats in order to aid in correct beat recognition. Examples of
such approaches include the use of Discrete Wavelet based statistics [107], FFT
spectral components [108], Coefficients of Hermite basis functions representation [109], ECG wave intervals, amplitudes and/or selected sample points [87],
[110], [111], heuristically defined morphological features [112] and higher order
statistics [113]. However, as pointed out in [113], morphological descriptors
and wave attributes extracted in the time domain, as well as frequency domain
features tend to vary significantly for beats belonging to the same ECG class,
even for recordings extracted from the same patient. In addition to that, morphological features rely heavily on accurate detection of beat boundaries, a
computationally intensive process which is sometimes defined heuristically
and can be severely impaired in the presence of considerable signal noise [114].
An alternative approach to ECG feature extraction is proposed by Herrero et al. in [115] (which is also utilized in [112] as well by the same group).
Their approach consists of utilizing the Matching Pursuit algorithm [91] in order to decompose an ECG beat into a linear expansion of waveforms selected
from a redundant wavelet packet dictionary. Then the expansion coefficients
along with the normalized residual energy are used as inputs to an Artificial
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Neural Network (ANN) to classify the beat. The main disadvantage of their
approach is that for every beat that needs to be detected, a different decomposition is required and an individual neural network is employed, e.g. five in total, which is equal to the number of distinct classes. The computational overhead is further increased by the use of two ECG leads and by the computation
of the normalized residual energies.
Motivated by the approach presented in [115], we propose in this section a variation of that scheme, which is considerably more computationally
efficient due to the following reasons: a single ECG lead is used, less features
are derived and a single ANN is required for classification and the residual
energies do not need to be computed. To illustrate the effectiveness of our approach, we describe in detail the feature extraction process and we evaluate
our method using the MIT-BIH Arrhythmia database [99]. We also study the
effect of the following attributes on the classification performance: the number
of atoms used for approximation, the type of wavelet employed for constructing the dictionary and the number of ECG samples around the R peak that are
processed. Finally, we discuss the improvement in terms of the significantly
reduced computational overhead, a fact which allows for implementation of
the proposed scheme in a resource constrained portable device.
As it was mentioned above, beat morphologies may show significant intra-class variability. For example in Fig. 3-20 we can see all the PVC beats ex78

tracted from record 200 of the MIT-BIH Arrhythmia database superimposed on
each other. The pattern corresponding to that particular beat class shows significant variability even in the one single recording taken from one patient. As a
result, employing the MP algorithm on a single ECG beat template of each class
(in order to decide the atoms to be used for approximating that particular class)
could result in dismissing signal details of same-class beats with considerable
morphological deviations from the chosen template.
As a result, we have followed a modified MP approach in our study
which works as follows:

Fig. 3-20. Superimposed PVC beats from record 200 of the MIT-BIH Arrhythmia database.
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1) First we select 10 representative beats for each class of interest from
each MIT-BIH record that actually contains beats corresponding to that specific
class (resulting in a set containing 380 normal beats, 250 PVC beats, 40 LBBB
beats, 60 RBBB beats, 110 APC beats, 20 paced beats and 20 PFUS beats). For
each beat we collect 256 samples around the R peak using the database’s annotations (90 samples before the R peak and 165 samples after). We also save the
R-to-R interval before the R peak as well as the average RR interval before the
previous beat, which is taken as the average of the five preceding intervals.
2) Then for each class we try to determine the set of most representative
atoms by identifying in each step the atom which maximizes the sum of absolute values of the projections of all beats in that class on the specified atom, e.g.:
(Eq. 3-25)
After pi has been determined, we subtract the projection of the ECG
beats on that wavelet packet from their previous residuals (individually) and
then the process repeats until we have a satisfactory number of atoms. Our approach here varies from the one from Herrero et al., who initially perform the
MP algorithm for every beat in their training set individually and then choose
the set of atoms that have maximum overall correlation with the ‚denoised‛
waveforms, without considering the overall residual energy in their choice of
atoms.
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3) For every class we collect the top-ranking atoms returned from the
previous steps. Then we look at all the atoms collected for all classes and we
discard the ones that are repeated. The remaining wavelet packet waveforms
are kept and are utilized for projecting the ECG beats. The inner products of
these projections together with the RR interval features mentioned in 1) are utilized as inputs to a single ANN to perform beat identification. Before feeding
the inputs to the ANN, all data are normalized by subtracting the mean and
diving by the standard deviation, while for the testing data the mean and standard deviation obtained during the training phase are employed.
It should be noted here that before performing the above procedures,
we preprocessed all MIT-BIH Arrhythmia records using a) a median filter with
a 300ms window to remove baseline wander and b) 4-level undecimated wavelet denoising to remove high frequency noise. Also, only a single-lead of ECG
data was used, namely the modified limb lead II (MLII), which has been obtained via chest electrodes, producing a trace that is morphologically similar
from that recorded with a wearable chest band. Furthermore, the beat types
that were considered in our study are: Normal (N), Premature Ventricular Contraction (PVC), Left Bundle Branch Block (LBBB), Right Bundle Branch Block
(RBBB) and Paced. Examples of these beat patterns are shown in Fig. 3-21. We
also considered classifiers that identified Atrial Premature Contractions (APC)
and Fusion of Normal and Ventricular Beat (PFUS).
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Fig. 3-21. Several beat types extracted from records 106, 208, 111, 118 and 217 of the MIT-BIH
Arrhytmia database.

All beats pertaining to above classes were extracted from all MIT-BIH
Arrhythmia records (except for records 102 and 104 that do not include a MLII
lead trace) using the first half of each record as part of the training set and the
second half in our testing set. The precise number of beats that were utilized
from each class for training and testing are shown in Table 3-1.

Table 3-1. Number of beats from each class used for training and testing.

Number of Beats

Training

Testing

N

37373

37352

PVC

3542

3531

LBBB

4036

4033

RBBB

3626

3623

Paced

1808

1808

PFUS

367

367

APC

1237

1233

Total

51989

51947
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3.3.4

Results
In order to determine the most suitable wavelet type to construct the

wavelet packet dictionary, we experimented with Daubechies (d), Coiflet (c)
and Symmlet (s) wavelets. Fig. 3-22 and Fig. 3-23 depict the approximation error versus the number of atoms used for approximating a normal beat and a
PVC beat. The most efficient wavelet from each family (s8, d8 and c3) was determined empirically after several tests, whereby the ability of each wavelet to
approximate selected patterns of interest was evaluated. These figures show
also the approximation error in the case that 64 samples around the R peak are
used for each beat.

Fig. 3-22. Normalized approximation error (e.g. normalized residual energy as defined in section
3.1.4) vs number of atoms (normal beat).
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It can be noticed that in this case, by using just 8 atoms of either family, the approximation error for both types of beats is less than 1%.
In addition to that, when performing steps 1-to-3 as described in the
previous section, we found that in general the Symmlet 8 family achieved the
best performance in terms of average and maximum residual error energy for
most of the beat classes. However, as we can see for example in Fig. 3-23 for the
case of the coif3 wavelet family and the PVC beat, other types of wavelets
might be particularly efficient in representing a specific beat-type.

Fig. 3-23. Normalized approximation error (e.g. normalized residual energy as defined in section
3.1.4) vs number of atoms (PVC beat).
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To illustrate how ECG beat patterns get approximated by a sub-optimal
linear combination of wavelet packet atoms we show in Fig. 3-24 a normal ECG
beat (taken from record 123 of the MIT-BIH Arrhythmia database) and its approximation using 8 coiflet3 wavelet packet atoms. The approximation error in
this case is 2.53%. Also in Fig. 3-25 we can see the top 6 wavelet packet atoms
that were selected by the Matching Pursuits algorithm. The 6 waveforms (together with the next 2 wavelet packet atoms) are weighted according to the
projection coefficients and then added together to produce the approximation
of the ECG beat that we saw in Fig. 3-24.

Fig. 3-24. Original signal (normal beat pattern taken from MIT-BIH Arrhythmia DB record 123)
and MP approximation using 8 coiflet3 wavelet packet atoms.
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Considering the fact that this level of approximation is obtained by a
simple linear transform (a multiplication of a 256-point vector with a 256 8 matrix) and that we end up with an 8-dimensional pattern word in contrast to the
original 256 element vector, we automatically notice the advantages of employing the MP algorithm for feature extraction and compact waveform representation. However, we still need to verify that the extracted MP coefficients (e.g.
inner products between ECG beats and wavelet atoms) constitute good features for beat discrimination and classification.

Fig. 3-25. The first six wavelet packet atoms chosen from the MP algorithm in order to
approximate the ECG beat dipected in Fig. 3-24.

To do that, as a first test we examined the discrimination of N and PVC
beats using 10 atoms of a Symmlet 8 wavelet packet dictionary. It turns out
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there are no common atoms selected for the two classes and as a result we end
up representing each beat with 22 features (10 atoms for each type of beat plus
the 2 RR interval features). Using a single 2-layer ANN with 22 hidden neurons
and 2 output neurons, all employing hyperbolic tangent transfer functions, the
sensitivity of the classifier for normal beats was 99.6% and for PVC beats 97.8%,
which are almost identical with the accuracy of the corresponding classifier
proposed in [115], which employs 48 features (2 ECG leads, MP residuals and
some Independent Component Analysis derived features) and a 3 layer ANN.
Further tests included the classification of the 5 beat types mentioned in
the previous section. In this case we experimented with the number of samples
around the R peak that were utilized (256, 128 or 64), with the type of wavelet
employed and with the number of atoms used for approximation. Sensitivity
and Specificity results for the five beat classes in various cases are shown in
Table 3-2. In all cases a 2-layer MLP ANN was employed, with the number of
hidden neurons equal to the number of input features and 5 output neurons,
one corresponding to each class. It was found that employing a 3-layer MLP
did not result in greater classifier accuracy, while it significantly increased the
training time (plus there is added computational load due to the extra layer).
We notice from Table 3-2 that using more samples around the R peak
(to possibly include parts of the P and T waves) does not necessarily increase
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the classification accuracy, to the contrary performance tends to be slightly degraded when using more samples.

Table 3-2. Classifier performance in various cases
Class
# Beats
Sens. (1)

N
37352
99.4%

PVC
3531
95.3%

LBBB
4033
94.7%

RBBB
3623
77.2%

Paced
1808
99.9%

Spec. (1)

96.5%

99.1%

99.5%

99.9%

99.4%

Sens. (2)

99.2%

97.9%

92.6%

99.3%

99.9%

Spec. (2)

99.3%

99.0%

99.8%

99.9%

99.9%

Sens. (3)

99.3%

97.7%

94.8%

98.2%

99.9%

Spec. (3)

98.9%

99.5%

99.8%

99.9%

99.7%

Sens. (4)

99.4%

97.3%

92.3%

99.1%

99.9%

Spec. (4)

97.5%

99.6%

99.8%

99.9%

99.9%

Sens. (5)

99.1%

96.4%

93.8%

97.9%

99.9%

Spec. (5)

98.6%

99.3%

99.6%

99.9%

99.9%

Sens. (6)

99.1%

97.3%

95.3%

98.2%

99.8%

Spec. (6)

98.5%

99.4%

99.6%

99.9%

99.9%

Sens. (7)

99.0%

97.3%

93.3%

98.3%

99.9%

Spec. (7)

98.9%

99.0%

99.6%

99.9%

99.9%

Sens. (8)

99.3%

97.3%

93.6%

99.3%

99.9%

Spec. (8)

99.2%

99.5%

99.8%

99.9%

99.7%

Sens. (9)

99.0%

96.7%

95.2%

98.0%

99.9%

Spec. (9)

98.6%

99.3%

99.7%

99.9%

99.9%

Case (1): 6 atoms/class; 22 features; s8 wavelet; 64 samples
Case (2): 8 atoms/class; 31 features; s8 wavelet; 64 samples
Case (3): 10 atoms/class; 39 features; s8 wavelet; 64 samples
Case (4): 8 atoms/class; 29 features; s8 wavelet; 128 samples
Case (5): 10 atoms/class; 32 features; s8 wavelet; 256 samples
Case (6): 10 atoms/class; 32 features; d8 wavelet; 64 samples
Case (7): 10 atoms/class; 32 features; c3 wavelet; 64 samples
Case (8): 15 atoms/class; 52 features; s8 wavelet; 64 samples
Case (9): same as case (9) only PCA was employed to reduce the number of features to
32
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As a result, extracting just 64 samples around the R peak, which corresponds to
about a 178ms window for 360Hz sampling frequency, was proven sufficient
for achieving satisfactory performance. In addition to that, less samples translates to less computations as we will see in the next section.
We can also see that utilizing 10 atoms to approximate the beats in each
class leads to the best overall performance, while using significantly more
atoms, as in the last 2 cases, did not lead to better results (even when we employed Principal Component Analysis to reduce the number of features). Additionally, it is also verified that employing Symmlet wavelet packets yields the
best performance compared to other wavelet types, at the expense of employing more wavelet packets than in the other 2 cases, e.g. 39 versus 32.

Table 3-3. Confusion Matrix for the case of 7 classes

N

PVC

LBBB

RBBB

PACED

PFUS

APC

N

36644

62

54

59

1

35

170

V

236

3420

21

4

0

70

77

L

247

25

3958

0

2

0

0

R

36

4

0

3557

0

0

5

P

0

0

0

0

1805

0

0

F

106

8

0

0

0

262

0

A

83

12

0

3

0

0

981

SE%

98.1%

96.9% 98.1% 98.2% 99.8% 71.4% 79.6%

SP%

97.4%

99.2% 99.4% 99.9%
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100%

99.8% 99.8%

Finally an additional test was performed attempting to consider also the case of
APC and PFUS beats by using 64 samples/beat and 8 atoms/class selected from
the s8 wavelet family (requiring 34 features). Table 3-3 presents the corresponding confusion matrix, yielding degraded sensitivity for the two additional
beat types, as PFUS and APC tend to be misclassified as either normal or PVC.
To further evaluate the performance of the proposed ECG beat classification scheme, we will now consider some of the most popular approaches
found in the literature for ECG classification in order to compare the performance of the described scheme with other state-of-the-art ECG classifiers.
However, one thing that needs to be mentioned at this point is that although
the MIT-BIH Arrhythmia database has been adopted by the majority of the researchers working on ECG classification, the comparison metrics, the number
of beats used and the number and types of arrhythmic beats that are classified
tend to vary significantly. For example, about 70% of the ECG beat annotations
are Normal Beats [87]. As a result, some researchers have chosen to utilize
more balanced datasets in their work, by including almost same number of
beats that they are interested in classifying [116]. Consequently, such an approach cannot yield directly comparable results since they are based on significantly different training and testing subsets of the database.
Table 3-4 compares the classification accuracy (for the five main beat
classes considered in our work e.g. normal, premature ventricular contraction,
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left bundle branch block, right bundle branch block and paced beat) of our
work with other popular approaches. We are aware that there are other advanced methods that can be employed for ECG classification [100], but the
purpose of our comparison here is not to strictly prove which classifier derives
the most accurate performance, but to indicate that after extensive training and
tests, the proposed approach, as simple as it is, it derives classification results
compared to high-accuracy algorithms while at the same time being computationally inexpensive so that it may be easily implementable and executable in
real-time on a resource constrained device such as a smart-phone.

Table 3-4. Classification accuracy comparison for the five main beat classes considered
in our study.
N

PVC

LBBB

RBBB

Paced

Our Method

99.1%

97.3%

95.3%

98.2%

99.8%

Christov et al. [112]

98.9%

94.8%

98.9%

98.7%

99.9%

Herrero et al. [115]

99.7%

95%

99%

99.6%

99.6%

Oresko et al. [111]

99%

92.6%

-

98%

96%

Suarez et al. [117]

99.5%

81.6%

99.4%

98.9%

99.5%

Yu et al. [118]

99.7%

98.5%

96.3%

99.2%

99.4%

Rodriguez et al. [110]

97.9%

92.8%

98.9%

96.7%

98%

de Chazal et al. [87]

99.2%

81.2%

-

-

-

Osowski et al. [113]

98.1%

96.6%

97%

94%

-
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3.3.5

Conclusions
To conclude our contribution in this section, we have studied the effec-

tiveness of using the projections of ECG beat samples on wavelet packet atoms
obtained from the Matching Pursuit algorithm, as features for ECG classification. We examined the effects of the number of atoms, number of data samples,
of the wavelet type and of the number of classes in the performance of an
ANN-based classifier. Our goal was to derive a compact set of features, which
can be easily computed from a single-lead ECG, to be used as inputs of a single
MLP network.
Compared to the approach of Herrero et al. [115] our approach achieves
comparable classification accuracy, with considerably less features and less
computational effort, for all beat types, except for the LBBB class where the
sensitivity is at best 95%. This highlights the fact that to better identify the beats
of this class two leads might be more useful.
Calculation of the projection coefficients is achieved by simple matrix
multiplication and is proportional to the number of features used (which depends on the number of classes, the type of wavelet and the number of atoms)
and to the number of data samples extracted around the R peak. For example,
in the case (3) of Table I, to project each beat we need to multiply a 1 64 data
vector with a 64 39 atom matrix, which requires 39 64=2496 multiplications
and 39 63=2457 additions. Then to classify the beat we need to feed it to a 39-5
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MLP, which requires 39 39=1521 multiplications and 39 39=1521 additions in
the first layer and 5 39=195 multiplications and as many additions in the
second layer (plus applying the hyb. tangent 44 times). In total we have: 4212
multiplications and 4173 additions.
In the case of [115], 11 features are extracted with 256 samples per beat
and per lead, leading to 110 features per beat, while 5 different ANNs are required for classification. In total, if we follow all the calculations, we see that
there are totally 147345 multiplications and 149785 additions required (plus
applying the hyb. tangent 830 times), which are about 35 times than in our
case, a fact which highlights the effectiveness of our proposed approach.
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4

CHAPTER 4: THE FUNCTIONAL DESIGN FRAMEWORK OF
THE PROGNOSIS WEARABLE HEALTH MONITORING SYSTEM
In this chapter we introduce the concept of the proposed Prognosis

wearable health monitoring system by providing an in-depth analysis of the
underlying functional design framework and reasoning mechanism. First a generic modular architectural model of a multi-sensor wearable health monitoring system will be presented and discussed in order to identify the key hardware and software components of a WHMS. Then, a novel physiological data
fusion strategy based on a context-free formal language will be presented. Finally, we will provide a detailed functional description of the Prognosis WHMS
in terms of a Stochastic Petri Net (SPN) model, which is able to capture and illustrate the concurrent and synergistic tasks that are present in the proposed
system.

4.1

Generic WHMS Architecture
In this subsection we will discuss a generic architecture for wearable

health-monitoring systems in order to provide more insight into the specific
hardware and software components, of which an intelligent multi-sensor personal health system is composed. We will be using this architectural model
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throughout this chapter as the starting point or reference, on which the novel
components that are presented in this dissertation will be added.
The generic architectural model is depicted in Fig. 4-1. Physiological
biosensors constitute the front-end components of the system and they can be
employed to measure a variety of bio-signals produced by the human body,
including vital signs such as blood pressure, pulse rate, body temperature and
respiration rate as well as other physiological signals like electrocardiogram,
electromyogram and oxygen saturation. A comprehensive list of currently
available biosensors along with the type of physiological data they are used to
measure was given in Table 2-1.

Fig. 4-1. Generic WHMS architecture
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However it is not within the scope of this research to investigate new sensing
technologies or to analyze current ones. In contrast to that, the work presented
and proposed here is based on current sensor availability, however it is scalable and easily expandable and could thus incorporate new sensing technologies
in the future.
As it was seen in the various systems that were reviewed in the second
chapter, the wearable physiological sensors can be either embedded in clothing
as smart textiles or they can be integrated on other types of wearable devices,
such as wrist devices, ear-lobe sensors, finger sensors, arm bands, chest belts,
waist belts etc. In the latter case, the distributed bio-sensors are capable of wirelessly communicating their measurements and thus constitute a Body Area
Network (Fig. 1-1), which can be either formed through Bluetooth enabled devices or through Zigbee motes. Basic signal conditioning operations such as
filtering, amplifying and analog-to-digital conversion or even basic feature extraction is usually performed by dedicated hardware, which is either embedded on the sensor as a single integrated chip (IC) or on the central node.
The central node of the WHMS consists of some type of portable platform, such as a personal digital assistant (PDA), smart-phone, pocket PC or
even a custom designed microcontroller board. In either case, the WHMS central node is responsible for several tasks:
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1. Handling the communication with the on-body distributed biosensors,
which involves: collecting physiological measurements, communication
synchronization, sending control signals for adjusting sensors’ parameters,
e.g. sample rate, accuracy etc and finally also receiving sensor status data.
2. Performing additional digital signal processing on the acquired signals for
feature extraction.
3. Verifying the received data, e.g. checking the validity of the received data
via an advanced algorithm and discarding those that are found to be erroneous.
4. Comparing the extracted features or values from each signal with the thresholds, limits or patterns located in the local signal database, which may
contain patient-specific information about abnormal states, in order to possibly detect any health risks. This task is what we will be referring to as
embedded decision support.
5. Generating alarm signals for the user.
6. Displaying the collected measurements on the Graphical User Interface
(GUI) in real-time.
7. Transmitting the extracted medical information about the user to a remote
medical station, e.g. to a medical center or to a physician’s cell phone, either
in real-time or in terms of report forms upon request or upon detection of
events.
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The functional description of the WHMS given above pertains to the
majority of the up-to-now developed wearable system prototypes or commercially available products in the field of remote health monitoring. However,
features 3 and 4 of the central node, e.g. validity check and embedded decision
support, as seen in the previous chapter, are either barely or partially supported in most systems, for example by employing simple if-then rules to provide notifications when certain measurements exceed certain predefined thresholds.
In addition to the previously mentioned WHMS components, we propose to include an additional feature in the system design in order for the system to be able to get additional feedback from the user about non-measurable
symptoms, namely to add a voice-driven interaction mechanism between user
and WHMS. This is shown graphically in Fig. 4-1 where the system is capable
of verbally interacting with the user by means of a speech recognition/synthesizer component and an automated dialogue system. The motivation behind this approach is illustrated in Fig. 4-2.
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Fig. 4-2. Tables describing the extraction of symptoms from body signals by available biosensor
technologies and human-system interaction.

Namely, the fact is that for an accurate estimation of one’s health condition and
the diagnosis of many, if not the most, diseases several other symptoms than
just the ones detected from biosensor measurements, need to be taken into consideration [119], [120], [121]. These symptoms, like cough, malaise or chest discomfort for example, are either not measurable at all or they cannot be estimated without using invasive methods, e.g. as in the case of determining electrolyte levels in the body.
Coming back to Fig. 4-2, the green frame includes a comprehensive list
of most of the physiological parameters, which can be measured noninvasively and which need to be taken into consideration and properly evaluated in order to diagnose a patient. This list is not exhaustive and it does not
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include findings, which can only be obtained from thorough clinical examinations and tests like MRI, CT scan, chest radiology and other medical and laboratory examinations typically performed in a hospital. By using bio-sensor technologies such as those listed in Table 2-1, the symptoms listed in the light blue
frame in Fig. 4-2 can be detected (symptoms 1-11).
Entries 12 and 13 in the green frame and all the entries in the red frame
in Fig. 4-2 constitute additional symptoms and physical signs, which are associated with a great variety of diseases. These symptoms, once detected or quantified, provide important information, which together with the measured vital
signs provide a more comprehensive description of what is referred to as the
clinical presentation, which under proper interpretation may lead to a specific
diagnosis. However, in order to get feedback from the patient about the possible existence of these symptoms either the patient himself has to describe them
or in case of some of these physical signs (12 and 13), they can only be measured in an invasive way using current sensor technologies.
As a result, by incorporating a speech recognition module in the system
design along with an automated speech dialogue system between the device
and the user, additional non-measurable symptoms related to the physical
condition of the patient could be captured by the WHMS.
Finally, returning to Fig. 4-1, alarm signals and measured physiological
data along with the feedback from the patient can be transmitted through the
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cellular network or the Internet to the medical center and possibly also to a
dispatched ambulance in case of an emergency, as it was also described in Fig.
1-1. As the healthcare center keeps a database with the long-term detailed medical history of the patient, the received data and the detected patient symptoms
can be put into a wider context and can also be further evaluated by a supervising physician to derive a more accurate estimation of the patient’s health.

4.2

The Prognosis Formal Language
The Prognosis language is a theoretical model, around which the weara-

ble monitoring and early prognosis system has been designed. The basic hypothesis of this model is that the various body or physiological signals produced
by the human body are composed of ‚symptoms of health‛ whose occurrence
under certain conditions may indicate the presence of a specific health risk. The
aim of the Prognosis formal language is to provide an efficient and compact representation of the multiple combinations of extracted physiological measurements in order to aid in the association of ‚pathological‛ symptoms and patterns with the detection or estimation of a corresponding health condition.
The proposed formal language model is coupled with the generic
WHMS architecture described in the previous section. Specifically, the sensors
that are included in the WHMS provide real-time measurements of physiological data, from which corresponding symptoms of health are extracted. These
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symptoms may be considered as normal (benign) or alarming (e.g. dangerous
or hazardous). However the degree of dangerousness (or severity) and the degree of actual occurrence of a specific symptom are fuzzy in nature [122]. As
the philosopher of medicine Kazem Sadegh-Zadeh has stated in [123]: ‚health
is a matter of degree, illness is a matter of degree and disease is a matter of degree‛. Furthermore, the founder of fuzzy logic, Lofti A, Zadeh was the first one
to suggest that a fuzzy set could be used to denote the degree of relation of a
disease to various symptoms, which are also fuzzy in nature as well [124].
As a result, the fuzzy symptoms that can be extracted from the physiological sensors generate the set of terminal symbols of the Prognosis formal language. The three basic types of symptoms that can be extracted from the acquired physiological signs correspond to the three basic types of signals or information the system is able to collect about the patient, namely: a) signals that
are ‚value-specific‛, e.g. their instantaneous value carries the actual diagnostic
content, b) signals that are ‚morphology-specific‛, e.g. their structural morphology and timing are the elements that carry important diagnostic information and c) voice recordings that may reveal the presence of a specific health
symptom as described by the user.
In the following subsections we will first describe how fuzzy symptoms
are extracted from each family of collected data and how these symptoms are
finally described in terms of terminal (fuzzy) symbols in the formal language.
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This section will finally be concluded by giving a formal definition of the Prognosis formal grammar and by providing simple illustrative examples to show
the language’s operation.

4.2.1

Category of value-specific physiological symptoms
The most typical and common physiological data, which can indicate

the presence of symptoms that fall in this category, are systolic and diastolic
blood pressure, respiration rate, body temperature, glucose level, heart rate
and oxygen saturation. These types of physiological signals are characterized
as value-specific because according to their current value we may extract a certain symptom (or decide that the signal level is not alarming). For example, a
body temperature measured over 100⁰F is normally considered as fever (or
light fever) [120]. Furthermore, a heart rate under 50 BPM (beats per minute) is
considered as abnormally low.
The value range of this category of physiological data can be divided in
several levels of importance. For example, blood pressure measurements are
commonly classified as indicating hypotension (low blood pressure), a normal
blood pressure level, prehypertension (slightly high blood pressure), stage 1
hypertension (high blood pressure) and stage 2 hypertension (very high blood
pressure) [120]. This categorization of signal values into levels of importance
serves the purpose of indicating the severity level of a physiological measure-
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ment and also the purpose of formally describing the progression of a possible
abnormal health incident. A rather simple and straightforward manner according to which signal levels could be characterized is depicted in Fig. 4-3, e.g. a
value can be characterized as being either normal, low or high or even very low
or very high according to crisp thresholds.

Fig. 4-3. Crisp characterization of hypothetical signal values

However, the characterization of signal values in a crisp manner as
shown in Fig. 4-3 is rather subjective and strict and also it does not capture the
level of progression of a specific symptom. A better alternative is to employ
linguistic variables, e.g. fuzzy sets [125], to describe the degree of occurrence of
a certain symptom. This approach has also been adopted successfully in several
other works concerned with computer aided medical diagnosis, such as in the research efforts presented in [126], [127]. We should also stress the fact here that
it is generally accepted that there are no universal and fixed thresholds for characterizing signals levels as being normal or abnormal or very risky etc [120].
On the other hand, some rules of thumb or generally accepted signal limits do
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exist. However, in this research we want to consider the fact that different individuals due to their individual physiology and medical history, nutrition,
genes etc may have different normal signal values. As a result, the thresholds
for characterizing signal levels will be adaptable in the system and not hardcoded. This issue will be thoroughly discussed and addressed in Chapter 6.
Finally, coming back to the fuzzy characterization of health symptoms
extracted from raw physiological measurements, we can make use of the approach presented in Fig. 4-3 and then by fuzzifying the limits between signal
levels we can get the corresponding fuzzy symptoms. Fig. 4-4 through Fig. 4-9
depict how fuzzy symptoms are extracted from the systolic and diastolic blood
pressure and from the heart rate, respiration rate, body temperature and oxygen saturation levels.

Fig. 4-4. Fuzzy symptoms extracted from systolic blood pressure.

Fig. 4-5. Fuzzy symptoms extracted from diastolic blood pressure.
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Fig. 4-6. Fuzzy symptoms extracted from the heart rate level.

Fig. 4-7. Fuzzy symptoms extracted from the respiration rate level.

Fig. 4-8. Fuzzy symptoms extracted from the body temperature level.

Fig. 4-9. Fuzzy symptoms extracted from the oxygen saturation level.

The reason for deciding to define symptoms as fuzzy sets on the range
of measurements of each bio-signal will be made obvious later on when we de106

fine the Prognosis formal language, where the fuzziness of the symptoms will
help us determine a confidence level (or ‚degree of support‛ as stated in [126])
for the currently estimated health state of the patient.
We should also note here that the membership functions chosen in the
fuzzy sets shown in Fig. 4-4 through Fig. 4-9 are trapezoidal. However this is
just an assumption that we adopt in our model since there are numerous types
of different memberships functions that can be employed for describing a
fuzzy set [125], for example triangular, sigmoidal or Gaussian. For now we can
assume that these functions are trapezoidal, however there are techniques that
can be used to derive an optimal estimation of the shape of the membership
functions for a given problem as we will explain in chapter 6.

4.2.2

Category of morphology-specific physiological symptoms – ECG
This category includes body signals, which describe the electrical activi-

ty of various body parts, amongst which the most common ones are the electrocardiogram (ECG), the electroencephalogram (EEG) and the electromyogram (EMG). Detecting healthy and pathological symptoms in such kind of
signals is a complicated process and it requires careful conditioning of the signal (e.g. filtering, amplifying etc) and intelligent signal processing for feature
extraction [96].
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In this work we will only consider electrocardiographic signals. ECG’s
are a well-studied medical tool, which has also been widely employed in
WHMS (as we saw in Chapter 2). Furthermore the automatic detection of heart
beats, the extraction of ECG related parameters and the classification of beats
and rhythms as normal or arrhythmic has been widely researched by the engineering and medical community (as discussed in Chapter 3). Furthermore in
Chapter 3 we presented a methodology for classifying ECG beats on a resource
constrained device, while achieving close to real-time performance and classification accuracy within medically acceptable margins.
In any case, the goal of the ECG processing stage is to derive a confidence grade for the detected type of heart beat, which will be utilized by the
Prognosis formal language in the estimation of the user’s health condition.

4.2.3

Category of non-measurable symptoms
This category of symptoms includes conditions and information which

is not measurable and not-quantifiable by conventional bio-sensors of any type.
As mentioned in the beginning of this chapter, patient symptoms such as malaise, headache, dizziness, chest-pain, sputum, disorientation, back pain, running nose etc are conditions that cannot be measured by sensory devices. As a
result, only the patient himself can provide information of this sort to the diagnostician or to the wearable system via a question-answer process.
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For example, a patient may signify during an examination that he has
been experiencing chest discomfort. The physician will then try to acquire detailed information regarding that symptom e.g. does the symptom show instantaneous or periodic occurrence, is it mild or severe, is the symptom aggravated by movement, are there any other relevant symptoms etc. This extra information can aid the physician in diagnosing the cause of the corresponding
condition of the patient.
As it will be discussed in chapter 7, we propose the integration of a user-device dialogue scheme in order for the WHMS to be able to capture and
also to take into consideration such non-measurable symptoms. For example
the user may indicate the presence of a condition, such as headache for example and then the system could proceed to ask the user to quantify that symptom, e.g. as being benign, mild or weak, moderate, strong or severe. These linguistic variables describing the severity level of the corresponding symptom
may be translated to a score in the [0, 1] scale in order to provide a quantitative
estimation of the symptom’s strength. This quantification of the symptom’s
strength can be utilized from the Prognosis language in the process of estimating the health status of the user with a specific degree of confidence, a process
that will be explained thoroughly in the subsequent sections.
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4.2.4

The Prognosis Formal Grammar

4.2.4.1

Basic Definitions
As we know a formal language [128] is produced by a grammar which

is defined as:
Definition 1: A formal grammar G is defined as:
set of non-terminals or variables,
and

whereby:

is the alphabet,

is the

are the production rules

is the start symbol.

In addition to that the definition of a regular language is:
Definition 2: A regular language is a formal language produced by a grammar G,
whose production rules P have the form:
nal symbols,

and B are non-terminal symbols and

where:

are termi-

is the empty symbol.

We also know that a regular language is equivalent to a Finite State
Machine:

Definition 3: A Finite State Machine (FSM) is denoted
is a finite set of states,
to ,

is a finite alphabet,

where:
is a transition function from

is the initial state and F is the set of final/accepting states.

Extending the above definitions to fuzzy regular languages and fuzzy
automata as described in [129], we can define a fuzzy finite automaton as:

Definition 4: A fuzzy automaton is a 7-tuple
is a crisp automaton,
weight to every transition and

, where:
associates

a

is a t-norm.

In the case of fuzzy finite automata as defined above, we can also see
the equivalence between a FSM and a regular language. Namely, the above
fuzzy automaton is equivalent to a fuzzy regular language, which has a weight
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associated with every transition. At the end of a string production, the derived
word has a membership degree associated with it, which is obtained by applying the t-norm on the sequence of derivations.
Adopting the fuzzy automaton model for our case and defining Prognosis as a fuzzy regular language, we can give the following definition:
Definition 5: The set of states

or equivalently the set of non-terminals V denotes

the set of all possible health states of the patient/user. These states are defined as
the states resulting from all possible combinations of health symptoms which are
extracted from the measured physiological data, from the user’s context and
from the user’s non-measurable symptoms. There are no explicitly defined accepting/final states as any state included in the FSM signifies a possible health
state of the user and as such we will always consider a continuous transition
(trajectory) between states from the moment the system is turned on until it is
turned off.
Definition 6: The alphabet

consists of the set of all observable symptoms (and

contexts) in the system. Examples of these symptoms include: tachycardia, hypertension, fever, high respiration rate, low oxygen saturation, ectopic heart
beat, abnormal heart rhythm, cough, chest-pain, lying on back, running etc.
These symptoms are defined as fuzzy (linguistic) variables and each one has a
degree of membership (DOM)

associated with it, where:
,

and x is the actual measured value. The DOM denotes the certainty or strength
of the corresponding symptom.
Definition 7: The start symbol S or the initial state q0 signifies the initial (normal)
health state of the user.
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Finally, before moving on to formally defining the set of production
rules of Prognosis (or equivalently the transition function in the FSM representation) we need to consider how diseases or disorders are usually specified in
medical terms and how their correlation to a variety of symptoms is analyzed
by diagnosticians. As it is described in [122], a general outline of a systematic
diagnostic approach is:
1. Obtain case facts (physiological measurements, symptoms, medical
history etc).
2. Evaluate the importance of different signs and symptoms.
3. Make a differential diagnosis, e.g. list all possible diseases which the
specific case can reasonably resemble.
4. Try to exclude diseases by further evaluation of additional signs
and symptoms.
Following that way of thinking we may be tempted towards trying to
imitate that process in deriving a specific diagnosis. However this is not the
goal of the proposed model. What we are actually aiming at here is a way of
following the progression of health symptoms so as to be able to derive at any
given time an estimation of the user’s health condition in order to possibly
detect health risks by identifying dangerous health trends.
To be able to do that we need to embed knowledge into our model regarding how the occurrence of several symptoms is related to a variety of
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disorders and to what degree the presence of a specific symptom under a certain context points towards a specific medical disorder or health state. This is
what is commonly regarded as medical knowledge and it is the element that
will help us determine the confidence factors relating the occurrence of a symptom to the detection of a certain disorder. In other words, medical knowledge
will aid us in defining the approximate values of the connection weights or
equivalently the degrees of confidence associated with each production rule in
the language or with each transition in the FSM representation of the model.

4.2.4.2

Some notes on Medical Expert Systems and Medical Knowledge Representation
As we explained, gathering medical knowledge in order to establish a

well-defined, easy-to-access and standardized knowledge representation
scheme is of crucial importance to the current research goals of this dissertation. Before elaborating on this part, we need to briefly mention some research
efforts and corresponding decision support systems (DSS) which constitute
pioneer works in the field of medical expert systems and which have greatly
inspired the author in his current research.
One of the earliest and most influential medical expert systems was
MYCIN [130], [131] and particularly its essential version called EMYCIN [132],
[133]. MYCIN was a rule-based systems using weighted rules and combining
functions to calculate the global degree or certainty of suggested diagnoses. It
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was used to diagnose several types of infections and to suggest treatment options. Two basic measures of uncertainty were used in MYCIN, the measure of
belief (MB[h,e]) which expresses the degree to which an observed piece of evidence e increases the belief in a hypothesis h and the measure of disbelief
(MD[h,e]) that expresses the degree to which an observed piece of evidence e
decreases the belief in a hypothesis h:

(Eq. 4-1)

(Eq. 4-2)

Where P(h|e) and P(h) represent conditional and a priori probabilities
and the final certainty factor of the hypothesis h given the evidence e is given
by:
(Eq. 4-3)
CADIAG-II (Computer Assisted DIAGnosis) [133] - [135] was an expert
system for internal medicine, aiding physicians in diagnoses and utilizing
fuzzy set theory and the compositional rule of inference by Zadeh [124]. Adlassnig [134], [135] defined two fuzzy relations to describe the ‚medical knowledge‛ connecting symptoms, findings, test results and disorders: occurrence
(of frequency of occurrence) and confirmability

(how strongly does a

symptom confirm a disorder). These relations or metrics can be quantified by
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the following formulas which are based on specifying relative frequencies (F(:)
denotes frequency of an event):
(Eq. 4-4)

(Eq. 4-5)
These functions could be determined by (a) linguistic documentation by
medical experts and (b) medical database evaluation by statistical means (as
described by the two formulas above), or a combination of both. Adlassnig
used max-min inference rules to quantify the degree of membership of a given
patient P to a specific disorder D. By doing that one could distinguish between
three resulting qualities of examined diagnoses: confirmed diagnoses, excluded
diagnoses and generated diagnostic hypotheses.
As it is shown by the example of the two medical expert systems discussed above, fuzzy quantities utilized in fuzzy reasoning can either be specified using statistical means or by expert-knowledge acquisition. In many cases,
such as the ones addressed by the EMERGE expert system for evaluating diagnoses of patients suffering from chest pain and the Hypernet expert system for
diagnosing heart disease (reviewed by Hudson et al. in [136]) there might be
labeled experimental data available to construct the rule base. Large evidence
bases are required especially when parameters such as the ones described by
(Eq. 4-1) - (Eq. 4-5) are to be determined, since these metrics are statistical in
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nature. However, as it is elegantly emphasized by Lovell et al. [137], ‚the largest hurdle facing the design and validation of the DSS for monitoring chronic
disease patients is a lack of an evidence-base for training such a system". To put
it in different words, there is a serious lack of an evidence-base with labeled
physiological training data in order to derive accurate estimates of the quantities that were defined above for the case of unsupervised physiological monitoring.
In order to construct such a knowledge-base, one would need to monitor several patients over an extended period of time while working with an expert/physician who would be responsible for labeling the acquired multidimensional data and quantifying the patients’ health condition. Then by having
such data at our disposal, we could not only apply approaches such as the ones
adopted in MYCIN and CADIAG-2, but one could also train statistical pattern
recognition

schemes

[138]

(or

well-studied

probabilistic

knowledge-

representation models such as Bayesian Networks and Markov Models) in order to enable the system to accurately recognize certain deterioration events as
they are occurring. Again as Lovell et al. denote [137]: ‚Given the obstacles involved in designing a DSS for telehealth applications, a practical approach will
likely involve a combination of a heuristic system design, inspired by existing
guidelines and clinical expertise, which facilitates incremental improvement
through user feedback and ongoing assessment of classification performance."
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As a result, the approach adopted in this research is to embed medical
knowledge in the WHMS in terms of documented medical experience and
guidelines in the basic form of IF-THEN rules. However in the next two chapters we will elaborate more on how initial choices can be made for several
rules, the parameters of which can be then fine tuned during a patient-learning
process. For now, we will focus on describing how medical knowledge is
usually found in common medical textbooks (or even how it is captured by
professional physicians), how we can capture this information and represent it
in a standardized manner and finally how information relating symptoms and
disorders can be integrated in our model. To illustrate the above point we will
use the example of a relatively common disorder, e.g. pneumonia. The medical
knowledge that will be referenced in this part is taken from [120]. Summarizing
the knowledge and the sign and symptom description regarding pneumonia
we can define the following knowledge structure:
Disorder type: Pneumonia
General Information
Frequency of occurrence: common
Risk level: very high
Risk factors
Alcoholism
Respiratory rate ≥ 30 breaths/min
Hypotension
Typical setting
History of predisposition to aspiration <sometimes>
Clinical Presentation and findings (Symptoms)
Acute or subacute onset of fever <usually>
Cough <usually>
Purulent sputum <usually>
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Dyspnea <usually>
Rales <very common>
Sweat <common>
Chills <common>
Chest Discomfort <common>
Hemoptysis <common>
Fatigue <common>
Anorexia <common>
Headache <common>
Abdominal pain <common>
Hypothermia <common>
Tachypnea <common>
Tachycardia <sometimes>
Mild oxygen desaturation <sometimes>
Malaise <sometimes>
Weight loss <sometimes>
Differential Diagnosis
Upper respiratory tract infections
Reactive airway diseases
Congestive heart failure
Pulmonary hemorrhage
…

It is evident from the structure of the above data that such type of medical knowledge can be captured and stored using an object markup language
such as XML. An example representation of the above medical knowledge is
given below in XML representation (where for simplicity we have not defined
a schema and the corresponding required tags):
<Disorder type=”Pneumonia”>
<info>
<frequency>common</frequency >
<risk_level>high</risk_level >
</info>
<risk_factors>
alcoholism##high respiration rate##hypotension
</risk_factors>
<setting frequency=”usually”>
predisposition to aspiration@@sometimes
</setting>
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<symptoms frequency=”usually”>
fever##cough##purulent sputum##dyspnea##
</symptoms>
<symptoms frequency=”very common”>
rales
</symptoms>
<symptoms frequency=”common”>
sweat##chills##hemoptyis##fatigue##
anorexia##headache##abdominal pain##hypothermia##
tachypnea##chest discomfort
</symptoms>
<symptoms frequency=”sometimes”>
tachycardia##mild oxygen desaturation##
malaise##weight loss
</symptoms>
<diff_diagnosis>
upper resp tract infection##reactive airway disease##
congestive heart failure##...
</diff_diagnosis>
</Disorder>

By repeating the above process for every disorder of interest we can
create a standardized knowledge base using the same template, which allows for
quick parsing and searching. The way this knowledge base can be utilized to
determine the dependence or relation between a certain disorder and a set of
manifestations (symptoms) is by using linguistic variables. For example, in the
above case of pneumonia there are certain symptoms that give a stronger indication of pneumonia and others that might or might not be present at all, thus
in a sense they are ‚contributing less‛ to the occurrence or the confirmation of
that specific disorder. More specific, if the following symptoms are observed:
headache, anorexia and tachycardia, which are labeled as being either common
or less common (e.g. ‚sometimes‛) symptoms in the case of pneumonia, we
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will only have a very weak indication that the patient is suffering from pneumonia. However in the presence of fever, cough and dyspnea there will be a
very strong indication towards that specific disorder.
The previous example serves the purpose of illustrating the process of
determining causal associations between symptoms and disorders and assigning corresponding weights to these relationships. We can consider the following causal relevance levels: never, sometimes (occasionally), often, usually and
always. This set of levels is practically a set of linguistic variables and can be
assigned a corresponding causal relevance grade. An example of how this
could be done is given in Fig. 4-10 (a similar approach to what is proposed in
[126]).

Fig. 4-10. Correspondence between causal relevance level and weight

Another example can be given in the case of hypothermia. Clinically it
is described as the reduction of the body temperature below 35⁰C (95⁰F) and it
includes several stages. The low body temperature value is a symptom that
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needs to be present in order to be able to diagnose hypothermia. Other clinical
findings that further suggest the presence of hypothermia are: bradycardia,
bradypnea, hypotension and the onset of atrial (or even ventricular) fibrillation. However in the case that some of these ‚side-symptoms‛ have occurred,
but decreased body temperature has not been observed, we may not come to
the conclusion that the patient is experiencing hypothermia. Of course there
might still be some other hazardous health condition(s) that is present and that
could be the cause of these observed symptoms.

4.2.4.3

Production Rules and the Language’s Operation
In the previous section we described intuitively how causal weights be-

tween symptoms and disorders are utilized together with the level of fuzziness
of the corresponding symptoms (as described in the previous subsection) in
order to derive a quantitative estimation about our confidence regarding the
presence of a specific health state. These weights constitute the function
that was first introduced in Definition 4: and which assigns a weight to every possible transition in the FSM. More formally we can
give the following definition:
Definition 8: The weighting function ϕ: (Q ×Σ × Q) → [0, 1] associates a weight
to every transition or production rule in the language and represents the causal
associations between symptoms and disorders/health states.
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Finally, coming back to the definition of the Prognosis fuzzy regular
language (or the equivalent fuzzy FSM), we still need to define two more elements in order to provide a complete definition of our proposed model: a)
what are the production rules P (or the transition function δ) and b) how the
causal weights and the fuzziness of the detected symptoms are fused together
to derive a confidence level (or degree of membership) at a given derivation
level of the language.
Definition 9: The production rules P (and equivalently the transition function δ) of
the Prognosis language are of the form

, where A signifies the current

health state of the user, B is the new estimated health state (B can be equal to A)
and α is a new observed symptom that is being processed (consumed) by the language.
From the previous definition we can understand that the number of
possible transitions can be quite large, since by taking into account ten different
bio-signals for example we can have a very large set of combinations (which
depends upon how many symptoms or fuzzy sets we may define for each biosignal). To understand the magnitude of this problem we may consider that
even in the case that each bio-signal derives a binary result, we will still have
=1024 different combinations!
In order to clarify how transitions are made and how the corresponding
confidence score of the current state of the model is evaluated we will now
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consider a somewhat trivial example, which we will then gradually make more
complex to illustrate the operation of the Prognosis regular language:
Example 1: Let us consider the trivial case whereby the WHMS measures only 1 parameter, e.g. heart rate, which can only give rise to three individual fuzzy symptoms: bradycardia, normal heart rate and tachycardia. We will denote these states as B, N and T respectively and consider B and T as pathologic
and N as healthy. In addition to that let us assume that the symptoms that can
be extracted from the heart rate measurements are three as well, e.g. ‚low HR‛
(denoted ‘b’), ‚normal HR‛ (denoted ‘n’) and ‚high HR‛ (denoted ‘h’). In this
simplistic example we consider all the weights corresponding to transitions (or
production rules) to be equal to one, e.g.
.
The FSM that corresponds to Example 1 can be seen in Fig. 4-11 (N is
the starting state). Now assume that the following sequence of symptomconfidence pairs is extracted: n (1.0), n (0.8), h (0.7), h (0.8), h (0.9), h (1.0), h (1.0),
h (0.8), h (0.6), n (0.6), b (0.6), where in this case we have only considered the
symptom with the highest confidence in each time instant.
We now want to go through the sequence of extracted symptoms and
derive the estimated state of the fuzzy FSM along with the corresponding confidence level. We assume that we begin at state N with confidence 1.0.
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Fig. 4-11. Fuzzy FSM for Example 1

At every derivation step, we will apply the compositional rule of inference as
defined by Zadeh [122]:
(Eq. 4-6)
In the above formula, μSi(s) signifies the degree of membership or the confidence level of the Si symptom and wR(s) denotes the connection weight between the current state and the state we are transitioning to. What the above
formula means, is that when a new symptom is acquired, we will look for the
most plausible transition (or production rule), by trying to find the one that
maximizes the confidence level. The confidence level of a transition is defined
as the ‚fuzzy AND‛ e.g. the minimum value of the symptom fuzziness level
and the weight of the transition. Finally after the value μ(D) has been computed, we will evaluate the confidence of the new state as the average of the
previous state and the new computed confidence μ(D) (the reason for this is
more thoroughly explained in the beginning of the next chapter but simply put
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it is done to prevent confidence levels from being driven towards zero and to
account for the ‚momentum‛ of the state model).
Illustrating the above scheme with the provided example we have the
sequence of transitions presented in Table 4-1:

Table 4-1. Transition Information for Example 1

State
St. Conf.
Transition
Tr. Conf.

N
1
n
1

N
1
n
0.8

N
0.9
h
0.7

T
T
T
T
T
T
T
N
B
0.4 0.55 0.73 0.87 0.94 0.87 0.74 0.43 0.3
h
h
h
h
h
h
n
b
0.7 0.9
1
1
0.8 0.6 0.6 0.6
-

Example 2: We now consider a more complex example which is however based on the previous paradigm. We assume that the WHMS can measure
the heart rate and the body temperature as well and that the corresponding
states that interest us are the same states as before for the heart rate and the following three states for the temperature: fever (F), normal temperature (N) and
hypothermia (C). As a result the total number of states in the current FSM will be
3×3=9 states: NN, NF, NC, TN, TF, TC, BN, BF and BC, whereby the first letter
signifies the state of the heart rate value and the second letter the one of body
temperature.
Furthermore, in our current example we account for the case where the
symptoms extracted from the heart rate measurement include additional and
finer fuzzy sets, e.g. ‚very low hr‛ (vlhr), ‚low hr‛ (lhr), ‚normal‛ (nhr), ‚high
hr‛ (hhr) and ‚very high hr‛ (vhhr). Correspondingly for the temperature val125

ues we will have ‚very low temp‛ (vlt), ‚low temp‛ (lt), ‚normal‛ (nt), ‚high
temp‛ (ht) and ‚very high temp‛ (vht). Consequently, in the current case the
weights on the transitions will have a bigger impact as there is a different contribution of a ‚high hr‛ value to the state tachycardia than the contribution
from the symptom ‚very high hr‛. The corresponding FSM of Example 2 is depicted in Fig. 4-12.

Fig. 4-12. Fuzzy FSM for Example 2

In this case, where we have used a ‚fuzzier‛ approach since the domain
of symptom values is divided into more fuzzy sets, the transition weights play
a more significant role. For example consider the case of the transition from the
initial NN state to the TN state. This can be done by either detecting a ‚high
heart rate value‛ or a ‚very high heart rate value‛. However the corresponding
weight for the latter transition (or production) will be stronger than the one for
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the former transition, as a very high heart rate will contribute more towards an
actual tachycardic patient state.
In Example 2, we can consider the Prognosis model as simulating two
fuzzy FSMs in parallel. For every type of biosignal, corresponding fuzzy symptoms are continuously extracted and contribute to state transitions in the manner that was described in Example 1. By combining the confidence level of parallel states, we can deduct an overall confidence for the current state in Fig. 412. Using this approach, the aforementioned model can be expanded to consider all types of symptoms extracted from the physiological measurements described in the previous subsection. However, in the case of detectable conditions, symptom contributions to the corresponding state should be weighted
appropriately, according to the causal association relevance. This is illustrated
in the following example.
Example 3: Finally, we will consider a more concrete example, which
will illustrate the application of the proposed formal language approach in estimating the user’s health, and consequently, accessing the risk level of the user’s health status. In this example, we will assume that the system is capable of
continuously monitoring the following physiological parameters: ECG, HR,
blood pressure, oxygen saturation, respiration rate, and that, it is also able to capture verbal feedback from the user. Furthermore, let the set of extractable symp-
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toms be of the form lspo2, vhhr, ‚low blood pressure‛ (lbp), etc. Additionally,
consider the following symbolic representations for user health states.
1) S1 : Hypoxemia.
2) S2 : Coughing.
3) S3 : Hypotension.
4) S4 : Tachycardia.
5) S5 : Dizziness, weakness, or nausea.
In Fig. 4-13, a part of the Prognosis fuzzy FSM that corresponds to the
aforementioned system is shown. In Fig. 4-13, several selected user health
states are depicted along with a small subset of symptoms that cause transitions between these states (not all possible transitions are being shown to avoid
confusion). The combination of S3, S4 , and S5 have been known to be an indication (are always present) of acute cardiogenic shock [120], [121] and possible additional symptoms, such as tachypnea, arrhythmias, and sweating can further
enhance that indication and also increase the severity level of the condition. In
addition to that, the state S1S2 corresponds to a strong indication of anoxic syncope, a hypothesis that is enhanced by the presence of dizziness or nausea.

128

Fig. 4-13. Fuzzy FSM for Example 3

We can now consider the following scenario: The user is initially in
state N and then gradually his blood pressure levels start dropping and his
pulse rate starts increasing. This transition is depicted in Table 4-2, where a series of hypothetical fuzzy symptoms (along with their confidence level) are extracted and the corresponding estimated health state is shown (of course this
could happen in a more gradual or complex manner, but we assume relatively
rapid transitions here for the sake of discussion and without loss of generality).
As the state S3S4 is close to the ‚high risk‛ state S3S4S5 the system decides to inquire the user regarding the presence of additional symptoms. Given the case
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that the user indicates the presence of dizziness, the system may deduct a transition to the neighboring state S3S4S5 which requires immediate attention and
thus the system will generate an alarm and notify the health care provider or a
supervising physician.

Table 4-2. State Transition Sequence for Example 3

Current
State

HR

SpO2

BP

Resp
Rate

VF

ECG

N 1.0

n 0.9

n1

n 0.7

n1

-

N 0.9

N 0.95

n 0.8

n1

lbp 0.6

n1

-

N 0.9

S3 0.64

n 0.7

n 0.9

lbp 1

n1

-

N 0.8

S3 0.78

n 0.6

n 0.9

vlbp 0.6

n 0.9

-

N 0.9

S3 0.79

hhr 0.6

n 0.9

vlbp 0.8

n 0.8

-

N 0.8

S3S4 0.61

hhr 0.9

n 0.8

vlbp 1

n 0.7

-

N 0.8

S3S4 0.73

vhhr 0.7

n 0.8

vlbp 1

n 0.6

-

N 0.7

S3S4 0.76
S3S4S5
0.57

vhhr 0.9

n 0.8

vlbp 1

hrr 0.6

dizziness

PVC 0.6

vhhr 1

n 0.8

vlbp 1

hrr 0.7

-

PVC 0.6

To evaluate the confidence or degree of support of a user health state,
after every ‚collection cycle‛ of physiological measurements (Eq. 4-7) is applied, where N is the number of bio-signals that did not change state, M is the
number of bio-signals that did change state, μSi is the confidence for the state of
the ith bio-signal and μ(n) is the overall confidence of the health state estimation
at discrete time n.
(Eq. 4-7)
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In estimating the confidence of the state S3S4S5 a weighted average of
the strength of the symptoms that are causally associated with the specific condition will be calculated. In addition to that a bias b will be used, representing
the confidence level that the user is indeed in the previous stage S3S4:
(Eq. 4-8)

4.3

SPN-based Operation modeling
Using Stochastic Petri Nets (SPN) [139] as a graphical modeling tool, we

are able to provide a detailed and at the same time easy-to-comprehend functional description of the wearable health-monitoring system. Furthermore
SPNs enable hierarchical top-down modeling of the system while at the same
time being able to capture the effects of concurrency and synchronization of
events that take place in the system.
It should be noted that in the SPN model to be presented the following
convention has been adopted: While tokens are removed from input places and
deposited in output places in a deterministic manner (e.g. a transition fires either immediately or after a random time delay if and only if there is a token in
each one of its normal input places and also there are no tokens in any of its
inhibitor input places and it deposits a token in each of its output places), the
firing of transitions that have common normal input places and/or common
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inhibitor input places will happen in an non-deterministic manner. We will refer to this property of the SPN as the random transition property.
Specifically, consider a set of transitions T1, T2, …, TN that all have at least one
common input or one common inhibitor place and that happen to be all
enabled at a given time instant. We assume that these co-enabled transitions
are each assigned a probability pi, where:

, such that when they are

all enabled, only one of the enabled transitions will fire with probability pi. In
addition to that we assume that the described firing probabilities are markingdependent, e.g. a specific model state (or marking) may ‚favor‛ the firing of a
certain transition over the rest of the co-enabled transitions.

4.3.1

SPN Model - Level 1
Fig. 4-14 presents the first level of the hierarchical SPN model of the

Prognosis WHMS, which simulates the high-level interaction between the basic
entities in the system, e.g. the human user, the device and the medical center.
As we can see from the diagram, there is always a token at the place
representing the user/patient (as due to the immediate feedback transition
there will be one token generated when the current token is consumed) denoting the fact that the user is constantly ‚ON‛, meaning that the human body
provides the WHMS with body signals in a continuous fashion. Furthermore
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the user is able to provide voice feedback to the system to record nonmeasurable health symptoms.
The WHMS device is capable of directly communicating with the user
in terms of an automated HMI dialog system, whenever the system detects a
health status of high risk or the user notifies the system about a symptom like
for example chest pain that may require ‚further investigation‛.

Fig. 4-14. Level 1 of the SPN Model: User-Device-Medical Center-Ambulance Interaction

Furthermore, the WHMS provides either regular updates of the user’s
health condition or upon request from the medical center (which is also a place
in the SPN that constantly has a token). Finally the system may ‚decide‛ that
the user requires immediate medical attention based on the aggregated physiological symptoms and thus may send an alert to the medical center or even re133

quest for an ambulance to be dispatched in case the medical center approves
that action as well. This is denoted in Fig. 4-14 by the use of places P4 and P5,
where a token might be generated in one of the cases described above.
Regarding the property described earlier about the SPN model and
which we have adopted here, e.g. that enabled transitions with at least one
common input place may be chosen to fire in a stochastic manner, we can see
this in the following example:
Transitions T1 (system ‚talks‛ to the user), T2 (inform the medical center about an emergency), T3 (send a report or regular update to the medical
center) and T10 (consume or process a series of measurements) all share place
P1 (the WHMS) as input. When there is one (or more) token in P1, all the above
mentioned transitions will be enabled. However, in such a case, due to the
adopted property, only one of these transitions will fire, which will result in
one token from P1 to be consumed and in one token being deposited in each
output place of the firing transition.

4.3.2

SPN Model - Level 2
In the following we describe the second level of the hierarchical SPN

model of the WMHS, which is depicted in Fig. 4-15. In this level, the functionality of the wearable device is simulated in a scenario in which the following sensors are assumed to be available: ECG, SpO2, thermometer, respiration sensor,
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blood

pressure

monitor,

accelerometer,

GPS

and

a

voice

recogni-

tion/synthesizer system to capture direct patient feedback.
The central node of the WHMS (microcontroller board, PDA, smartphone etc) continuously gathers physiological parameters from the wearable
sensors in a round-robin fashion to create input symbols for the Prognosis language. For example the pulse oximeter sends an estimation of the oxygen saturation and the heart rate of the user every 1 second. Similarly, the central node
polls the thermometer and the respiration rate sensor every second to acquire a
measurement.

Fig. 4-15. Level 2 of the SPN model: Description of the wearable system’s interaction with the
peripherals/wearable sensors

However, since available blood pressure monitors are cuff-based, the
central node needs to request from the BP device to initiate a measurement and
it should also be able to collect it when it is made available. Regarding the ECG
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collection, because the electrocardiogram is sampled at a high rate, e.g. 250 Hz
or even more, it is more reasonable to transmit packetized samples of the ECG
every second (as denoted by the weight 250 over the arc leaving place P2). That
approach allows also for easier synchronization with the collection of the rest
of the bio-signals.
In this SPN level, we can see again how the random transition property
affects the sequence of events. For instance, place P0, e.g. the central node, is a
common inhibitor place for all sensors (or sensor buffers). This way we are trying to simulate the fact that whenever there is a token at P0, the central node is
busy collecting data from one of the sensors. On the other hand, no token at P0
means that the central node is ready to request or collect data from a sensor.
However at any given time only one sensor-place will remove a token and then
deposit that token at P0.
Finally the voice recognizer module has the ability to deliver information regarding non-measurable symptoms to the central node, in case the user
has recorded such a phenomenon. As in the case of the ECG sensor, to favor
the round-robin-based synchronized collection of signals, the central node polls
the voice recognizer for any possible detected symptoms. This polling scheme
can be thought of either as sequential polling of digital and analog ports on a
microcontroller board or as the beaconing mechanism available in Zigbee
which allocates specific time intervals to distributed sensor nodes or finally as a
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Bluetooth piconet, where master and slaves take turns communicating in an
inherent round-robin scheme.

4.3.3

SPN Model - Level 3
In the final level of the top-down hierarchical SPN model depicted in

Fig. 4-16 we describe the way the central node operates. We provide an insight
to how the collected physiological (and voice) data are used to create input vectors, e.g. to form words/strings of symptoms of the Prognosis language, which
in turn parses the derived string to make a decision/estimation about the user’s
health condition.

Fig. 4-16. Level 3 of the SPN model: Functional description of the central node.

There are three basic types/categories of data that the WHMS can collect
(as previously described in this chapter): a) ‚scalar‛ data, like the temperature
value, the systolic or diastolic blood pressure etc, which according to their val137

ue give rise to specific symptoms or not, b) ‚morphology‛ specific data, which
in the current scenario are comprised of the ECG signal, which need to be analyzed to possibly detect patterns of high risk and c) voice data which may correspond to non-measurable symptoms that the user has chosen to communicate to the device.
When either a new type a) or type b) measurement is collected, it is buffered in the system in a dedicated ring buffer for each bio-signal. Then that data are checked for validity, e.g. a decision on whether the data are erroneous or
valid needs to be made based in terms of statistically examining the signal’s
trend to possibly eliminate outliers or by using any provided sensor status info.
If the data are found to be valid, they are used to extract the corresponding
fuzzy symptom. At the last stage the extracted symptoms or language symbols
are passed on to the Prognosis language which updates or creates the string,
which gives a thorough estimation of the user’s health.
Regarding voice recordings, which can also be void in terms of null
feedback, they are processed and converted to text in order for them to be ‚understood‛ by the system’s language. After cross-checking the detected word(s)
with a database of non-measurable symptoms, an indication of some incident
like for example ‚back pain‛ may be identified and then passed onto Prognosis
as further contribution to the input vector of the string formation mechanism.
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Finally, the Prognosis scheme produces an output in terms of a word or
string, which may give rise to either a normal/healthy indication (null string) of
the user’s status or to an unknown/erroneous status or more importantly to an
alarming state. In such a case an alarm message will be generated and sent to
the medical station and moreover the system may ‚decide‛ to take further action in terms of initiating a dialogue with the user or suggesting him to take
several actions which may help prevent an escalation of the occurred or even
future event.
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5

CHAPTER 5: MODELING THE PROGNOSIS LANGUAGE USING
MODIFIED FUZZY PETRI NETS
In the previous chapter we described a fuzzy formal language model

for capturing the transition of the WHMS’ user between different health states
and for estimating his/her health at any given time. As it was mentioned in section 4.2.4.3, by using the FFSM approach, where in practice we are simulating
several fuzzy FSMs in parallel, the following problem arises: the amount of
possible states in the system can become very large as the number of different
physiological parameters (and their respective fuzzy sets) that are measured by
the system increases. To illustrate this more concretely we can consider the case
where the WHMS records the following features/signals, where we also denote
the number of fuzzy terms by which each variable is represented:
ECG (about 6 different beat types and 8 different rhythms resulting in 15
distinct combinations)
Heart rate (6 different states)
Respiration rate (4 different states)
Skin/body temperature (5 different states)
Systolic & diastolic blood pressure (5 different states)
Oxygen saturation (4 different states)
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Symptoms described by the user (for 10 different symptoms we can have
210=1024 combinations, without considering level of severity of symptoms)
Calculating all possible combinations using the above attributes leads
us to the following result: 15 6 4 5 5 4 1024=36,824,000 distinct states! This
number can keep growing if we also take into account factors such as the user’s
age, weight, height, gender, medical history, current medication, the activity
that is being performed etc. It is thus obvious that the FFSM approach can become computationally very expensive when so many cases are considered, especially since our aim is to derive an embedded decision support scheme that
should at least be partially implementable on a portable resource-constrained
device.
Furthermore, our FFSM model does not consider certain important aspects in a diagnosis making process which will be discussed in this chapter. For
example the effect of negative evidence on a decision or the exclusion of a disorder due to certain findings has not been considered. In addition to that, the
FFSM model does not provide a means for adaptive parameter estimation and
assumes fixed well-estimated parameters for the fuzzy IF-THEN rules that are
included in its knowledge base.
In an attempt to overcome these limitations, we present in this chapter
an advanced decision-making model which is based on a modification of the
concept of Fuzzy Petri Nets (FPN), to which we will simply refer as ‚Modified
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Fuzzy Petri Net‛ (MFPN). In what follows, we will introduce the concept of
FPNs and of the MFPN and then we will explain analytically the process of decision making using the proposed reasoning mechanism.

5.1

Fuzzy Petri Nets
Fuzzy Petri Nets (FPN) are an extension of the classical Petri Net mod-

eling tool and were introduced in [140] and [141] as a means of supporting approximate reasoning, fuzzy knowledge representation and decision making. In
contrast to the conventional Petri Net model, where tokens are assigned to
places and generated from transitions in a crisp manner, in the FPN case, each
token is accompanied with a fuzzy value which indicates the degree of certainty of a given event or proposition. There have been several formal definitions
of FPN models [140]-[148] in an attempt to capture concisely the effect of multiple weighted fuzzy production rules in rule-based decision making.
A Fuzzy Petri Net for representing Weighted Fuzzy Production Rules
(WFPR) is defined as:

,

(Eq. 5-1)
where:
P = {p1, p2,…, pn} is a finite set of places,

T = {t1, t2,…, tm} is a finite set of transitions,
D = {d1, d2,…, dn} is a finite set of propositions,
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Λ = {λ1, λ2,..., λm} is a finite set of thresholds and 0≤ λi ≤1 for all λi

Λ,

I: T→P∞ is an input function, a mapping from transitions to places,
O: T→P∞ is an output function, a mapping from transitions to places,
α: P→[0,1] is an association function (fuzzy term), a mapping from
places to real values between zero and one (which indicates the fuzzy
truth values of propositions or the fuzzy marking of places),
β: P→D is an association function, a bijective mapping from places to
propositions,
γ: T→Λ is an association function, a bijective mapping from transitions
to thresholds,
W = WI WO, where:
WI: I→ [0,1] is an association function, a mapping from the input function to real values between zero and one (which assigns a weight to
every input arc of a transition),
WO: O→ [0,1] is an association function, a mapping from the output
function to real values between zero and one (which assigns a weight to
every output arc of a transition or in other words it represents the confidence level in a given transition for a certain consequent proposition),
P ∩ T ∩ D ∩ Λ = , |P| = |D|, |T| = |Λ|, where || denotes cardinality.
Using the above definition of a Fuzzy Petri Net we can represent the
following 4 types of weighted fuzzy production rules:
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(Eq. 5-2)

Type 1: IF d1 AND d2 THEN d3

(Eq. 5-3)

Type 2: IF d1 THEN d2 AND d3

(Eq. 5-4)

Type 3: IF d1 OR d2 THEN d3

(Eq. 5-5)

Type 4: IF d1 THEN d2 XOR d3

For each WFPR we may define weights for every antecedent (denoted
as ‚w” and taken from the set WI) and every consequent (denoted as ‚μ” and
taken from the set WO) element and also a threshold value ‚λ‚, which controls
the firing of a rule. Let ‚α(di)” signify the fuzzy truth value of proposition i, ‚ ‛
signify the fuzzy AND operation (which can be the max function or some other
t-norm) and ‚ ‛ signify the fuzzy OR operation (the min function or some other s-norm). Then the fuzzy truth values of the consequent portions of the above
4 rules are computed as follows:
(Eq. 5-6)

Type 1: IF [α(d1) w1] [α(d2) w2] > λ
THEN α(d3) = ( [α(d1) w1] [α(d2) w2] ) μ

(Eq. 5-7)

Type 2: IF (α(d1) w1) > λ
THEN α(d2) = [α(d1) w1] μ2
AND α(d3) = [α(d1) w1] μ3

(Eq. 5-8)

Type 3: IF [α(d1) w1] [α(d2) w2] > λ
THEN α(d3) = [α(d1) w1 μ1] [α(d2) w2 μ2]

(Eq. 5-9)

Type 4: IF (α(d1) w1) > λ1 AND (α(d1) w2) > λ2
THEN EITHER α(d2) = [α(d1) w1] μ2
OR α(d3) = [α(d1) w1] μ3

The aforementioned WFPRs can be mapped directly to their FPN representations as it can be seen in Fig. 5-1, Fig. 5-2, Fig. 5-3 and Fig. 5-4.
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Fig. 5-1. FPN representation of a WFPR of Type 1.

Fig. 5-2. FPN representation of a WFPR of Type 2.
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Fig. 5-3. FPN representation of a WFPR of Type 3.

Fig. 5-4. FPN representation of a WFPR of Type 4.

As stated before, in the FPN model, each token is associated with a
fuzzy truth value and since each place is mapped to a proposition di, a place
containing a token with value α(di) means that the degree of truth of the corresponding logical proposition is α(di). In addition to that, transitions are the
means by which knowledge and/or belief is propagated in the network. Fur146

thermore, an input weight w from a place to transition denotes how much a
proposition influences a given WFPR, while an output weight μ represents the
belief in that specific rule with regards to a specific consequent proposition. It
is worth noting that the effect of weights on a WFPR is of importance mainly in
the case of type 1 rules, e.g. in the case of composite conjunctive reasoning,
whereby all antecedents need to be accounted for and weighted in order for the
rule to fire. In the rest of the rules, weights can be usually assumed to be 1.
One thing we should note here and which has been a common misconception in publications regarding FPNs is that the FPN of Fig. 5-4 does not
represent a rule like:
If d1 THEN d2 OR d3
Instead it represents the XOR rule that we showed before. This is in
agreement with the way transitions take place in a regular Petri Net, whereby a
transition that is enabled and fires will remove a token from all of its input
places and place a token in all of its output places. As a result, in Fig. 5-4, if
place p1 has a token that results in a fuzzy value greater than both thresholds λ1
and λ2, then both transitions will be enabled but only one (and exactly one) can
fire and not both. In the case of FPNs where tokens are not removed when a
transitions takes place but rather copies of tokens are passed on [141], [143],
this type of FPN will mean that both transitions will become enabled and thus
there is no difference in this case from rule of type 2.
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Another important issue, that we need to consider when reasoning with
FPNs, is the ‚diminishing token syndrome‛ as it has been noted in [149]. Specifically, as a token progresses through the Fuzzy Petri Net and as rules are applied along the reasoning path, the token value is bound to be a decreasing
function with time, as it is constantly being multiplied with weights that are
non-greater than zero and is also ANDed with other tokens. This issue is also
made obvious in the equivalent representation of a Fuzzy Finite State Machine
(FFSM) as it is described in [150]. In this case, the constant application of maxmin rules results in a monotonic decrease of the fuzzy membership values of
the states in the FFSM.
We have addressed this problem in the FFSM case in our work (as we
saw in section 4.2.4), where the new computed confidence level for a given
state is combined with the previous one to derive the actual final degree of
membership in that state. In that sense, the current momentum of the FFSM is
also taken into consideration. In addition to that, the scheme we proposed does
not have the form of a feed-forward network, but rather in includes loops and
also several continuously repeating fuzzy events (fuzzy symptoms extracted
from physiological measurements) which constantly change the state vector of
the FFSM. In this way fuzzy membership values are always ‚refreshed‛ and
this prevents them from continuously diminishing. However this model suffers
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from the issues and limitations that were mentioned at the beginning of the
current chapter.
In the next section we will introduce a model of a Modified Fuzzy Petri
Net (MFPN), which overcomes the limitations of the conventional FPN models
that have been proposed in the corresponding literature. It should be noted
however that the MFPN will be defined in a way that is considered optimal for
the problem in question (e.g. estimation of user’s health state using basically a
fuzzy IF-THEN rule-base) and to address some of the issues not addressed by
the FFSM and the FPN (e.g. inhibition/exclusion, obligatory/optional findings,
momentum and most importantly rule adaptation/learning). As a result the
presented modified FPN should not be considered as a general improvement of
the FPN, but rather as an extension of it in order to better address a particular
problem.

5.2

A Modified Fuzzy Petri Net (MFPN) Model
Fuzzy Petri Nets are used for knowledge representation and fuzzy rea-

soning rather than for system operation modeling compared to conventional
Petri Nets (deterministic or stochastic). As a result, in the case of FPNs it makes
intuitively more sense to not consider token consumption in a place when an
output transition fires. After all, a place in a FPN represents a logical proposition and the token value stands for the degree of truth of that specific predi149

cate. If that proposition constitutes one of the antecedents of a production rule
and that rule fires, the proposition does not cease to be true (to the same fuzzy
level as before). In contrast to this example, tokens in conventional Petri Nets
tend to represent some quantity or some resource of the system that is being
modeled. For example, the number of tokens in a place could stand for the
number of customers waiting in a queue or a single token could signify a semaphore in a concurrent program.
Thus, in our case we will not consider consumption of tokens, but we
will rather treat token values as permanent once they get evaluated, until of
course they get updated. Besides the intuitive reason behind this approach that
was mentioned above, we wish to have a ‚momentum property‛ in the system.
This means that once a transition fires, the token value (or fuzzy truth) of each
of the output places will be evaluated based both on the level of firing of the
transition as well as on the previous token value(s) of the output place. However in order to prevent enabled transitions from firing continuously, we will
also introduce another property describing places in FPNs that will denote if
the token value has been updated since the rule fired the last time. If none of
the token values in the input places of a transition have been updated, then the
transition will not be enabled. As soon as one of the input places gets updated
the rule will be evaluated, as it will then be possible for the rule to produce a
different and updated output.
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In addition to these properties we also wish to integrate the notion of
obligatory and optional predicates for a WFPR and also the concept of proving
and not proving evidence [135] in the reasoning model. Specifically, a symptom Si will be considered obligatory for a disease Dj if the absence of Si implies
directly the ruling-out of Dj. In addition to that, a symptom Si will be considered as proving with respect to disorder Dj if the presence of Si constitutes
sufficient evidence to conclude that Dj is present.
Given the previous discussion, we now provide the definition for the
proposed modified FPN:
A Modified Fuzzy Petri Net (MFPN) for representing Weighted Fuzzy
Production Rules (WFPR) is defined as:

,

(Eq. 5-10)

where P,T,D,Λ,I,O,α,β,γ and W are defined as in (Eq. 5-1) and:
o: I→ {0,1} is an association function, a mapping from the input function
to either the value 0 or 1 (used to check substantiation of the obligatory
antecedents in a WFPR).
r: I→ {0,1} is an association function, a mapping from the input function
to either the value 0 or 1 (denoting whether the corresponding input
attribute is considered as proving for the corresponding rule).
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u: P→{0,1} is an association function, a mapping from places to either
the value 0 or 1 (denoting whether the corresponding proposition, e.g.
its fuzzy truth, has been updated or not).
m: P→{0,1,2,3,…} is an association function, a mapping from places to
positive integers (denoting the number of momentum terms used in a
place pi).
Finally we will also consider that the mapping α from places to the interval [0,1] can also be a mapping from places to a fuzzy set (this will be explained more when we describe the reasoning scheme based on the MFPN in
the following section).
To illustrate the usefulness of the newly defined attributes, let us consider a hypothetical case where the following rule R1 needs to be evaluated:
IF d1 (obligatory and proving for R1)
AND d2 (obligatory and not proving for R1)
AND d3 (optional and proving for R1)
AND d4 (optional and not proving for R1)
AND NOT d5 (presence of d5 excludes R1)
THEN d6
This rule is shown schematically in Fig. 5-5. Considering the MFPN definition given in (Eq. 5-10), the output of the rule will be computed now as:
(Eq. 5-11)

,
where:
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, where

signifies whether antecedent i of rule R1 has

been updated since the rule’s last evaluation (independently of whether
the rule fired or not).
, where
considered obligatory (
tional (

signifies whether antecedent i of rule R1 is
if

and

otherwise) or op-

always, since optional evidence of a rule should not pre-

vent a transition from firing). In the case of the inhibitory input place p5
we will compute

as:

.
, where

and

is the probabilistic t-conorm, e.g.

for proving propositions and

for not-proving propositions. The reason that the probabilistic sum is
employed to evaluate

is because intuitively it makes more sense to

increase the confidence in the rule’s substantiation whenever more than
1 proving propositions are true (or true to a certain degree).
, is the weighted level of firing of rule R1.
These weights represent what we referred to in section 4.2.4.2 as ‚causal
relevance‛, e.g. a fuzzy value indicating the likelihood or possibility of
displaying symptom Si when disorder Dj is present.
(with

and

), stands for a momen-

tum term indicating the degree to which the current firing strength of
the rule {

} and the previous fuzzy truths of the proposition
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{

} contribute to the computation of the new fuzzy

truth of proposition d6. M6 denotes the amount of ‚memory‛ used in
place p6.

Fig. 5-5. A conjuctive WFPR with five antecedents with different attributes

In the above WFPR we have assumed that the threshold for firing is is
λ=0 and that the output weight (e.g. the belief or trust in the rule) is μ=1. Also
we can notice that we have used a white bar to represent this particular rule (a
similar distinction is made in Stochastic Petri Nets, where this bar denotes
probabilistic transitions). The distinction is made here to denote the fact that
the particular IF-THEN rule is a rule representing medical knowledge and it
needs to be handled differently. However, whenever we will employ the regular black bar, we will evaluate the rule as it was defined by (Eq. 5-6)-(Eq. 5-9),
while still considering the updating property of rules and the momentum terms.
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Before moving on to describing the reasoning process, which uses the
modified FPN model described in this section, we need to define the knowledge-base that is employed in order to derive estimation of the user’s health
state. This will be done in the following section by listing several fuzzy IFTHEN rules that have been integrated in the Prognosis prototype. After we do
that, we will be able to describe in detail how a decision is reached and how the
system generates hypotheses about the user’s condition.

5.3

Knowledge-base representation as fuzzy IF-THEN rules
In this section we will provide a list of some of the IF-THEN rules that

constitute the initial knowledge base for the Prognosis WHMS. Propositions (in
the antecedent part of the rules) will be described linguistically and they will
have the general form:
1. <physiological parameter> is <fuzzy set>, for value-specific physiological parameters (section 4.2.1)
2. <ECG> shows <beat/arrhythmia type>, for ECG data (chapter 3)
3. patient has <symptom type>, for non-measurable symptoms indicated from
the patient (section 4.2.3)
Given the above definitions, we provide a list of rules that show the
medical knowledge that has been incorporated in the current prototype (where
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the parameters of the rules that are required for calculating their substantiation
according to (Eq. 5-11) have been omitted here for presentation purposes):
IF heart rate is very high AND
blood pressure is very low AND
respiration rate is (very low OR very high) AND
temperature is low AND
oxygen saturation is low AND
ECG shows ventricular arrhythmia
THEN acute cardiogenic shock
IF temperature is very high AND
respiration rate is very high AND
patient has cough
THEN pneumonia
IF blood pressure is very low AND
respiration rate is very low AND
temperature is very low AND
ECG shows ventricular arrhythmia AND
patient has (dizziness OR weakness)
THEN hypothermia
IF blood pressure is (very high OR very low) AND
respiration rate is very high AND
heart rate is (very high OR very low) AND
ECG shows ventricular arrhythmia AND
patient has (dyspnea AND cough)
THEN acute left ventricular failure
IF blood pressure is high AND
patient is experiencing chest pain OR shortness of breath AND
ECG is abnormal
THEN angina
IF blood pressure is very high OR
blood pressure is very low OR
heart rate is very low OR
respiration rate is very high OR
respiration rate is very low OR
temperature is very high OR
temperature is very low OR
oxygen saturation is very low OR
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ECG is abnormal
THEN alarm
IF heart rate is very high AND
activity level is very low
THEN alarm

5.4

Reasoning using the knowledge-base and the MFPN
As the previous section shows, there might be a considerable number of

production rules that will need to be evaluated whenever new sensor readings
are received by the WHMS. This can be graphically depicted in a parallel structure as the one shown in Fig. 5-6, which displays schematically part of the reasoning process using the MFPN. The functionality of each of the 4 layers is explained below:
-

Layer 1: This layer holds the actual crisp inputs of the sensors. The
places in this layer deviate from their conventional definition in Petri
Net or an FPN since they can hold real values.

-

Layer 2: As the real values from Layer 1 get propagated to Layer 2 they
pass through a set of transitions that have a single input place and multiple output places. Each of the output arcs has a different effect on the
propagated values, as each arc is associated with a fuzzy term. As a result, what this process represents is the fuzzification of the input values,
where the membership of the crisp parameters in the fuzzy sets (fuzzy
symptoms) defined in 4.2.1 is computed. The places in this layer do not
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have momentum terms and they hold the fuzzy membership values of
the most recent physiological measurements.
-

Layer 3: The purpose of this layer is to compute an averaged/smoothed
confidence in the symptoms extracted in the previous layer. As a result,
the places found here utilize momentum terms and permit the confidence in a specific symptom to rise as more measurements indicating
the same state are collected. In addition to that, and depending on the
number of momentum terms used, outlier values can be suppressed.

-

Layer 4: This layer holds the degree of support of the consequent part of
all the IF-THEN rules in our knowledge-base. The places in the previous layer represent the antecedent parts and their fuzzy token values
represent the strength of confirmation of the corresponding symptoms.
The transitions (e.g. the WFPRs) between layer 3 and layer 4 are computed according to the MFPN model.

-

Layer 5: Finally, this last layer holds a single place which we define as
the overall ‚unhealthiness of the user‛. The fuzzy truths of the disorders computed in the previous layer are combined together using logical
disjunction (probabilistic t-conorm) and their aggregation produces a
single value, which provides an indication of the patient’s health instability level (‚0‛→100% healthy and ‚1‛→100% unhealthy or unstable).
The intuition behind the computation of this metric is that as the num158

ber of disorders, which are found to be possible (non-zero degree of
support), increases then the more likely it is for the patient to reside in
or to be entering an unstable or alarming health state. The threshold for
which the condition of the user should be considered critical must be
determined through a learning process and an initial approach towards
achieving that will be presented in the next chapter.

Fig. 5-6. MFPN for user’s health state estimation

To fully understand the above MFPN architecture, we can look at a submodule of the MFPN shown in Fig. 5-6. This sub-module, which is shown as a
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dashed rectangle in Fig. 5-7, displays how the confidence about the user’s heart
rate level/status is continuously estimated and how confidence levels of other
symptoms might be combined to fire one of the transitions between the 3rd and
4th layers in Fig. 5-6. Analogously we can consider a similar sub-module for estimating the certainty factor for the fuzzy sets that divide the universe of discourse of the rest of the recorder physiological parameters.

Fig. 5-7. FPN representation of a sub-module of the Prognosis reasoning process.
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6

CHAPTER 6: A PATIENT OR POPULATION-LEARNING
MODEL
When it comes to making specific decisions about a patient, such as de-

tecting health alarming trends or even diagnosing a disorder, a doctor needs to
consider the individual physiology and medical history along with general
medical diagnosing guidelines. In addition to that, monitored physiological
parameters such as blood pressure, heart rate, ECG, respiration rate, oxygen
saturation etc, may have significantly varying normal or healthy levels (or
morphologies when talking about the ECG) amongst individuals. In that direction, we propose a patient-learning approach in that the system first requires a
supervised learning period in order to learn the user’s ‚healthy physiological
behavior‛ by using a neural-fuzzy-based scheme, which builds on the FPN
model described in the previous chapter. After learning the parameters for the
weights and the membership functions used in the reasoning process, the system can operate autonomously in order to provide individualized useradapted detection of health abnormalities and risky conditions.
However, before moving further, it should be noted that our efforts are
not aiming towards a system that will replace the doctor in any way, but towards a healthcare solution that will ensure patient safety round-the-clock via
early detection of individual health hazards and that will thus potentially improve the quality of life of people at risk.
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6.1

The concept of the health-history database
As it has already been discussed, a multi-parametric WHMS is capable

of continuously measuring, recording and transmitting a wide variety of physiological signals. However in our system we seek to integrate additional functions instead of just data logging. Namely, the system should be able to extract
higher level of information from the collected data by itself and transmit this
information to the medical center’s database and/or to the supervising physician if required. This concept was first introduced in Chapter 3, where an ECG
analysis algorithm is employed to extract characteristic signal attributes and to
derive a per-beat signal characterization. Then in chapters 4 and 5, we described how symptoms or risk-levels are extracted from other types of physiological measurements. Both types of physiological information as well as voice
feedback constitute the overall evidence about the user’s occurring symptoms,
which are examined according to certain medical rules to possibly detect a
health hazard. However the rules according to which symptoms are extracted
are not universal. To the contrary, these rules are strongly dependent upon the
individual user’s physiology, his medical history and his current context.
To illustrate the previous point, we can consider again the case of the
heart rate level. A measurement between 60 and 100 beats per second (bpm) is
generally considered as normal, while a heart rate less than 60 bpm is considered as a bradycardia and a value greater than 100 as tachycardia (provided
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that the heart rhythm is regular). However, for a given patient/user a certain
tachycardic heart rate value might be quite acceptable and not endangering at
all, while for another one the same heart rate measurement may indicate a hazardous or unstable health state. Different persons might have considerably
different resting heart rate levels for example, and still individually those levels
might be considered normal, because it is not generally easy to define an optimal HR for a given person [151]. Similar reasoning pertains to the rest of the
continuously measured physiological signals.
To summarize this point, as it is shown in Fig. 6-1, we would like for the
system to be able to utilize raw measured data in order to extract basic health
information and then by using an individualized ‚healthy-history‛ database to
create actual medical knowledge and individualized decisions about the patient/user. This extracted higher-level knowledge can save time (and in the
long run also reduce medical costs) when it comes to making quick decisions
and possibly taking emergency actions about a patient and especially when
there are several patients to consider or supervise in the same time frame. In
addition to that, such individualized patient models, may lead to better understanding of long-term physiological trends that might be indicators for specific
health disorders. As a result, such models might be then be utilized to prognose with high likelihood the occurrence of health conditions and also hopefully prevent them by early medical intervention.
163

Fig. 6-1. Creating higher-level health knowledge about the user.

6.2

Adapting the WHMS’ decisional capability to the user
As described in the previous section, we seek to integrate in the Prog-

nosis WHMS the necessary intelligence for it to be able to make patient-specific
decisions/estimations regarding the health status of the corresponding patient.
In addition to that, when making such decisions, the system must also take into
account the context in which the corresponding physiological data were captured.
To further explain this we can consider one more time the case of a
heart rate value being measured over 100 BPM, e.g. tachycardia, for a certain
period. Such a heart rate value range may be perfectly normal when the corresponding individual is exercising, which the system can ‚verify‛ by checking
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one or more of the following: if there is or has been immediately before high
degree of movement (e.g. by checking the magnitude of the acceleration vector)
and/or if the user is showing a decrease in skin temperature (due to perspiration) and increased respiration rate. On the contrary, the same heart rate measurement along with increased blood pressure while the patient is laying on a
bed (e.g. the posture value is close to -90 degrees), might have a completely different meaning and might indicate a hazardous health state. A tachycardic
heart rate might also still be benign in the previous scenarios, except for example in the case that there is an accompanying ECG abnormality, like an absence
of P waves or irregular heart rhythm, or for example in the case that the user is
experiencing chest discomfort.
The previous example attempts to point out the level of complexity involved in the task of classifying a user’s physiological data as being either
normal (healthy) or pathological. Ideally, the patient’s medical history, his personal attributes (age, height, weight etc), his current context and the rest of the
concurrently measured physiological parameters will need to be taken into account. Such a task could be performed by comparing vectors of measured data
with the contents of a corresponding database. However there would be two
drawbacks in such an approach: Firstly, frequent searching even in a relatively
small database can be quite tedious and computationally expensive for a
hardware-constrained portable platform and secondly it would be practically
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impossible to construct a database including all possible combinations of data
vectors and corresponding patient symptoms.
From the previous discussion it is made obvious that it would be preferable to have some type of automatic weight adjustment strategy that would
update the parameters involved in the reasoning process according to known
and clinically labeled input-output combinations. Artificial neural networks
have been used extensively in cases where automatic and adaptive learning of
weights is required. However, while neural networks are good at recognizing
patterns, they are not good at explaining how they reach their decisions [152].
On the contrary, fuzzy-logic based structures for decision making are capable
of reasoning with incomplete and ambiguous information and have a very
clear structure for explaining their reasoning results. Their main disadvantage
is though that they do not have any way of acquiring rules and optimizing the
parameters that are part of their inference logic. The pros and cons of fuzzy
systems and neural networks appear to be complementary in a sense, an observation which has lead to the development of various types of fuzzy-neuro
and/or neural-fuzzy systems [152]-[154].
Thus, the integration of a neural-fuzzy approach in our system appears
to be a promising alternative to address the issue of progressively adapting the
parameters involved in the decision making process to the physiology of the
individual user. Such an approach has indeed been adopted in the case of the
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Prognosis prototype and will be developed in detail through the rest of this
chapter. However, before we do that it would be appropriate to include a brief
introduction to the area of neural-fuzzy systems.

6.2.1

Neural-Fuzzy Systems
Fuzzy systems and neural networks have been combined in various

ways for the purpose of either enabling a neural network to handle fuzzy inputs and possibly generate fuzzy outputs as well or having the neural network
implement fuzzy decision making and aid in rule generation and fuzzy parameter estimation [153]. The latter option will be of special interest to us in the
following section.
As it was mentioned before, the main issue with fuzzy systems is knowledge acquisition and rule-base construction. This has been done traditionally
in the case of expert systems (like the ones mentioned in Chapter 4), either via
expert knowledge acquisition or statistical methods (whenever such data are
readily available). Additionally, since the reasoning process is based on production rules, the universe of discourse (e.g. the input space) of each input variable needs to be partitioned appropriately (e.g. as it was done with the fuzzy
sets which were defined heuristically in section 4.2.1). As a result, applications
of fuzzy systems tend to be restricted to occasions where expert knowledge is
available and the number of input variable is small.
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Neural-fuzzy systems constitute extensions of neural networks and can
be used to automatically extract fuzzy rules from numerical data and to compute optimal shapes and parameters for membership functions. Tuning of
membership function is considered particularly important, because as it was
mentioned above the effectiveness of the employed fuzzy model depends
greatly on the fuzzy partition of the input-output space. Since this process can
be regarded as an optimization problem, aNNs constitute a possible solution to
this problem.
ANFIS (Adaptive-Network-Based Fuzzy Inference System) proposed
by Jang [154] in 1993 is a neuro-fuzzy model capable of learning the shape parameters of membership functions of the antecedent and consequent part of
fuzzy rules. By employing a hybrid learning scheme ANFIS can compute complex nonlinear input-output mappings using both experts’ knowledge and labeled examples. ANFIS is particularly suitable for the case where several IFTHEN rules (with more than 1 antecedents ANDed together) are evaluated on
the same output variable and the results of all the rules are combined together
using the center of gravity method. This type of network is particularly suited
for the case of fuzzy controllers, where the confidence of several input-output
mappings need to be evaluated in parallel and then the overall output is acquired by applying a defuzzification scheme which weights every rule output
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accordingly. The way the learning mechanism works is by a) computing some
measure of the overall network error after each pattern has been presented:
(Eq. 6-1)

,

where ok is a vector representing the actual output of the network when pattern
xk was presented to the system and dk is the desired output. Then the steepest
(or gradient) descent method can be applied to learn all the unknown parameters in the model, e.g. consequent part of the fuzzy rules, shape parameters of
antecedent’s membership functions etc:
(Eq. 6-2)

,

where zi is the attribute that we want to update and n>0 is the learning rate parameter.

Fig. 6-2. An ANFIS type-3 neuro-fuzzy network
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Jang has also modified the training algorithm by defining a hybrid
learning technique that combines the gradient descent method and the Least
Squares Estimate (LSE) to estimate the network’s parameters. A neuro-fuzzy
network, on which this learning approach can be applied, is shown in Fig. 6-2.
The purpose of the 5 layers in the network is to provide the following:
Layer 1: How much does the input satisfy the linguistic label of the node?
Layer 2: Firing strength of the associated rule (rule nodes)
Layer 3: Normalization of the firing levels
Layer 4: Individual rule output computation
Layer 5: Overall system output (combination)
Another application of the neuro-fuzzy approach is in constructing
adaptive-network-based classifiers, where the degree of firing of a rule indicates the degree of membership of the input pattern to the class represented by
the consequent part of the rule in question [152]. Such a neuro-fuzzy classifier
can be seen in Fig. 6-3.

Fig. 6-3. An adaptive neuro-fuzzy classifier (image taken from [152]).
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In this case Layer 1 represents the fuzzification of the inputs and Layer 2 holds
the rule nodes. In Layer 3 the outputs are linearly combined and in the final
Layer the linear sums are passed through sigmoidal activation functions to
compute the degree of membership of the input in each class.
One basic assumption that has been made in the above neuro-fuzzy systems is that the input space has been already partitioned into fuzzy sets and
that the fuzzy rules have all been provided a priori. Wang et al. [155] described
in 1992 a heuristic method for fuzzy rule generation, whereby the input space
of each variable is divided in fuzzy intervals and then input-output pairs are
utilized to determine the fuzzy rules, along with their attributes. Their approach however does not give any recommendation on how to choose the
fuzzy sets in the inputs, while it might also allow a very large number of rules
to be generated.
A conceptually similar approach was given by Abe et al. [156] in 1995.
According to their method, fuzzy rules with variable fuzzy regions are defined
by activation hyperboxes which show the existence region of data for a class
and inhibition hyperboxes which inhibit the existence of data for that class.
Their approach results in trapezoidal membership functions and it produces
fuzzy decision boundaries that yield very accurate performance. However, as
in the previous case, the number of generated rules can grow very high while it
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also assumes that data are clustered in hyperboxes in higher dimensional spaces.
Mitra et al. [157] defined a fuzzy multi-layer perceptron model in 1992.
According to their model, input data are first transformed into 3 basic fuzzy
sets that divide the universe of discourse of every variable. Then the inputs are
propagated through multiple hidden layers that retain their sigmoidal activation functions. As an input pattern may have fuzzy memberships to more than
one cluster (class), the network’s outputs are in terms of fuzzy belonging values, which are then used to create the error vector during training (instead of
crisp, e.g. 0 or 1, classification results). This allows the net to more efficiently
classify data with overlapping class boundaries and to avoid oscillations of the
decision surface when almost identical pattern are clamped to different classes.
They used that model to construct a connectionist expert system, which can
handle linguistic inputs and hedges (very low, kind of high, about, etc). Finally,
the difference between the output of a neuron (class membership value) and
the sum of the outputs of the rest of the neurons is taken as a certainty measure
on that decision.
Another approach presented by Figueiredo et al. [158] in 1999, consists
of a neurofuzzy network that learns in two phases: 1) A self-organizing phase
that lets the input layer neurons to cluster and to perform weight adaptation
(competitive learning) and 2) a second phase which uses a supervised learning
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scheme for rule consequents adaptation. This approach can be considered as
more generic and allows data to cluster more freely than to impose certain
shapes on the membership function, but it also assumes that there is a large
and representative dataset available.
Finally, a similar approach to [158] was published by Juang et al. [159]
in 1998. They proposed an On-Line Self-Constructing Neural Fuzzy Inference
Network (SONFIN), which used a structure learning phase (unsupervised) in
order to determine the partition of the input space, construct the fuzzy rules
and identify the optimal consequent structure. Then using a supervised parameter learning phase, the attributes of the membership functions and the
weights of the rules were fine-tuned.

6.2.2

Adaptive parameter estimation for user-learning
The way we have defined the MFPN shown in Fig. 5-6, shows that the

Prognosis reasoning process has a similar structure to the neuro-fuzzy systems
that were discussed in the previous section. This direct analogy motivates us to
employ in our case some of the parameter estimation techniques that were
mentioned before. However, the main problem that we face here (as it was also
pointed out in section 4.2.4.2) is the lack of a large-scale evidence-base containing a variety of labeled multi-dimensional physiological recordings. As a result, in our case we must concentrate on a more conservative approach, which
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will start off with some expert system structure as the one that we described in
the pervious chapter. Then this network can be continuously improved during
a supervised patient-learning phase in order to fine tune the system’s
attributes. Ideally such a dataset could be collected and then processed offline
in order to determine and label the important physiological changes in the monitored users.
Given a new input vector

the inputs will be first fuzzified (e.g. up-

date the fuzzy values in Layer 2), then they will be propagated to Layer 3
where the smoothed confidence of the symptoms is computed (using also the
momentum terms of the places). Finally the fuzzy symptom truths are used to
fire the production rules that constitute the system’s knowledge base and generate the confidence level of the disorders that are currently considered in the
evidence-base. These values will also be aggregated to generate a value that
indicates the overall healthiness of the user.
In the system’s training phase, the outputs of Layer 4 will be used to
generate the errors that will be propagated back to the network to update its
parameters. As the MFPN’s outputs are in terms of fuzzy values *0,1+ that indicate the degree of confidence that a specific disorder is present, the target values according to which the error will be computed need to be in the same form.
As a result, with each input vector we need a set of output labels describing the
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degree of membership (or better occurrence) of each disorder. These labels can
be chosen from a set like:
{not present, highly unlikely, unlikely, slightly unlikely, somewhat possible,
possible, very possible, probable, very probable, highly probable, certain}
The above linguistic parameters can be mapped to the interval [0,1] in
order to acquire numerical values for computing the network’s errors:

,

(Eq. 6-3)
where

is the output of the ith rule and

is the target value for that rule,

e.g. a linguistic label taken from the set discussed above and mapped to a real
number between 0 and 1.
In order to propagate the error to the input layers and update the value
of an adjustable network parameter z we need to compute:
(Eq. 6-4)
where f is the activation function in the previous layer. Since we need to compute partial derivatives in order to evaluate the updating formula for an
attribute, we can not employ non-differentiable operators such as max and min.
Instead we may use the probabilistic sum and the probabilistic product or alternatively employ sigmoidal activation functions. Without loss of generality we can
consider that the output of a production rule i is computed as:
(Eq. 6-5)
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In this case if we want to update one of the weights wji of the normalized
weighted sum given by f in the fourth layer we have to compute (where we can
omit parameters

and

, since they are equal to 1 in this case and we have

also omitted index k of the kth training input-output pair to avoid confusion):

,

(Eq. 6-6)

where:

(Eq. 6-7)

If we now want to update a weighting parameter wrl involved in the
computation of the confidence of a place pl in layer 3 we have to evaluate the
following partial derivative:

,

(Eq. 6-8)

we denote as

where:

the confidence of place j in layer 4, as

the confidence of

place l in layer 3 and as C the set of places in layer 4 whose confidence is computed by a weighted production rule that has place

(and thus proposition

dl) in its antecedent part.
The first partial derivative in the sum of (Eq. 6-8) has been computed
above as part of (Eq. 6-6). The second derivative is given by:
(Eq. 6-9)
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Also the last partial derivative of (Eq. 6-8) can be computed very easily if we
consider that the fuzzy conjuctions of layer 3 are evaluated with the probabilistic t-norm.
Finally, the weight can be propagated in a similar manner up to the input layer, where the shape parameters of the fuzzy sets that divide the universe
of discourse of the input features can be updated. Again, it would be favorable
to employ continuous functions to describe the fuzzy sets. As a result we can
employ Gaussian, bell-shaped or sigmoidally-shaped membership functions
instead of the trapezoidal functions that we used to describe the fuzzy sets in
section 4.2.1. In Fig. 6-4 and Fig. 6-5, we see fuzzy sets representing the various
levels of systolic blood pressure, whereby in the first case bell –shaped membership functions have been used:
(Eq. 6-10)

while in the second case the membership functions are composed as a difference of two sigmoidal functions, e.g.

, where:

(Eq. 6-11)
(Eq. 6-12)
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Fig. 6-4. Bell-shaped membership functions for the fuzzy sets of systolic blood pressure.

Fig. 6-5. Membership functions using a difference of sigmoidal functions for the fuzzy sets of
systolic blood pressure.

The above process can lead to optimal parameter estimation for the
fuzzy inference mechanism described in the previous chapter. The main challenge here is though to determine the set of production rules that will be employed in order to describe the clusters that are created in the multidimensional input feature space. To do that, expert’s knowledge needs to be
acquired during a patient-learning process, whereby the rules to be included in
the individual knowledge-base should be chosen with respect to the individual’s physiology, pathology and medical history.
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7

CHAPTER 7: USER – DEVICE INTERACTION AND SYSTEM
SIMULATION
As it was stated in the previous two chapters, the process of assessing

the patient’s health status could be significantly enhanced if the user of the
Prognosis wearable platform could interact with the system. The reason behind
this is that a) it would help and hopefully also motivate the user to have an
even more active role in his personal health management and b) most importantly it would provide a greater context for physiological measurements
which would have been otherwise impossible to capture in a remote and unsupervised health-monitoring scenario.
In this chapter we will briefly discuss the interaction mode that is integrated in the Prognosis system, by introducing a well-known speech recognition
platform that we employed in the system design and by providing simple examples of user-device dialogue. Finally we will describe a simulation framework that has been developed to simulate the operation of the Prognosis system
according to the overall operational model of the system described in the current chapter and in chapters 4 and 5.
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7.1

Prototyping the Human-Device Interaction
In order for the wearable system to be capable of capturing important

diagnostic information from the user’s voice recording, the interaction scheme
between the user and the system must be well-defined. In addition to that, we
need to take two more criteria into consideration: Firstly, the fact that the feedback mechanism must not be allowed to grow very high in complexity since it
is either going to be implemented directly on a hardware-constrained mobile
platform, e.g. on a dedicated processing board, or an implementation approach
such as the one adopted by Google search [160] or by other voice recognition
applications for mobile phones such as Vlingo [161], may be taken. In the latter
case, a voice recording is being taken on the mobile device and then that recording is sent via a network connection to a dedicated speech recognition
server, which attempts to identify the uttered phrase and then returns the identified sentence in the form of a string to the mobile application.
Secondly the interaction process must be user-friendly to ensure usability and thus also user acceptance. In order to achieve those goals as well as realtime performance it is necessary for the system to be able to respond to specific
user feedback, e.g. to request more information, to ask the user to repeat something he said, to inform him about an event etc in a well defined manner.
There is a variety of speech recognition software available, most of
which being proprietary. The most important freely available software in this
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field are HTK developed at Cambridge University [162] and Sphinx-4 [163] developed from the CMU Sphinx Group at Carnegie Mellon University in collaboration with Sun Microsystems Laboratories, Mitsubishi Electric Research
Labs and Hewlett Packard. HTK’s source code has been written in C, while
Sphinx-4 has been entirely developed in Java. Both tools are considered to be
state-of-the-art speech recognition software and both of them are based on
Hidden Markov Models (HMMs) for statistical speech recognition. For the prototyping of the Human-Device Interaction (HDI) in the Prognosis wearable system we have used Sphinx-4. The reason for choosing Sphinx-4 over HTK is
simply the fact that Sphinx-4 has been developed in Java and since this is the
language in which the system prototype has been programmed (as it will be
discussed in the next chapter which describes the system’s implementation), it
will be easier to integrate and interface it with the rest of our work.
The first step in defining the interaction scheme between the user and
the system consists of specifying what the vocabulary to be used is going to be.
The vocabulary includes all possible words that the system needs to be able to
understand. Examples of words in the vocabulary could be simple answers like
‚Yes‛ or ‚No‛, a set of nouns or phrases describing the possible symptoms of
the patient like ‚headache‛, ‚malaise‛, ‚chest pain‛ etc and a set of adjectives
to describe the type of a certain symptom like ‚continuous‛, ‚acute‛ etc.

181

Another important step is the matching of the vocabulary words to
their phonetics, e.g. describing how each word is pronounced. Examples of
some of the words in the dictionary are given bellow:
YES
NO
HEADACHE
ACUTE
CHEST PAIN
PERSISTENT
COUGH
DIZZINESS

y eh s
n ow
hh eh d ey k
ah k y uw t
ch eh s t . p ey n
p er s ih s t ah n t
k aa f
d ih z iy n ah s

The next step consists of defining the grammar which specifies the constraints of the expected utterance. Here we have to consider what type of feedback the system should be expecting from the user, e.g. phrases like ‚I feel intense pain on my chest‛ or ‚I am dizzy and weak‛. The more complex the
phrases that the system should be able to recognize, the more complex the
grammar will get.
It should be noted here that in general the performance of speech recognition software in terms of accuracy and speed is strongly dependent on the
size of the employed vocabulary. Furthermore by trying to limit the grammar
to one-word phrases and thus requiring mostly isolated word recognition the
performance of the speech recognizer can be further increased (or not allowed
to deteriorate). In accordance to these guidelines, we had initially decided to
include only one-word phrases in the vocabulary for the HDI in Prognosis. The
reason is that there is a considerable amount of symptoms and symptom de182

scriptions that we need to guarantee that the system will be able to comprehend and also that the interaction should be as fast as possible, while remaining simple and easy to program and utilize. However, we can, without too
much extra computational burden, define a somewhat more complex grammar
that would also allow the recognition of short phrases like the ones mentioned
above.
Sphinx-4 provides a grammar definition language for specifying grammars for phrases like these. The language consists of a set of variable definitions followed by regular expressions that describe the phrases to recognize.
An initial grammar for the Prognosis HDI is given by (where < > denotes a nonterminal symbol and λ is the null variable):
<START> <SENTENCE_START><QUANTIFIER><INTENSITY><FREQUENCY><DURATION>
<SYMPTOM><PROP><LOCATION><PROP><SIDE>;
<SENTENCE_START>  I feel | λ;
<QUANTIFIER>  very | slightly | λ;
<INTENSITY>  weak | medium | strong | λ;
<FREQUENCY>  continuous | intermittent | λ;
<DURATION>  instantaneous | persistent | λ;
<SYMPTOM>  malaise | dizziness | pain | numbness | cough | headache | weakness | stomach ache |
fatigue | nausea | discomfort;
<PROP>  on | over my | on my | λ;
<LOCATION>  arm | leg | torso | head | λ;
<SIDE>  left | right;

After defining the vocabulary and the grammar of the interaction
scheme, an HMM (or a set of HMMs) needs to be trained for every word or
phrase and thus for their corresponding phonemes by using a number of examples for that spoken word or phrase. Training of the HMM refers to the
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process of estimating the parameters of each HMM and thus constructing
acoustic models for words and phrases. In the case of continuous speech recognition each word will be defined as a sequence of phoneme-based HMMs.
Finally to recognize some unknown word or phrase the likelihood of each
model generating that word or in the more complex case the likelihoods of all
the paths in the HMM interconnected network will be calculated and the most
likely model or path will be identified.

7.2

An example of HDI via voice
In this section we present a possible scenario to illustrate the operation

of the Prognosis wearable system and especially the interaction between the
user and the device via the voice module. Consider the case where the user of
the wearable system is an elderly individual with a personal medical history of
signs or tendency towards cardiovascular disease. We can imagine this person
going about his daily activities either in his own home or even at a care center,
while he is wearing the wearable health-monitoring system, for example a
chest belt measuring ECG, body temperature and respiration rate, a wristbased pulse oximeter and a cell-phone placed on his waist with a hands-free or
Bluetooth earpiece.
Now consider the following scenario: The patient starts to feel a slight
discomfort in the chest along with a feeling of malaise. His heart rate may also
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increase and his heartbeats may become more irregular. Furthermore, his respiration effort may also become stronger and quicker and there might be a
slight decrease, perhaps in a longer period of time, of his blood oxygen saturation level. The patient decides he should sit down but does not consider his
condition alarming or hazardous enough to call for help. However the moment
the system detects all the above events, e.g. the raise in the levels of some of the
bio-sensors’ measurements along with a possible arrhythmia, it decides to take
action and initiates a brief dialogue with the user in order to obtain more information about his condition and then to act accordingly. The first thing the
system may ask the user for, is if he needs immediate help or not. Supposing
the user answers no to the previous question, the system may continue to inquire about any other possible symptoms that the patient may be experiencing.
Then the patient mentions the term chest pain. In that case a small series of
chest pain related questions may follow, which can lead to the establishment of
such a health-condition context so that the system may indeed choose to send a
notification to the medical station or to the supervising physician. Eventually
appropriate help and care may be provided on time to the patient in order to
possibly avoid the deterioration of his condition.
The previously described scenario is illustrated in the following in
terms of the events that occur and the actual dialogue that may take place:
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User: <Feels a slight chest discomfort and some of his vitals start to go out of range>
System: Some of your vitals are out of regular range. Do you need immediate help?
User: No
System: Do you have any other symptoms?
User: Yes
System: Please describe your symptoms
User: I have slight chest discomfort.
System: <the system does not acknowledge the user’s phrase>
Please state your symptom again in a brief manner
User: chest pain
System: <Recognizes the symptom>
Is the symptom intermittent or continuous?
User: continuous
System: Is the symptom instantaneous or persistent?
User: persistent
System: Is the pain radiating to your arms?
User: Yes
System: Is the pain aggravated by movement or breathing?
User: No
System: Are you experiencing any other symptoms, such as hemoptysis or sputum?
User: No
System: Describe your pain level on a scale from one until ten
User: five
System: <decides that according to the user’s answers and his recent vital signs the user
could be in an alarming health condition>
< notifies the medical center by sending an alarm message via GPRS>
I have notified the medical center about your current condition
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As the above example illustrates, the interaction between the system
and the user can either be invoked by the user himself or by the system, in case
specific changes are noticed in the user’s physiology. This can be done by basically constructing a decision tree like structure, where according to the irregularity detected by the system and the user’s previous responses and medical
history, appropriate questions may be invoked to get additional important
feedback from the user about his symptoms. Such a process is shown in Fig. 7-1
in the form of a Petri Net, where the system evaluates the answers and other
preconditions to decide on posing a certain set of questions.

Fig. 7-1. HDI interaction initiated by the system.
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7.3

Simulation Framework
In this section we will describe the simulation framework we have de-

veloped according to the SPN and FPN-based models of the WHMS, which
were presented in chapters 4 and 5. The purpose of the derived simulation is to
illustrate the feasibility as well as the actual operation of the Prognosis WHMS.
In addition to that it can be used to study the dependencies between the various components of the system and to highlight the synchronization and concurrency issues that arise in such a system design. The presented framework
has been implemented in Java, since the Java programming language can facilitate a modular and hierarchical design approach, in correspondence to the SPN
model. Furthermore Java provides the required synchronization and concurrency primitives for simulating the various tasks that can be present in a
WHMS model as explained below.
As we have seen so far, a wearable health-monitoring system may
comprise a variety of bio-sensors. In the WHMS simulator, the types of sensors
that can be selected to be included in the system’s simulation include an ECG
monitor, a thermometer, a blood pressure monitor, a respiration rate sensor, a
pulse oximeter and a speech recognizer/synthesizer module to capture additional feedback from the user in terms of verbally-described symptoms. In the
initial simulator’s design we have assumed that the ECG monitor includes an
automated classifier, thus its output is comprised of per beat classification re188

sults along with the raw ECG data. Such a classifier can be implemented via a
light-weight and computationally-inexpensive algorithm for ECG classification, like the one discussed in Chapter 3.
Under the previous assumption, the collection of physiological measurements in the central node as it was depicted in Fig. 4-15 can take place according to two different disciplines:
 The central node (e.g. the main thread or the main processing unit) is responsible for polling the distributed biosensors (or the ring buffers dedicated to each type of signal) for data in a round-robin manner and at a constant rate and therefore it enforces explicit synchronization in the way the
data are collected.
 Dedicated threads (or even dedicated hardware) are assigned for collecting
the measurements from each sensor and for asynchronously signaling the
event of new data being collected to the main monitoring thread or process
(or to the main processing unit). The main process is synchronized with the
event of ‚data arrival‛ and wakes up after a complete cycle of data collection to process the new set or the new vector of measurements according to
the Prognosis language data fusion scheme.
The former is a more centralized and thus a more straightforward and
rather simplified approach to data collection, as there is an explicit synchronous manner of data gathering: the central node continuously and iteratively
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addresses each sensor in a round robin fashion and either collects data from the
sensor’s buffer or requests that an instant physiological measurement is performed.
The latter case is a quasi-asynchronous distributed approach to data
collection and therefore it is more complex and more general than the former
one. For every type of bio-signal to be monitored, there is a dedicated process
responsible for collecting the data, pre-processing it and passing it over to the
main monitoring process. Such a process can be thought of as either a thread or
a dedicated hardware module, which signals (interrupts) the main process
when new data are available. However, even in this case there is implicit synchronization in the main process, as we are assuming that the distributed
processes have been programmed to collect data at a regular rate. Finally, the
main process is awoken upon a ‚new data collected‛ event (or upon completion of a new cycle of data collection from each sensor) and it immediately
starts fusing the data according to the Prognosis scheme, in order to derive an
estimation of the user’s health condition.
In the current implementation of the WHMS simulator all the biosensors (or bio-signals) are represented by individual classes – threads, which
constantly generate new data in a semi-random manner and deposit them in
dedicated ring buffers. It is up to the main process to read new data in the buffers before they get overwritten, but this issue is dealt with in this case by ex190

plicitly defining identical data delivery rates for all types of sensors. Furthermore signal samples are not generated in a totally random way, but in a rather
biased manner based on previous data and also based on recent values of other
bio-signals, e.g. low oxygen saturation is more possible to coincide with high
respiration rate etc. For example, heart rate values will be generated according
to a normal distribution where the initial mean is set as a generally normal
heart value, e.g. 65 BPM. The subsequent heart rate value will be generated
from a Gaussian distribution as well, however this time the mean of the normal
distribution from which the new value will be generated is the previous heart
rate value. That way simulated bio-signals will have a smoother time graph
and thus they will be more realistic. Furthermore, the values of other signals’
previous values will control the standard deviation of the signal generator, e.g.
‚extreme‛ or ‚unstable‛ values in other signals should increase the ‚instability‛ of the current signal as well, which means increasing the standard deviation of the corresponding bio-signal and therefore allowing it to possibly take
more extreme values as well.
Regarding ECG data, in the WHMS simulator they are not being generated randomly but they are rather taken from real ECG recordings. Namely,
the simulator upon start-up will let the user choose among the 48 available
ECG recordings in the widely studied MIT-BIH Arrhythmia Database [99].
These ECG recordings have been annotated on a beat-by-beat basis by profes191

sional physicians, which have also provided annotations regarding the heart
rhythm, e.g. normal, sinus bradycardia, atrial fibrillation, ventricular bigeminy
etc. These annotations have been directly employed in the WHMS simulator as
an automated ECG classifier, providing concrete heartbeat and heart rhythm
classifications.
In Fig. 7-2 the start-up menu of the WHMS simulator is shown. As explained before, the user can choose one of the available ECG recordings in the
MIT-BIH Database to be included in the simulation. Furthermore, the type of
sensors that will compose the system to be simulated can be chosen at the same
set-up screen. Finally, the size of the simulation step can be manually selected,
where 1 sec corresponds to normal or real-time operation (e.g. sensors readings
are collected every 1 second).

Fig. 7-2. WHMS Simulator start-up screen
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Slower (or even faster) simulation steps may also be chosen in order to study
more closely the simulator’s operation and results.
Coming back to the simulator’s actual operation, once a new measurement is acquired, it will first be checked for validity. In the case that there is a
redundant number of sensors used to monitor each bio-signal, erroneous values can be relatively easy detected by considering the correlation of the measured data between sensors of the same type. However the fact that a single sensor is employed for each bio-signal makes this task very challenging. A simple
approach to this issue is to make use of a linear predictor for each type of signal
and then calculate the difference between the predicted value and the actual
value that was measured by the sensor. Then if that difference is found to be
greater than a predefined threshold the corresponding measurement can be
considered erroneous. The drawback of this method is that it requires calibration for each sensor in order to estimate the predictor’s order and parameters
as well as the threshold value to be used.
After validating each acquired measurement (or even pattern), the physiological data are fuzzified according to the fuzzy sets defined in section 4.2.1.
Then these fuzzy certainty values are used to compute the outputs of layers 3
and 4 in the FPN network shown in Fig. 5-6.
The system re-evaluates the condition of the user at any given time that
any new ‚pathological‛ or slightly abnormal signal state is detected. According
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to the estimated health-threat level, it may choose to either alert the user or to
request further information from him/her or even to send an alarm message to
a remote medical center or to the supervising physician’s cell-phone.
In Fig. 7-3 the main screen of the WHMS simulator is depicted.

Fig. 7-3. The main screen of the WHMS simulator.

The ECG plot displays real-time ECG data along with a per-beat classification. In addition to that, there is a plot for every one of the rest of the recorded bio-signals, where the signal’s trend and its instantaneous value is being depicted. Furthermore, there is a text box where any possible extracted
health symptoms are printed out, for example tachycardia or hypotension or
fever etc. An alarm-detection box is used to print out any recognized health
conditions, such as hypothermia or left ventricular failure for example,
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represented in the local signal database in terms of specific symptom strings or
words. A health-threat-level display bar is used, which illustrates the risk level
of the user’s health as perceived by the wearable system and which is based on
the computation of the fuzzy certainty of the single node in layer 5 of the FPN
shown in Fig. 5-6. Finally a pop-up dialogue frame appears (at the bottom of
the screen) whenever there is a user-device interaction initiated. This pop-up
frame displays the dialogue that takes place between the hypothetical user and
the system’s simulator.
Finally we should that the described WHMS framework simulates the
ideal operation and performance of an actual system prototype since:
The system is capable of performing accurate physiological sensing and
robust on-site signal processing & feature extraction/pattern recognition.
Outlier detection is carried out successfully in the measured data.
There is coherent speech recognition and user-device interaction.
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8

CHAPTER 8: SYSTEM IMPLEMENTATION
In this chapter we will provide a detailed description of the implemen-

tation of the prototype platform of the Prognosis WHMS. As it was shown in
the survey presented in Chapter 2, there are various approaches towards realizing a wearable health-monitoring system: utilizing motes (e.g. tiny wireless
sensor nodes), realizing a system based on a custom microcontroller board
with wired on-body sensors, employing textile sensors for a garment-based
system design and finally making use of off-the-shelf wireless sensors and
PDAs or smart-phones as system central nodes. Hybrid designs are also possible, whereby two or more system design approaches are merged. The approach
that has been adopted in our research to implement the Prognosis prototype is
to make use of off-the-shelf wireless-enabled bio-sensors and a state-of-the-art
smart-phone as the central node. The reasoning behind this choice is that a) it is
not the goal of the current research to develop application-specific hardware,
e.g. new wearable sensor technologies, b) wearable wirelessly-enabled biosensors constitute the current state-of-the-art in unobtrusive physiological
monitoring solutions, c) smart-phones and PDAs comprise a new wave of
portable computing devices, that are constantly becoming more powerful and
diverse and that will undoubtedly play a significant role in our future everyday life. As a result it is of particular importance to be able to realize intelligent
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and interactive health-monitoring capabilities with pervasive hardware technologies.

8.1

The WHMS’ Hardware Components
The components of the Prognosis WHMS prototype are depicted in Fig.

8-1.

Fig. 8-1. The Prognosis WHMS prototype
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The system is built around the BlackBerry Bold 9000 PDA/smart-phone
[164] developed by RIM [165], which has been chosen due to its following
properties:
Powerful processing capabilities (624 MHz processor) for a cell-phone.
J2ME (Connected Limited Device Configuration - CLDC 1.1 and Mobile
Information Device Profile - MIDP 2.0 APIs) and multi-threading/multiprogramming support.
The BlackBerry® Java Development Environment contains a plug-in for
EclipseTM to develop, debug and test BlackBerry device applications from
within the Eclipse Integrated Development Environment (IDE) [166].
Support for standard JAVA APIs, like the JAVA API for Bluetooth®.
Support for multiple simultaneous Bluetooth connections (maximum 5),
thus allowing the formation of Bluetooth PANs (Personal Area Networks)
or piconets.
3G (HSDPA) and WLAN (802.11a/b/g) support.
Table 8-1 provides a list of the most important hardware and networking specifications of the Blackberry Bold 9000.
The set of Bluetooth-enabled bio-sensors that have been currently employed in the WHMS prototype include the Bioharness BT chest belt by ZephyrTM [81], the 4100 Digital Pulse Oximeter by Nonin Medical [66] and a Blood
Pressure monitor from A&D Medical [167].
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Table 8-1. Hardware Specs of Blackberry Bold 9000

CPU
Memory
Weight
Operating
tem
Wireless
works
Wi-Fi
Bluetooth
Battery
GPS

Intel Xscale 624MHz processor
128MB RAM (Flash) & 1GB storage
133g
Sys- BlackBerry OS (proprietary software platform), supports
multi-programming
Net- GSM, GPRS, UMTS, EDGE, HSDPA
802.11a/b/g enabled
Bluetooth® v2.0, Serial Port Profile and support for up to 5
simultaneous RFCOMM connections (PAN)
1500mAhr Lithium battery, 13.5 days standby time
Built-in GPS

The Bioharness BT, which can be seen on the bottom left in Fig. 8-1, is a
physiological monitoring fabric-based chest-belt device capable of measuring
ECG, heart rate, respiration rate, skin temperature, activity and posture. The
communication protocol of the device is protected by a confidentiality agreement and cannot be elaborated upon here. However, the following specs can be
given:
The Bioharness BT can continuously stream data over a single Serial Port
Profile (SPP) connection (10m range) to a Bluetooth-enabled device.
The device is capable of periodically transmitting real-time ECG data,
which are sampled at 250Hz and digitized with 10bit resolution (it uses
dry-contact skin electrodes).
It is also capable of periodically transmitting heart rate, respiration rate,
skin temperature, activity level and posture measurements.
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The wireless pulse oximeter from Nonin® is a wrist-worn device (as it
can be seen on the bottom right in Fig. 8-1), which uses an infrared-lightemitting finger clip sensor to capture the photoplethysmograph (PPG) signal,
which captures the changes in blood volume. The pulse oximeter can transmit
the raw PPG signal or periodically derived values of oxygen saturation and
heart rate over a single SPP connection, with 10 meters maximum range.
The Bluetooth-enabled blood pressure monitor from A&D Medical, includes a base-device and a blood-pressure cuff which is placed around the user’s arm to take a measurement. When new data have been acquired by the device, it automatically sends them to any Bluetooth paired device. The data that
are communicated are the systolic and diastolic blood pressure levels as well as
the pulse rate. The main difference of this sensor with the previous two, is that
in this case a measurement needs to be initiated manually by the user and that
the device cannot be worn continuously.
Finally as it can be seen in Fig. 8-1, a Bluetooth headset is depicted to
represent the voice-interaction that is possible in the system. Future research
could investigate the feasibility of simultaneously incorporating a Bluetooth
headset for capturing voice feedback. However, in this case the effect of the
A2DP connection for the headset on the operation of the PAN should be carefully examined and evaluated.
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8.2

Implementation Walkthrough
The operation of the WHMS prototype with the previously described

hardware components is based on the formation of a Body Area Network
(BAN). In the context of Bluetooth this is referred to as a piconet or more generally as a Personal Area Network (PAN). In the simplest case, there are two
devices in the piconet, e.g. there exists a single point-to-point communication
link. The device that initiates the connection is called the master and all other
devices in the piconet are referred to as slaves. All devices that are part of the
same piconet share the same physical radio channel in that they are all synchronized to a common clock and a certain frequency hopping pattern, which
is derived from the master’s clock and the master’s Bluetooth device address.
The Bluetooth® specification permits up to seven slaves to be active in a
piconet. This constitutes a communication topology referred to as point-tomultipoint, as there is a physical link between each slave and the master. In this
formation the PAN’s master (e.g. the BlackBerry smart-phone) assigns dedicated time
slots to the peripherals and data are received in a protocol-inherent round-robin
manner, although it has been shown that are more efficient intra-piconet scheduling algorithms [168]. The type of Bluetooth connections between the BAN’s
master and the slaves are Serial Port Profile (SPP) connections that utilize the
Radio Frequency Communication (RFCOMM) protocol to emulate RS-232 serial ports.
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The J2ME software architecture of the currently implemented WHMS
prototype on the BlackBerry Bold platform can be seen in Fig. 8-2. All user actions in the Prognosis App are made available through a single Screen, in order
to avoid pushing more screens onto the stack (and thus increasing memory requirements) and in order to keep the application as simple and easy to use as
possible. The ‚Menu Button‛ of the BlackBerry device makes the following 4
actions available to the user: a) initiate a client socket connection to a remote
network server, b) initiate a connection to the Bioharness BT, c) initiate a connection to the Pulse Oximeter, d) exit the application.
By selecting b) or c), the application will try to locate an already paired
Bioharness BT (or Nonin Pulse Oximeter). If such a pairing is found, then the
application attempts to establish a socket connection to the corresponding Bluetooth-enabled bio-sensor with the appropriate protocol specification (SPP in
this case). After successfully establishing a connection, listener objects for handling input and output data are created and then the appropriate handshaking,
for setting up the operational mode of the sensor, is performed. Once the previous processes are completed, a new thread is created which is responsible for
monitoring the corresponding serial port connection.
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Fig. 8-2. J2ME Software Architecture of the Prognosis prototype.
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As it can be seen in Fig. 8-2, a SPP monitoring thread constantly waits
and receives a data packet from the sensor, then it un-marshals (de-serializes)
the received packet, it verifies the received physiological measurements (currently this is done just by checking the corresponding sensor’s status flags), it
performs appropriate pre-processing (in the case of ECG data, the R peaks are
detected by implementing in Java the algorithm developed by Patrick Hamilton and which can be accessed at [169]) and finally it delivers the data to the
Main Screen thread. Following that, the new data are saved in dedicated ring
buffers and then they are plotted on the screen. Fig. 8-3 shows two screenshots
of real-time data displayed on the smart-phone.
There is also a thread that listens continuously for incoming data from
the A&D BP monitor, since the BP monitor acts as a master device in the Bluetooth communication. Whenever new data are received, the listening thread
delivers them to the main thread.
Moreover, one of the side-buttons of the BlackBerry smartphone is utilized to initiate a thread which will take a voice recording from the user. When
the user releases the button, the thread handles the recorded data to the main
thread (and then it terminates) which will immediately send them via Wi-Fi to
the remote workstation for speech recognition. After the speech data have been
recognized, the result is sent back to the phone as a simple string.
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Fig. 8-3. a) Real-time data display. b) real-time ECG plot.

After receiving and plotting the data the main thread will deliver the
new measurements to the Data Fusion thread, which is responsible for parsing
the derived Prognosis string and for returning an estimation of the user’s health
condition to the main thread. Upon detection of an alarming health condition,
the main thread will communicate the alarm via the Wi-Fi socket connection to
the remote server.
Finally, in the current prototype we have realized an ‚intensive‛
physiological data monitoring mode, whereby all the physiological measurements captured from the WHMS are transmitted to the remote server for realtime data inspection. In this scenario, the server application (running on a conventional laptop computer) continuously receives data packets from the BlackBerry device and plots them on the computer’s screen for inspection. A GUI of
this application can be seen in Fig. 8-4. In this screen we can also see a window
displaying the current status of the Wi-Fi connection, trend graphs for all
measured bio-signals (as well as for the RR derived parameter) and finally also
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an indication of packets being lost in the Bluetooth BAN and over the Wi-Fi
socket connection.

Fig. 8-4. The GUI of the remote medical server.
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9

9.1

CHAPTER 9: CONCLUSIONS AND RESEARCH
CONTRIBUTIONS
A wearable system prototype for health monitoring
This dissertation work describes research related to the design of an in-

telligent, self-adaptive and interactive wearable system for health monitoring
of people at risk. To provide a deeper insight into the current state-of-the art of
WHMS, a comprehensive survey on corresponding research prototypes and
commercial products was carried out. This helped us identify the shortcomings
of the current technology, but also to define new capabilities that could be integrated in WHMS to improve their overall functionality and also the users’
quality of life.
The developed prototype platform utilizes cheap off-the-shelf components and constitutes a novel paradigm of how multiple Bluetooth-enabled biosensors can be utilized for ubiquitous health monitoring applications. The developed interfaces on both the smart-phone and the remote workstation allow
the user of the WHMS and the person supervising the patient to have a complete picture of the user’s health and to have instant access to real-time and
past physiological data.
The following full-paper refereed publications support the new scientific contributions of the Prognosis prototype:
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Journals
Pantelopoulos, N. Bourbakis, ‚A Survey on Wearable Sensor-based Systems for Health Monitoring and Prognosis‛, IEEE Trans. on Systems, Man
and Cybernetics-Part C: Applications and Reviews, Vol. 40, pp. 1-12, Jan. 2010.
A. Pantelopoulos, N. Bourbakis, ‚Prognosis - A Wearable Health Monitoring System for People at Risk: Methodology and Modeling ‚, IEEE Trans. on
Inf. Tech. in Biomedicine, Vol. 14, pp. 613-621, May 2010.

Conferences
Pantelopoulos, N. Bourbakis, ‚Efficient single-lead ECG Beat Classification
using Matching Pursuit based Features and Artificial Neural Network‛,
(accepted for presentation in) 10th Intl. Conf. on Inf. Tech. and Appl. in Biomed., Corfu, Greece, Nov. 2010.
A. Pantelopoulos, N. Bourbakis, ‚A Wearable Platform with off-the-shelf
Components for Quality Analysis of Physiological Data‛, (accepted for
presentation in) Bodynets Conf., Corfu, Greece, Sept. 2010.
A. Pantelopoulos, N. Bourbakis, ‚A Health Prognosis Wearable System
with Learning Capabilities using NNs‛, in Proc. 21st Intl. IEEE ICTAI, 2009,
pp. 243-247.
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A. Pantelopoulos, N. Bourbakis, ‚SPN-model based Simulation of a Wearable Health-Monitoring System‛, in Proc. 31st Ann. Intl. IEEE EMBC, 2009,
pp. 320-323.
A. Pantelopoulos, N. Bourbakis, ‚A Formal Language Approach for MultiSensor Wearable Health-Monitoring Systems‛, in Proc. 8th Intl. IEEE BIBE,
2008, pp. 1-7.
A. Pantelopoulos, N. Bourbakis, ‚A Survey On Wearable Biosensor Systems for Health Monitoring‛, in Proc. 30th Ann. Intl. IEEE EMBC, 2008, pp.
4887-4890.

Book Chapters
Pantelopoulos, N. Bourbakis, ‚Design of the new Prognosis Wearable System-Prototype for Health-Monitoring of People at Risk‛, Book Chapter in
Advances in Biomedical Sensing, Measurements, Instrumentation and Systems,
Springer, Jan. 2010.

9.2

Research contributions
The new research contributions can be synopsized in the following

points:
Investigation of efficient methods for denoising of the ECG signal was carried out, whereby unusable segments are detected by examining the energy
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of the various wavelet scales of the DWT transformed signal. Retained signal portions are denoised via the undecimated wavelet packet transform
which is utilized for the first time for ECG denoising and yielded promising results in the presence of white and pink noise.
A novel and efficient methodology for ECG beat classification was proposed. It utilizes features obtained by projecting the ECG templates on selected wavelet packet atoms. Extensive analysis was carried out to indentify the optimum decomposition structure, by examining the effect of the
wavelet type utilized, the number of samples used and the number of
atoms chosen on the accuracy of the classification. The developed method
is both simple and fast and yields comparable performance to other more
complex classifiers.
A novel model based on a fuzzy regular formal language was defined,
which describes the current state of health of the WHMS user. It considers
symptom ambiguity and causal relationships between various disorders
and symptoms to derive a thorough estimation with a certain degree of
confidence. This approach was inspired by pioneering medical expert systems (MYCIN and CADIAG-2), from which it borrowed some of its concepts and fused them together to yield a new representation. It is hoped
that such a solution can lead to early detection and hopefully also to pre-
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vention of health episodes by carefully following, capturing and describing
the health trends recorded from physiological and contextual sensors.
An extension of the decision making methodology based on a modified
Fuzzy Petri Net (FPN) model was presented, which considers additional
concepts such as obligatory and proving symptoms, in its reasoning
process. The developed model has the form of a feed-forward fuzzy Petri
Net that propagates the beliefs of symptoms to yield the confidence of the
disorders described by the rule base. Finally all fuzzy membership values
of the last layer of the network are combined together to estimate the overall healthiness of the user and produce an index of his health deterioration,
which can be considered as an index of health stability and which can also
be utilized to trigger alarms.
A user-learning strategy based on a neural-fuzzy extension of the FPN was
presented. Neuro-fuzzy networks were studied and a novel approach inspired by this domain was integrated with the Prognosis reasoning model
in order to derive optimal parameter estimation and thus provide individualized health decision support.
A system-patient dialogue interaction was defined in order to capture nonmeasurable patient symptoms such as chest pain, dizziness, malaise etc.
This is done for the first time in the context of wearable health monitoring
systems and allows out prototype to acquire feedback from the user which
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is not observable via physiological sensor readings. This information can
greatly enhance the embedded decision ability of the system and provides a
more comprehensive user health status evaluation.
A system prototype was developed which is based on a smart-phone that
runs multi-threaded J2ME software for handling multiple simultaneous
Bluetooth connections with off-the-shelf wireless bio-sensors. Although
there have been several examples in the research community that leverage
cell-phones and wireless sensors, the developed platform utilizes multithreaded code ssin order to communicate with a variety of bio-sensing devices, process their results, acquire voice-feedback from the user and communicate raw and fused information to a remote location.

9.3

Future Research
Although this research tried to address several issues that have to do

with deploying a wearable system prototype, our focus was mainly on two
broad subjects: a) ECG signal processing employing portable devices in an unsupervised scenario and b) designing an overall framework for enabling personalized decision support and interaction with the system’s user. As with any
engineering project there are several areas on which the proposed prototype
could be improved.
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One major point is ECG denoising and feature extraction. ECG denoising needs to consider several types of noise and is generally a very challenging
research problem. [100]. Adaptive models can be employed to estimate optimum filters to remove artefact noise from the signal. Other physiological parameters can be used as reference signals. Additionally, the possibility of accurately detecting wave boundaries of an ECG signal being recorded on a portable device can be explored. Although the proposed ECG classification methodology proved very accurate, there is a need for quantification of some important wave attributes (such as QT duration and ST elevation), which might be
proven particularly important in the decision making process.
Additionally, the knowledge base of diseases/disorders that system
takes into consideration when trying to estimate the user’s health condition can
be expanded with more rules and questionnaires can be utilized to acquire
more detailed expert knowledge. In addition to that, a study to identify important parameters (mean, max, min, variance, derivatives etc) to improve the performance of health status classification and trend evaluation/healthy history
database creation can be performed.
Finally a large scale of multi-dimensional data can be captured from a
variety of patients, which can then be later used to define comprehensive statistical models that are capable of detecting even the slightest physiological
changes or health trends that might be an indication of future health deteriora213

tion. Such an approach was adopted by Tatassenko et al. [170] which resulted
in the BioSignTM system, which fuses five vital signs in real-time to identify patient ‚departure from normality‛.
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